Ipond2: The Next Generation The Development And Application Of Improved Methods For Assessment Of Replisome Protein Dynamics by Rivard, Rebecca
University of Pennsylvania
ScholarlyCommons
Publicly Accessible Penn Dissertations
2017
Ipond2: The Next Generation The Development
And Application Of Improved Methods For
Assessment Of Replisome Protein Dynamics
Rebecca Rivard
University of Pennsylvania, rsrivard5@gmail.com
Follow this and additional works at: https://repository.upenn.edu/edissertations
Part of the Cell Biology Commons, and the Molecular Biology Commons
This paper is posted at ScholarlyCommons. https://repository.upenn.edu/edissertations/2552
For more information, please contact repository@pobox.upenn.edu.
Recommended Citation
Rivard, Rebecca, "Ipond2: The Next Generation The Development And Application Of Improved Methods For Assessment Of
Replisome Protein Dynamics" (2017). Publicly Accessible Penn Dissertations. 2552.
https://repository.upenn.edu/edissertations/2552
Ipond2: The Next Generation The Development And Application Of
Improved Methods For Assessment Of Replisome Protein Dynamics
Abstract
Faithful replication of the genome during cell division is essential for the avoidance of disease-promoting
mutations. Until recently, accurate quantification of replication factor alterations in response to cellular stress
primarily relied on low sensitivity assays such as cell staining and nuclear extraction assays. In the past few
years, the Cortez, Groth, and Santocanale laboratories have developed procedures to retrieve and analyze
proteins associated with actively replicating DNA (iPOND, NCC, and Dm-Chp, respectively). Herein, we
report improvements to iPOND that increase protein yield and quantitative sensitivity, as well as permit
better statistical evaluation of candidate factors (iPOND2). These improvements were achieved by
employment of sucrose based density gradient fractionation of samples prior to EdU-biotin retrievals. The use
of iPOND2 increased the dynamic range of protein quantification by Mass Spec by more than 40-fold
compared to recent iPOND. We investigated the replisome component response to stress and assessed the
role of p97-mediated degradation in protein turnover at the fork with or without cell cycle checkpoint protein,
ATR. Furthermore, increased replisome component yields permitted the detection of ubiquitylated peptides
without secondary affinity-based retrievals. Due to the increased yield of iPOND2 we were able to combine
iPOND2 with other purification methods such as K-ɛ-GG IP to gain further utility from the addition of
sucrose fractionation to iPOND. For example, we have further improved our ability to analyze ubiquitin sites
on the replisome in a high-throughput way and potentially developed a method capable of assessing
terminated fork or origin composition across a variety of treatment conditions. In summary, iPOND2 exhibits
greatly improved replisome retrieval specificity, yield, quantitative dynamic range, and statistical power to
detect changes in replication-associated factors in response to stress conditions. iPOND2 can be used alone,
in conjunction with a variety of MS analytical methods, and combined with secondary affinity purifications to
improve our understanding of replisome dynamics following stress.
Degree Type
Dissertation
Degree Name
Doctor of Philosophy (PhD)
Graduate Group
Cell & Molecular Biology
First Advisor
Eric Brown
Second Advisor
Brad Johnson
This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/2552
Keywords
ATR, iPOND, Replication, Replisome
Subject Categories
Cell Biology | Molecular Biology
This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/2552
iPOND2: THE NEXT GENERATION 
 
THE DEVELOPMENT AND APPLICATION OF IMPROVED METHODS FOR 
ASSESSMENT OF REPLISOME PROTEIN DYNAMICS 
Rebecca S. Rivard 
 
A DISSERTATION 
In  
Cell and Molecular Biology 
Presented to the Faculties of the University of Pennsylvania 
In 
Partial Fulfillment of the Requirements for the 
Degree of Doctor of Philosophy 
2017 
 
Supervisor of Dissertation 
_______________________ 
Eric J. Brown, Ph.D. 
Associate Professor of Cancer Biology  
 
Graduate Group Chairperson 
________________________ 
Daniel S. Kessler, Ph.D. 
Associate Professor of Cell and Developmental Biology  
 
Dissertation Committee  
Brad Johnson, MD, Ph.D., Associate Professor of Pathology and Laboratory Medicine  
Luca Busino, Ph.D., Assistant Professor of Cancer Biology  
Benjamin Garcia, Ph.D., Presidential Professor of Biochemistry and Biophysics and 
Epigenetics 
Paul Lieberman, Ph.D., Wistar Institute Professor of Microbiology  
ii 
 
DEDICATION PAGE 
 
This thesis is dedicated to the souls of all the graduate students that were lost in the pursuit 
of knowledge.  
And to my family and husband who were essential in saving me from becoming one of 
them. To them I will be eternally grateful.  
  
iii 
 
ACKNOWLEDGEMENTS 
 
Kasia Kulej, Anja Bielinsky, Ya-chu Change, and Yee-mon Thu: Thank you for teaching 
me about MS and bioinformatics.  
Brad Johnson, Ben Garcia, Luca Busino, and Paul Lieberman: Thank you for all of your 
support and feedback. 
Eric Brown, Ryan Ragland, Sara Small, Sima Patel, Jessica Tang, David Shang, Laura 
Murillo, Yu-Chen Tsai, Nishita Shastri: Thank you for your input on my projects, help with 
the eternal edits and revisions of my paper, and support.  
Lydia Mitchleson, Amanda Limas, Miles Abidila, Aseem Mulji: Thank you so much for 
helping to cheer me up when I needed it.  
Lizzie Bouton, Jaci Rifkin, and Mymy Simckes: You are some of my oldest friends who 
have helped me gained a lot of the strength required to complete this program and helped 
motivate me when I did not feel that I could to it on my own.  
Moose: Thank you for all of the cuddles and some much needed judgement. 
Robin Rivard, Mike Rivard, Bill Miles, Pat Smiley, Emma Rivard, and Abby Rivard: Thank 
you for being a wonderful and supportive family all the way through this process, and 
always lending a helping hand when I needed one.  
Theonie Anastassiadis: Thank you so much for being my bay mate and work wife. I could 
not have made it through the last few years without you as a constant source of help, 
smiles, support, and advice. I loved getting to travel the world with you and am so grateful 
that I have had you with me throughout this experience. You gave me a reason to come 
into work and I will miss getting to see you every day. No matter where we go in the future 
the Ebola Babes will always live on in our hearts.  
Tim Miles: Thank you for being the best husband ever. Thank you for always knowing 
what to say to cheer me up and loving and supporting me unconditionally. No matter how 
bad things got you were always there to help pick me back up again. Thank you for forcing 
me to take breaks when I need them and taking care of me. I love you so much and cannot 
thank you enough for everything that you have done for me, nor express in words what 
you truly mean to me. Thank you for being my everything. 
  
iv 
 
ABSTRACT 
 
iPOND2: THE NEXT GENERATION 
THE DEVELOPMENT AND APPLICATION OF IMPROVED METHODS FOR 
ASSESSMENT OF REPLISOME PROTEIN DYNAMICS 
 
Rebecca S. Rivard 
Eric J. Brown 
 
Faithful replication of the genome during cell division is essential for the avoidance of 
disease-promoting mutations. Until recently, accurate quantification of replication factor 
alterations in response to cellular stress primarily relied on low sensitivity assays such as 
cell staining and nuclear extraction assays. In the past few years, the Cortez, Groth, and 
Santocanale laboratories have developed procedures to retrieve and analyze proteins 
associated with actively replicating DNA (iPOND, NCC, and Dm-Chp, respectively). 
Herein, we report improvements to iPOND that increase protein yield and quantitative 
sensitivity, as well as permit better statistical evaluation of candidate factors (iPOND2). 
These improvements were achieved by employment of sucrose based density gradient 
fractionation of samples prior to EdU-biotin retrievals. The use of iPOND2 increased the 
dynamic range of protein quantification by Mass Spec by more than 40-fold compared to 
recent iPOND. We investigated the replisome component response to stress and 
assessed the role of p97-mediated degradation in protein turnover at the fork with or 
without cell cycle checkpoint protein, ATR. Furthermore, increased replisome component 
yields permitted the detection of ubiquitylated peptides without secondary affinity-based 
retrievals. Due to the increased yield of iPOND2 we were able to combine iPOND2 with 
other purification methods such as K-ɛ-GG IP to gain further utility from the addition of 
sucrose fractionation to iPOND. For example, we have further improved our ability to 
analyze ubiquitin sites on the replisome in a high-throughput way and potentially 
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developed a method capable of assessing terminated fork or origin composition across a 
variety of treatment conditions. In summary, iPOND2 exhibits greatly improved replisome 
retrieval specificity, yield, quantitative dynamic range, and statistical power to detect 
changes in replication-associated factors in response to stress conditions. iPOND2 can 
be used alone, in conjunction with a variety of MS analytical methods, and combined with 
secondary affinity purifications to improve our understanding of replisome dynamics 
following stress.  
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Chapter 1: 
Introduction: An overview of the current knowledge regarding DNA replication and 
repair 
 
R.S. Rivard1 
 
1Abramson Family Cancer Research Institute, Department of Cancer Biology, Perelman 
School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA 
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Introduction  
Faithful DNA replication is an evolutionarily conserved requirement for life and 
successful reproduction. While a certain amount of genetic variation is beneficial at a 
species level, accumulation of mutations in an individual due to inaccurate replication often 
leads to disease progression and death. Recent data suggests that the rate of 
spontaneous mutations per base pair per cell cycle is as high as 10-9- 10-10 (Mertz, Harcy, 
& Roberts, 2017; Saini et al., 2016). Thus, it is imperative that cells are able to identify and 
repair DNA damage as quickly as possible. Despite the danger of mutations, certain cell 
types and cellular processes, such as immune cells and meiosis, encourage 
recombination and potential mutation of genetic material in order to increase the diversity 
of life and defend against disease. Cells must carefully balance mutation and repair to 
prevent accumulation of damage that can lead to disease. Consistent with the importance 
of accurate DNA replication, cells have developed many checkpoints to ensure that 
replication and cell division do not proceed in heavily damaged cells. If defects in the ability 
of the cell to monitor and address impediments to faithful replication result in the 
accumulation of damage, a cell cycle checkpoint is activated preventing progression of 
replication until the damage is repaired. Failures in checkpoint response allows damaged 
cells to continue to replicate, often leading to diseases such as cancer. Interestingly, 
recent studies have shown that preventing checkpoint response in conjunction with high 
levels of DNA damage results in cell death. De-regulation of the cell cycle following high 
levels of cellular damage has begun to be used in the development of multiple cancer 
treatment drugs including ATR and CHK1 inhibitors (Min et al., 2017). The dynamic 
interplay between DNA damage, repair, and checkpoint activation is carefully regulated 
by the cell to prevent disease development or progression.  
Understanding the dynamics of replication- and repair-associated proteins is 
crucial for development of treatments for replication- and replication stress-related 
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diseases such as cancer, Fanconi Anemia (FA), and progeria. One of the most famous 
examples of a cancer driven by specific mutations in or loss of a DNA repair protein, 
BRCA-deficient breast cancer, has begun to be treated with PARP inhibitors with high 
success due to our increased understanding of the role of BRCA proteins in double strand 
break (DSB) repair (Laroche et al., 2017). As discussed below, BRCA1 and 2 are 
important drivers of DSB resolution. Inability to faithfully repair DSBs due to BRCA1 or 2 
mutations results in increased genomic instability that can lead to genetic alterations that 
promote development of cancer cells. Many cancers result from accumulation of multiple 
cancer promoting mutations and inability to faithfully replicate or repair DNA increases the 
frequency of these mutations. While extensive research has helped to clarify the 
previously obscure processes of DNA replication and repair, there is still a plethora of 
knowledge that is missing or unclear. Science is increasingly relying on high-throughput 
analysis of data sets for hypothesis generation and further investigation of complex cellular 
processes such as replication and repair. Unfortunately, many of the methods for high-
throughput analysis of replication components have high levels of background and low 
levels of replication component quantification. Our laboratory developed a method known 
as iPOND2 that increases high-throughput replisome quantification and specificity. 
iPOND2 isolates proteins associated with actively replicating forks, and excludes the 
majority of post-replicative chromatin, allowing high-throughput analysis of replisome 
dynamics under a variety of conditions. This method can be used to drastically expand 
our understanding of replication fork dynamics and regulation following replication stress, 
providing essential information for both basic biological understanding and treatment of 
disease.  
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DNA Replication  
In mammalian cells, DNA replication begins from multiple distinct origins and 
duplicates the paired strands of DNA in a semi-conservative manner. In humans, every 
cell cycle more than 6 billion base pairs (bp) of DNA must be accurately replicated (Venter 
et al., 2001). DNA replication occurs in three distinct steps, initiation, elongation, and 
termination. Each of these steps must be carefully controlled in order to prevent re-
replication of DNA, in-correct replication, or propagation of DNA damage. Here we discuss 
the current understanding of these processes; however, there are gaps in our knowledge 
of different aspects of DNA replication associated processes, most notably, the regulation 
of replication termination. 
Initiation  
In bacteria and yeast DNA replication begins at clearly defined origins of 
replication, but, mammalian origins of replication have proven difficult to identify. Only 
recently have advances in genome-wide approaches to origin mapping allowed the 
identification of thousands of mammalian origins (Prioleau & Macalpine, 2016). Despite 
the large number of identified origins, it is still not entirely clear what the requirements for 
defining a mammalian replication origin are. There were a high number of origins identified 
downstream of G-rich sequences, raising the possibility that G quadruplex formation (G4) 
contributes partially to origin formation. G4 chromatin structures, however, are not 
sufficient for establishment of a replicative origin (Rhodes & Lipps, 2015). Origin mapping 
remains an active area of investigation, as a more complete understanding of site 
requirements would allow analysis of a single replication fork dynamics and further 
investigation of replication initiation and licensing.  
Throughout late M phase and G1 phase of the cell cycle, pre-replicative complexes 
(pre-RCs) are assembled at origins of replication in a process called replicative licensing 
(Petrakis et al., 2016). The origin recognition complex (ORC) associates with CDC6 and 
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in conjunction with CDT1 recruits two copies of the replicative MCM2-7 helicase to DNA, 
composing the pre-RC (Riera, Tognetti, & Speck, 2014). Following pre-RC formation, the 
replicative helicase is activated through cyclin-dependent kinase (CDK)- and DBF4-
dependent kinase (DDK)-dependent recruitment of CDC45 and GINS. CDC45, the MCM 
helicase, and GINS form the CMG complex that is required for DNA replication. MCM2-7 
encircles one of the DNA strands splitting the helix and causing the formation of a 
replication bubble that spreads bi-directionally as replication proceeds throughout S-
phase (Fu et al., 2011). In order to prevent re-replication, helicase loading onto replication 
origins is blocked by ORC/CDC6 disassembly and ubiquitin-dependent degradation of the 
ORC complex (Ohta, Tatsumi, Fujita, Tsurimoto, & Obuse, 2003; Riera et al., 2014). A 
good deal is known about replication initiation, however, our understanding of what defines 
an origin still plagues the field. One of the potential expansions of iPOND2, described 
herein, is to use this method in conjunction with an immunoprecipitation (IP) against a 
replication origin-specific epitope, at which point one could further isolate and sequence 
the origin-associated DNA, and characterize associated proteins, expanding our 
understanding of mammalian origin requirements.  
Elongation  
Following replication initiation, DNA is elongated in a semi-conservative manner, 
meaning that each newly replicated DNA duplex contains one new and one parental 
strand. The MCM2-7 helicase unwinds the DNA helix and the single stranded DNA 
produced is bound by replication protein A (RPA) to prevent degradation. Three replicative 
polymerases (POLA, POLD, and POLE) travel the DNA template strand in a 3’ to 5’ 
direction incorporating nucleotides into the newly synthesized 5’ to 3’ strand of DNA. POLA 
is involved in initiation of strand synthesis, POLE synthesizes the leading strand, and 
POLD drives lagging strand synthesis (Lujan, Williams, & Kunkel, 2016). The lagging 
strand template strand runs in the 5’ to 3’ direction, forcing the polymerases to synthesize 
6 
 
small stretches of DNA at a time initiating from an RNA primer laid down by primases. 
These short fragments of DNA are known as Okazaki fragments (Bochao Liu, Hu, Wang, 
& Kong, 2017). Following polymerase processing, the RNA primers are removed and 
Okazaki fragments are ligated to one another by LIG1 to create a continuous strand. One 
of the common drugs used to cause replication stress is aphidicolin (APH), which inhibits 
POLA processivity that results in separation of DNA synthesis and unwinding, leading to 
accumulation of ssDNA and replication fork stalling. Another inhibitor of DNA replication, 
hydroxyurea (HU), has been approved for use in the clinic as an anti-cancer chemotherapy 
drug. HU inhibits RRM2, preventing synthesis of deoxy-ribonucleotides from 
ribonucleotides. When the deoxy-ribonucleotide levels are decreased it is more difficult for 
polymerases to progress, resulting in replication fork slowing, and eventual stalling at high 
enough concentrations of HU. The wide ranging effectiveness of APH and HU in 
replication fork stalling and generation of DNA damage emphasizes the importance of 
polymerase processivity in healthy DNA replication.  
A sliding clamp known as proliferating nuclear antigen (PCNA) is responsible for 
maintaining DNA polymerase (POLD and POLE) localization to DNA and continuous 
synthesis. PCNA is essential for faithful DNA replication and is responsible for regulation 
of a multitude of replication and repair pathways at the fork. The RFC complex (composed 
of RFC1-5) controls loading and removal of PCNA from DNA (Shiomi & Nishitani, 2017). 
RFC complex function can be further regulated through replacement of RFC1 with other 
substrates, allowing careful regulation of PCNA under a variety of conditions (Shiomi & 
Nishitani, 2017).  
There are multiple additional factors that are required for efficient and accurate 
DNA replication under a variety of conditions, some that are essential, and some that can 
be removed with only minimal cellular difficulties. Many of these additional factors are 
associated with how the replication fork relates to chromatin and damaging agents. For 
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example, topoisomerases are responsible for relieving the supercoiled tension created in 
front of and behind the fork due to MCM helicase unwinding. Loss or inhibition of 
topoisomerases can cause extensive problems in DNA replication, leading to the use of 
topoisomerase inhibitors in multiple types of cancer treatment (Hande, 1998; Pommier, 
2006). There are a large number of complexes that have been reported to be involved in 
replication, each of which are best suited to deal with a unique set of conditions including, 
heterochromatin, euchromatin, different types of DNA damage, and difficult to replicate 
regions. We hypothesize that there is a core replisome complex that is consistent across 
replication of different types of chromatin and includes certain accessory proteins involved 
in recruitment or removal of replisome components following changing conditions and 
requirements. An example of replisome alteration due to specific chromatin conditions 
occurs during telomere replication.  
Telomeres are highly repetitive genomic regions located at the ends of the linear 
eukaryotic chromosomes important for maintenance of genomic stability. The shelterin 
complex is known to help prevent activation of DNA repair mechanisms at the telomeres 
and has been reported to cause a barrier to DNA replication. A growing number of shelterin 
components that are not essential for DNA repair inhibition have been shown to contribute 
to efficient replication of telomeres (Higa, Fujita, & Yoshida, 2017; Maestroni, Matmati, & 
Coulon, 2017). One example is TRF1, which recruits a RecQ-like (RECQL) helicase, 
Bloom syndrome proteins (BLM), that helps to resolve G4 quadruplexes in addition to 
other replication fork blocking structures and is important for progression of replication 
through the G4 quadruplex rich telomere (Zimmermann, Kibe, Kabir, & de Lange, 2014). 
Similarly, RTEL1 can be recruited to replication forks through its PCNA-interacting protein 
(PIP) box to un-wind G4 quadraplexes in telomeres and throughout the chromatin to allow 
replication fork progression (Vannier et al., 2013). 
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Due to the large number of known DNA replication proteins, there are many 
questions remaining regarding how faithful DNA elongation occurs across a variety of 
chromatin types and conditions. Some of the most pressing questions include; how do the 
replication fork responds to collision with transcriptional machinery or chromatin 
structures, what are the minimum proteins required for replication in vivo, and how is DNA 
elongation regulated by post-translational modification (PTM)? There is no clear 
consensus regarding the proteins that compose the replisome during normal replication. 
As discussed in this thesis, our newly developed protocol, iPOND2, will help us address 
the questions listed above and more. Most notably, we developed a consensus replisome 
in order to provide a resource for the field that can be used to help determine how 
consistently a certain protein in associated with the replication fork. Our bioinformatics 
comparison of multiple data sets provides a mechanism by which multiple conditions and 
cell types can be compared to help determine changes in the core replisome and 
accessory proteins dependent on chromatin types, cell cycle phase, DNA damage, and 
more. 
Termination  
Replication elongation is finished when two replication forks collide with one 
another or encounter a chromatin end. While there has been extensive research 
preformed on the mechanisms underlying replication fork initiation and elongation, very 
little is known about the end of DNA replication. Only within the last 5 years has the role 
of unresolved fork termination in genomic instability begun to generate interest in this field 
(Rudolph, Upton, Stockum, Nieduszynski, & Lloyd, 2013). Recent evidence suggests that 
collision of replication forks does not cause stalling, as previously believed, and that the 
CMG helicases pass one another prior to their removal from DNA (Dewar, Budzowska, & 
Walter, 2015). The mechanism of this bypass and regulation of other replisome 
components during bypass has yet to be fully elucidated.  
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Studies in yeast and Xenopus egg extracts have demonstrated the role of ubiquitin 
segregase p97 (VCP/Cdc48/Ter94) in removal of replisome components from terminated 
forks (Maric, Maculins, De Piccoli, & Labib, 2014; Moreno, Bailey, Campion, Herron, & 
Gambus, 2014). In yeast, Dia2 is partially responsible for the ubiquitylation of MCM7 and 
subsequent removal of the helicase from DNA by Cdc48/p97; however, MCM7 was still 
ubiquitylated in Dia2 mutants indicating that Dia2 may not be the sole protein responsible 
for ubiquitylation and removal of the CMG complex. Prevention of disassembly of the CMG 
complex by Cdc48/p97 was lethal in yeast (Maric et al., 2014). Until very recently there 
was no known homolog of Dia2 in higher eukaryotes, but, p97-dependent removal of 
polyubiquitylated MCM7 remained an important step in replication fork termination as 
measured in Xenopus egg extracts (Moreno et al., 2014). In the last few months two more 
papers have been published, identifying E3 ligase, LRR1, as the ubiquitylase responsible 
for MCM7 ubiquitylation in Xenopus (Dewar, Low, Mann, Räschle, & Walter, 2017; 
Sonneville et al., 2017). These discoveries have expanded our understanding of 
replication termination, however, many details about this process are still lacking. It is 
important that we explore the mechanisms of replication fork termination and replisome 
regulation during termination more thoroughly. iPOND2 provides a potential for analysis 
of terminated replication forks or complexes removed from forks following replication.  
Replication fork response to DNA damage 
DNA replication has a high degree of fidelity despite constant assault by both 
intracellular and extracellular damaging agents that often lead to replicative stress. Even 
before the discovery of DNA, agents were identified whose application caused genetic 
changes that promoted diseases such as cancer. Some of these exogenous stressors 
include ultraviolet (UV) light, ionizing radiation (IR), and chemical treatments (Friedberg, 
2008; Kemp, Spandau, & Travers, 2017). Following the characterization of the DNA helix 
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in 1953, endogenous sources of DNA damage resulting from normal cellular metabolism 
such as hydrolysis and oxidation began to be identified (Lindahl, 1993). The constant and 
varied assault on DNA requires multiple protective mechanisms to maintain genomic 
integrity. There are many cellular DNA repair pathways that have been identified; however, 
here we will discuss only a few of these pathways in detail, focusing on those most 
important for repair during DNA replication. Further information regarding the pathways 
not covered can be found in these reviews (Menoni, Di Mascio, Cadet, Dimitrov, & 
Angelov, 2016; Schärer, 2013; Stojic, Brun, & Jiricny, 2004). Each of the DNA damage 
repair pathways requires a complex series of protein-protein interactions and PTMs in 
order to promote faithful repair.  
Trans-lesion synthesis  
Eukaryotic cells have two main mechanisms of handling single stranded lesions 
encountered during replication: template switching and trans-lesion synthesis (TLS). 
Template switching is a relatively error-free pathway that relies upon the use of a 
homologous template (Hung, Wong, Ulrich, & Kao, 2017). TLS utilizes specialized 
polymerases to bypass damage, potentially resulting in the introduction of mutations, but, 
the TLS polymerase η can replicate past damage very accurately (Branzei & Psakhye, 
2016; Waters et al., 2009).  
Polymerase-switching occurs during progression of replication when TLS 
polymerases are recruited to forks at sites of damage by RAD6/RAD18-dependent 
ubiquitylation of PCNA on lysine (K) 164 (Hoege, Pfander, Moldovan, Pyrowolakis, & 
Jentsch, 2002). TLS polymerases are then thought to take over for normal polymerases 
for a short time, although this swaping process has not been well characterized (Waters 
et al., 2009). iPOND2 has the potential to help us improve our knowledge of regulation of 
TLS polymerase recruitment by PTMs and other factors.  
Double strand break (DSB) repair  
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While there are multiple sources of DSB formation, one that is most closely linked 
to DNA replication occurs when the replication fork replicates over a nick or single ss-
break. There are three main mechanism of DSB repair: single strand annealing (SSA), 
non-homologous end-joining (NHEJ), and homologues recombination (HR). SSA causes 
annealing of homologous regions flanking the DSB and deletion of the intervening 
sequence resulting in high mutation levels (Bhargava, Onyango, & Stark, 2016). While 
SSA and NHEJ can occur at most times during the cell cycle, HR only occurs during S 
and G2 phase, when there are sister chromatids present to use as homologous templates 
(Bunting et al., 2010; Chapman, Taylor, & Boulton, 2012). 
The first step in DSB resolution is recognition of the break followed by the 
recruitment of necessary repair proteins. This process begins with the recognition of a 
DSB by the MRN (MRE11-RAD50-NBS1) complex and subsequent recruitment of auto-
phosphorylated ATM. ATM phosphorylates histone variant, H2AX that is recognized by 
mediator of DNA damage-checkpoint protein 1 (MDC1) (Bunting et al., 2010). 
Phosphorylation of MDC1 by ATM drives the recruitment of E3 ubiquitin ligases RING 
finger 8 (RNF8) and RING finger 168 (RNF168). RNF168 ubiquitylates surrounding 
chromatin-associated proteins such as histone H2A and creates a positive feed-back loop 
recruiting more RNF168. Additionally, ubiquitylation of Lys13 and Lys15 on H2A promotes 
stable association of 53BP1 with damaged chromatin (Bunting et al., 2010). 53BP1 acts 
as an inhibitor of end resection that is counteracted by BRCA1 during S/G2 phase, helping 
to drive the decision between use of the NHEJ and HR repair pathways (Bunting et al., 
2010; Lottersberger, Karssemeijer, Dimitrova, & De Lange, 2015).  
NHEJ ligates together the two free ends generated by a DSB. This process is error-
prone and can result in translocations, insertions, or deletions (Chapman et al., 2012). 
Following DSB signaling, as described above, the Ku complex binds non-resected DSBs, 
leading to recruitment of DNAPK and end-processing enzymes. End processing allows 
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end ligation between the two sides of the DSB (Bunting et al., 2010). Recent data suggests 
that the cell may avoid NHEJ-associated mutations through re-localization of DSBs away 
from highly homologous heterochromatin and to the nuclear periphery (Janssen et al., 
2016; Ryu et al., 2015; Swenson, Colmenares, Strom, Costes, & Karpen, 2016). While 
NHEJ has been widely investigated for its role in DSB repair, iPOND2 will help to expand 
this knowledge, specifically through support of the idea of damaged fork localization to the 
nuclear pore.   
HR is often referred to as the most faithful means of DSB repair; however, it mostly 
occurs during S and G2-phase when there are homologs stretches of DNA available for 
use in repair. Following recognition of a DSB, machinery is recruited to resect one of the 
DNA strands creating a 3’-ssDNA overhang. The MRN complex required for resection is 
evolutionarily conserved (Huertas, 2010). The MRN complex does not have very good 
activity in vitro, emphasizing the importance of both known and unknown accessory 
proteins in end resection (Huertas, 2010; Westmoreland & Resnick, 2013). Some MRN 
accessory proteins involved in end resection include the nucleases CtBP-interacting 
protein (CtIP), BLM, DNA replication ATP-dependent helicase (DNA2), and exonuclease 
1 (EXO1). Failed end resection often leads to mutagenesis, cancer, and chromosomal 
rearrangement (Bunting et al., 2010; Smith, Gupta, Kolodner, & Myung, 2005; Yong Yang, 
Gordenin, & Resnick, 2010).  
The overhang created following end-resection is protected by RPA and 
subsequently bound by RAD51, which promotes homology search and strand invasion, 
resulting in the formation of a displacement loop (D-loop) (Hanamshet, Mazina, & Mazin, 
2016). BRCA1 and BRCA2 help mediate RAD51 filament formation and invasion. The 
invaded strand provides a template for further synthesis of the 3’ overhang created by 
resection. At this point, the newly synthesized invasive strand can be used as a template 
for the resected strand or a double D-loop can be formed (Bunting et al., 2010). The 
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formation of a double D-loop occurs through the annealing of the displaced strand in the 
original D-loop to the resected end of the DSB, creating a Holliday junction (HJ). 
Resolution of a HJ requires the strands to be cut and re-annealed, leading to possible 
crossover recombination (Ciccia & Elledge, 2010). As mentioned above, knowledge of 
regulation of these processes can provide tools for prevention and treatment of cancer. 
Interstrand crosslink (ICL) repair   
Interstrand crosslinks (ICLs) are covalent linkages formed between the two strands 
of a DNA helix following treatment of cells with alkylating agents. ICLs are highly genotoxic 
and if they are not repaired they often result in chromosome instability and associated 
diseases such as Fanconi anemia (FA), a degenerative bone marrow disorder. Several 
mechanism have been proposed to repair ICLs created by different cross linking agents 
(Semlow et al., 2016; Z. Yang et al., 2017). Furthermore, ICLs are repaired differently 
during different phases of the cell cycle (Hashimoto, Anai, & Hanada, 2016). For example, 
during G1 phase of the cell cycle ICLs are repaired largely through utilization of the 
nucleotide excision repair (NER) pathway, while during S phase ICLs are most often 
repaired by the FA complex (FANC). Historically, the majority of proteins found to be 
involved in ICL repair during S-phase are part of the FANC, although these proteins have 
recently been shown to be involved in additional forms of replication repair (Hashimoto et 
al., 2016).  
The FANC coordinates the monoubiquitylation of FANCI and FANCD2 that is 
required for the recruitment of exonuclease complexes important for ICL resolution. These 
exonucleases include ERCC1-XPF, MUS81-EME1, and SLX4/FANCP that acts as a 
scaffold for the other nucleases (Coleman & Huang, 2016). The FANCI-FANCD2 complex 
is SUMOylated by SUMO E3 ligases PIAS1 and PIAS4, allowing for recruitment and 
polyubiquitylation of the complex by RNF4. DVC1-p97 subsequently removes the FANCI-
FANCD2 complex from damaged DNA following repair of damage (Coleman & Huang, 
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2016). Recent published and unpublished data demonstrate a novel role for BER protein 
NEIL3 in repair of psoralen generated ICLs (Semlow et al., 2016; Z. Yang et al., 2017). 
The discovery of a new ICL repair pathway within only the last few years emphasizes the 
limits of our current knowledge. Examination of changing replisome components following 
p97 inhibition and/ or treatment with ICL reagents by iPOND2 will likely provide important 
insights into mechanisms of repair used in each type of ICL repair.   
Nuclear localization of damaged DNA for repair  
In budding yeast, persistent DSBs are localized to the nuclear envelope through 
Brownian motion (Dion, Kalck, Horigome, Towbin, & Gasser, 2012; Horigome et al., 2014; 
Miné-Hattab & Rothstein, 2013). Furthermore, studies have shown an association 
between the nuclear pores and DNA repair machinery in yeast following DNA damage (J. 
A. Cobb et al., 2005; J. A. Cobb, Bjergbaek, Shimada, Frei, & Gasser, 2003). The 
localization of DSBs to the nuclear pore in mammalian systems is still controversial, 
however, within the last few years a series of studies have lent more credence to this 
model. One of the first indications of association between DNA repair and the nuclear 
periphery in mammals was from a genomic analysis showing the association between 
RAD51 and NUP43, NUP107, NUP133, and NUP160 (Katsani et al., 2014). Furthermore, 
there is an association between LINC complex members, prelamin A (LNMA) and 
SUN1/SUN2, and DNA damage (A. M. Cobb, Murray, Warren, Liu, & Shanahan, 2016; 
Lei et al., 2012; Lottersberger et al., 2015). 
Finally, the Chiolo lab showed that heterochomatin DSBs are localized to the 
nuclear periphery in Drosophila melanogaster through nuclear pore and INMP-dependent 
recruitment of STUbL/RENi (Ryu et al., 2015). These findings were further developed last 
year with the revelation that heterochromatin and euchromatin have different spatio-
temporal regulation following persistent DSBs. This study shows that despite movement 
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of both euchromatin and heterochromatin foci, heterochromatic DSBs initiate earlier repair 
events and localize to the nuclear envelope prior to RAD51 recruitment in live animals, 
likely due to the increased complexity and dynamics of heterochromatin (Janssen et al., 
2016; Ryu et al., 2015; Swenson et al., 2016). Furthermore, they showed that recruitment 
of the DSBs to the nuclear periphery was independent of HR proteins and were mostly 
repaired by NHEJ pathways (Janssen et al., 2016; Swenson et al., 2016). Data from the 
Karpen and Chiolo laboratories also suggests that DSB recruitment to the nuclear 
periphery is required for displacement of ATRIP to allow HR progression (Ryu et al., 2015). 
These studies support the model that heterochromatin localizes to the nuclear envelope 
following DSB formation but, the localization of more types of DNA damage as well as 
euchromatin associated breaks need to be further examined, especially in mammalian 
cells. Here we describe the association of replication forks with nuclear pore proteins 
following acute replication fork stalling. Furthermore, our iPOND2 data suggests novel 
roles of ATR and p97 in regulation of the nuclear localization of damaged replication forks 
in mammalian cells.   
Replication checkpoint activation 
If cells attempt to divide while there is still DNA damage present either due to 
impaired or delayed repair, it can lead to cellular catastrophe. Thus, it is important for the 
cell to carefully regulate cell cycle progression. Cell cycle progression is driven by 
fluctuating levels of a series of regulatory proteins, most notably cyclins and CDKs. There 
are also multiple checkpoints throughout the cell cycle that can limit cell cycle progression. 
One of the most important cell cycle checkpoints in monitoring DNA replication stress 
during S phase is the ATR checkpoint that prevents progression of the cell into mitosis if 
there is persistent damage.  
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The ATR-checkpoint is activated by accumulation of ssDNA. ssDNA can be 
generated by a variety of damage sources such as damage that leads to end resection or 
bulky DNA adducts that the helicase but not polymerase is able to pass. If the DNA 
helicase and polymerase become uncoupled, as occurs following treatment with APH or 
HU, ssDNA accumulates and is bound by RPA in order to protect the DNA from nuclease 
processing (Cimprich & Cortez, 2008; Toledo et al., 2013). RPA also recruits a series of 
proteins responsible for the activation of the ATR checkpoint at sites of replication fork 
stalling, including ATR-interacting proteins (ATRIP). RPA recruits the 9-1-1 complex 
(RAD9-RAD1-HUS1) that subsequently attracts the ATR activating protein, 
topoisomerase-binding protein-1 (TOPBP1). Following ATR activation, Claspin helps 
bring ATR and CHK1 together to stimulate CHK1-signaling of DNA damage to the rest of 
the cell. Additionally, RPA interacts with Tipin and TIMLESS that aid in recruitment of 
CHK1 to sites of damage so that it can be activated by ATR-dependent phosphorylation. 
Following their recruitment and activation, ATR and CHK1 phosphorylate a series of 
substrates leading to cell cycle stalling until the damaged fork can be repaired. This cell 
cycle stalling helps to mitigate accumulation of damage that can otherwise lead to disease 
progression (Cimprich & Cortez, 2008; Kemp et al., 2017). A more thorough explanation 
of ATR’s role in cell cycle regulation can be found in these reviews (Abraham, 2001; 
Cimprich & Cortez, 2008; Cortez, Guntuku, Qin, & Elledge, 2001; Wang, Khadpe, Hu, 
Iliakis, & Wang, 2003).  
While ATR’s role in stalling the cell cycle in response to accumulation of ssDNA is 
well established, there has been debate in the field regarding the role of ATR at stalled 
replication forks. An increase in DSB formation following ATR depletion, has suggested a 
cell cycle-independent role of ATR in prevention of DSB formation but, the mechanism is 
unclear (Ragland et al., 2013). There are currently three main models of the mechanism 
by which ATR contributes to DSB formation. The first model argues that, due to the 
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increased origin firing in cells that lack ATR, there is an increased need for RPA binding 
and protection of ssDNA, so much so that RPA levels become depleted and RPA is unable 
to protect all of the stalled forks from endonuclease action, elevating DNA break levels 
(Toledo et al., 2013). The second model, the one supported partially by data from our own 
lab, holds that ATR physically stabilizes replication components at stalled forks until the 
damage can be repaired, at which point the replication fork can progress normally. 
According to this model, when ATR is depleted the replisome is removed from the fork in 
an RNF4 and PLK1 dependent manner, allowing DNA processing and cleavage by 
endonucleases such as SLX4 (Carr, Paek, & Weinert, 2011; Ragland et al., 2013). The 
final model is that the role of ATR at stalled replication forks is to modify DNA remodeling 
helicases such as SMARCAL1 and ZRANB3 in order to prevent formation of HJ-like 
structures that can be cleaved by multiple endonucleases (Badu-Nkansah, Mason, 
Eichman, & Cortez, 2016; Couch, Bansbach, Driscoll, Luzwick, & Glick, 2013; Dungrawala 
et al., 2015; Sirbu et al., 2013). None of these models necessarily precludes the others; 
however, data from labs supporting different models are often at odds with one another, 
creating much debate in the field. iPOND2 provides some clarity as to which of these 
models is the most accurate, as well as providing an extensive list of ATR regulated 
proteins.  
The role of ubiquitylation at the replication fork 
In addition to ATR-driven phosphorylation, there are a multitude of PTMs that occur 
at the replication fork that are important for regulation of nearly all cellular processes and 
proteins. One PTM that is particularly pervasive is ubiquitylation, which controls a host of 
cellular processes including protein degradation, cell cycle progression, protein trafficking, 
DNA repair, and more (Chaugule & Walden, 2016; Sidor-Kaczmarek, Cichorek, Spodnik, 
Wójcik, & Moryś, 2017). Ubiquitylation involves the attachment of ubiquitin to a substrate 
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through the sequential action of three enzymes. The process begins with the formation of 
a thioester bond between ubiquitin and an ubiquitin-activating enzyme (E1). Next the 
ubiquitin is transferred from the E1 to a target protein through the action of an ubiquitin-
conjugating enzyme (E2) either alone or in conjunction with an E3 ubiquitin ligase. There 
are a large number of known E2 (approximately 40) and E3 (approximately 600) enzymes 
that confer a high level of specificity to ubiquitin modification (Cipolla, Maffia, Bertoletti, & 
Sabbioneda, 2016).  
The action of these three enzymes attaches the ubiquitin to its target substrate via 
its C-terminal domain, after which it can be ubiquitylated itself on one of its own lysine’s 
(K6, K11, K27, K29, K33, K48, K63, and K113). By this mechanism ubiquitin can form 
lysine specific chains or branching structures. The type of ubiquitylation that occurs in 
addition to the location of ubiquitylation governs the interpretation of the modification by 
sensors in the cell. While many of the roles of specific ubiquitin modifications are still not 
completely understood, it is widely accepted that K48 ubiquitin chain formation is a mark 
for proteasome-dependent degradation and K63 modification promotes protein-protein 
interaction (Varadan et al., 2004; Varadan, Walker, Pickart, & Fushman, 2002).  
Many E2 and E3 ligases have previously been shown to be involved in replication 
and repair of damaged DNA. Furthermore, many of these enzymes have been shown to 
modify PCNA, an essential part of replication fork progression, in response to DNA 
damage. Monoubiquitylation of PCNA at K164 leads to the TLS mechanism of damage 
bypass (discussed above), while K63 polyubiquitylation at this site favors template 
switching, demonstrating the specificity of the ubiquitin modification system in regulation 
of replication fork response to damage (Cipolla et al., 2016).  
p97, an ubiquitin segregase, has consistently been reported to be associated with 
regulation of DNA replication and repair. p97 is an evolutionarily conserved ATPase that 
moves substrates through its pore, in a mechanism to similar the proteasome, to remove 
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the substrate from complexes and unfold it. These substrates are shuttled to the 
proteasome for degradation or recycled following ubiquitin removal. The importance of 
p97 in cellular regulation is emphasized by the embryonic lethality of homozygous mutants 
and apoptosis in response to prolonged knockdown (Müller, Deinhardt, Rosewell, Warren, 
& Shima, 2007; Sidor-Kaczmarek et al., 2017). As discussed above, p97 has recently 
been shown to have an essential role in termination of DNA replication across species 
(Dewar et al., 2017; Maric et al., 2017, 2014; Moreno et al., 2014). Furthermore, p97 has 
been shown to be important for the regulation of ICL resolution by FANC (Semlow et al., 
2016). In addition to its roles in replication and repair, p97 is involved in many other cellular 
processes including endosomal trafficking, autophagy, ribosomal-associated degradation, 
endoplasmic reticulum assembly, and more (Ramadan, Halder, Wiseman, & Vaz, 2016). 
Due to the involvement of p97 regulation in multiple cellular processes it can be difficult to 
determine if its functions are direct or indirect, necessitating analysis at short time points 
and in carefully controlled systems. Inhibition of p97 in a high-throughput analysis would 
provide insight into regulation of replication components by ubiquitin-dependent pathways 
and p97. Understanding the role of p97 and ubiquitylation in replication component 
regulation and DNA repair will provide an important advancement in basic biological 
understanding, as well as our ability to understand and treat replication and repair related 
diseases.  
Methods of Replisome Analysis  
Ever since the discovery of DNA it has been difficult to assess the proteins that are 
associated with DNA replication. One of the most widely used methods for replication fork 
analysis has been based on chromatin fractionation (Méndez & Stillman, 2000). This 
protocol separates cytoplasmic and nuclear proteins, and then nuclear soluble and 
insoluble proteins. Nuclear insoluble proteins are then assumed to be associated with 
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chromatin and in cells with a high S-phase population are considered to be replication-
associated. However, not only are non-chromatin-associated proteins such as those in the 
PML bodies isolated by these techniques, but post-replicative material is isolated, 
complicating data analysis. Replisome components have also been analyzed using 
microscopy but, visible light microscopy, like western analysis, is often low resolution and 
can only be used to examine targeted proteins and correlative association. While 
microscopy, western blots, ELISA, and other previously used protocols can be useful for 
targeted investigation of specific proteins, the rapidly expanding field of replication fork 
dynamics requires a more high-throughput method of replication component analysis 
under a variety of conditions.  
Due to the uncertainly of where mammalian replication will initiate, it has 
historically been difficult to track and analyze individual replication forks. As mentioned 
above, recent advances in isolation of proteins associated with newly replicated DNA have 
provided an improved mechanism by which replisome researchers can analyze large 
scale changes in replication fork composition following different treatment conditions. The 
first of these revolutionary protocols to be published was isolation of proteins on nascent 
DNA (iPOND) (Sirbu, Couch, & Cortez, 2012; Sirbu, Couch, Feigerle, Bhaskara, & Hiebert, 
2011). iPOND relies on the incorporation of a thymidine analog 5-ethynyl-2’-deoxyuridine 
(EdU) into actively replicating DNA. Following fixation and harvesting of cells the alkyne 
group of EdU is covalently linked to biotin via a click chemistry reaction and the chromatin 
is sonicated. The sample is then bound to streptavidin beads in order to isolate the biotin 
associated newly replicated DNA (Moses & Moorhouse, 2007).  
Around the same time other groups were developing similar protocols, relying on 
biotin-streptavidin affinity for isolation of new DNA and associated proteins. The second 
published protocol utilizing this mechanism of replisome isolation is known as DNA 
mediated chromatin pull-down (Dm-ChP), which differs from iPOND mostly in its use of a 
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biotin-TEG conjugate for the click chemistry reaction (Kliszczak, Rainey, Harhen, Boisvert, 
& Santocanale, 2011). Furthermore, Dm-ChP was the first of these protocols to be used 
for high-throughput analysis by mass spectrometry (MS) although multiple labs quickly 
applied MS analysis to iPOND as well (Kliszczak et al., 2011; Lopez-Contreras et al., 2013; 
Sirbu et al., 2013, 2012). Finally, the Groth lab developed a protocol known as nascent 
chromatin capture (NCC) that is largely similar to the above protocols, however, NCC 
utilizes a pre-biotin conjugated dUTP rather than EdU for nascent DNA labeling (Alabert, 
Bukowski-Wills, et al., 2014).  
These protocols each have unique strengths and weaknesses; however, they all 
have one consistent weakness that compromised their ability to selectively pull down 
newly replicated forks. Since the incorporation of nucleotide analogs is an essential 
feature of each of these protocols, significantly more DNA is labeled then remains 
associated with the active replisome. The average mammalian replication fork travels at 
approximately 1-3 Kb/ min, meaning that a 10 min nucleotide analog pulse covers a 
minimum of 10 Kb (Conti et al., 2007). Active replisomes are thought to only occupy 100 
or fewer base pairs at the fork, meaning that at least 99% of isolated DNA is associated 
with post-replicative chromatin rather than actively replicating forks (Berezney, Dubey, & 
Huberman, 2000). Isolation of post-replicative chromatin can complicate the attempted 
analysis of only actively replicating forks. When we first brought the iPOND protocol to our 
lab we noticed variable results, likely due to extensive post-replicative material pull-down.  
Herein, we present an improved iPOND protocol that utilizes a sucrose gradient to 
separate post-replicative chromatin from active replication forks to increase specificity and 
yield (iPOND2). iPOND2 will help researchers answer many outstanding questions 
regarding DNA, replication, repair, and possibly even replication termination. Furthermore, 
we demonstrate the utility of iPOND2 in tandem-affinity purification protocols that can be 
used to expand the field’s understanding of replication fork dynamics. Some of the 
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outstanding questions that iPOND2 and its expanded protocols will help to answer include: 
what is the most consistent pool of replication associated proteins, what is the role of ATR 
at the fork in DSB formation, how are replisome components regulated in response to 
replication fork stalling, and how do ubiquitylation and p97 regulate replication and DNA 
repair? iPOND2 represents an important improvement in our ability to analyze replisome 
composition.  
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Summary 
A plethora of diseases are driven by defects in DNA replication, yet our ability to analyze 
subtle changes in replication-associated proteins remains limited. Recently, the Cortez, 
Groth, and Santocanale laboratories developed nascent-strand techniques that allow 
enrichment and identification of proteins associated with active replication forks. The most 
widely used of these methods is isolation of Proteins On Nascent DNA (iPOND). A key 
limitation to these approaches is concomitant enrichment of both replication and post-
replicative proteins that accumulate on nascent DNA behind the replication fork. Herein, 
we describe a significant improvement in specificity and yield of replisome component 
isolation through application of density-based fractionation step to samples prior to 
nascent-stand retrieval (iPOND2) coupled to label-free quantitative MS (DRIPPER). 
Comparison of iPOND2-DRIPPER replication protein enrichment with previously 
published data sets allowed the establishment of distinct Tiers of agreement between 
independent reports, with iPOND2-DRIPPER demonstrating the greatest level of overlap 
and highest dynamic range of commonly agreed upon factors. In summary, iPOND2-
DRIPPER represents a methodological advance for the study of replisome dynamics and 
has led to the establishment of a clearly defined consensus replisome.  
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Introduction  
Maintenance of faithful DNA replication is vital for healthy cell division. 
Unfortunately, replication disturbances often lead to DNA damage, which causes a 
multitude of mutations that promotes diseases including cancer. Often cancer cells are the 
most rapidly dividing cells in the body, thus the ability to inhibit replication should stop or 
delay cancer progression. Similarly, if DNA repair is inhibited, enough damage will 
accumulate in dividing cells to cause cell death. Many replication and DNA repair 
complexes have been successfully targeted for cancer treatment. As resistance to these 
treatments arise, however, combination therapies become more important, leading to the 
need for a more complete understanding of replication fork factor dynamics under 
conditions of stress (Min et al., 2017; Viziteu et al., 2017). Until recently, techniques for 
assessing DNA replication were limited to immunofluorescent detection of replication foci, 
chromatin fractionation, and biochemical in vitro assays. While these methods have 
generated significant advances in our understanding of replication factor function, they do 
not permit high confidence quantification of protein levels at the fork. This limitation has 
resulted in an inability to differentiate replication functions from alternative roles of these 
proteins throughout the nucleus.  
Recently, several laboratories have developed techniques to isolate and analyze 
proteins at actively replicating forks (Alabert, Lee, et al., 2014; Kliszczak et al., 2011; 
Lopez-Contreras et al., 2013; Sirbu et al., 2013, 2012, 2011). DNA Mediated Chromatin 
Pull-down (Dm-ChP), Nascent Chromatin Capture (NCC) and isolation of Proteins On 
Nascent DNA (iPOND), each utilize the incorporation of a nucleoside analog (EdU or 
biotin-dUTP) that marks actively replicating forks. In both iPOND and Dm-ChP, EdU is 
incorporated into cells and conjugated to biotin, or biotin-TEG in the case of Dm-ChP, via 
click chemistry. After labeling and crosslinking proteins to DNA, the cell lysate is sonicated, 
and labeled DNA is isolated using high affinity streptavidin-bound beads (Alabert, Lee, et 
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al., 2014; Kliszczak et al., 2011; Lopez-Contreras et al., 2013; Sirbu et al., 2012). These 
procedures isolate DNA that has just been duplicated by the replication fork and analyze 
the associated proteins. The nucleoside analog pulse is kept short to minimize enrichment 
of distantly post-replicative proteins. To limit the false positives, samples are compared to 
a control treated with a long thymidine (Thy) chase following the EdU pulse. The Thy chase 
results in the association of EdU with post-replicative components rather than replication 
proteins. The proteins identified in the Thy treated sample can be disregarded when 
examining changing proteins at active replication forks, as they represent post-replicative 
and other background material.  
Given the speed of mammalian DNA replication (approximately 1-3 Kb/minute) and 
minimum EdU labeling time (10 minutes), approximately 10 Kb of DNA are labeled and 
isolated by these protocols (Conti et al., 2007). It is unlikely that active replication forks 
occupy a space on DNA larger than 100-200 nucleotides (nt) (Berezney et al., 2000). 
Subsequently, a minimum of approximately 98% of EdU-containing DNA isolated by these 
protocols is associated with post-replicative material rather than active replication forks, 
resulting in high background protein levels and decreased specificity. Despite these draw-
backs, coupling the isolation of nascent DNA and associated proteins with mass 
spectrometry (MS) has helped pave the way for many advances in our understanding of 
replication fork dynamics (Alabert, Lee, et al., 2014; Dungrawala et al., 2015; Lecona et 
al., 2016). These protocols have been expanded and modified frequently to increase their 
resolution and range of applications, emphasizing the importance of developing protocols 
capable of visualizing replication-associated proteins and of optimizing them to best suit 
the needs of the replication community (Alabert et al., 2015; Dungrawala et al., 2015; 
Thomas Leung, El Hassan, & Bremner, 2013).  
When analyzing data using MS high levels of non-specific peptides, such as those 
from post-replicative chromatin, often mask changes in peptides from replication-
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associated proteins, decreasing the sensitivity of the output. Because of the high level of 
masking proteins inherent in these protocols, it is likely that small, rare proteins were being 
overlooked at the MS step. Thus, a complete understanding of replication fork dynamics 
necessitates the development of a technique to minimize background proteins present in 
the sample prior to MS analysis.  
Herein, we describe the addition of a density based fractionation to iPOND, 
hereafter referred to as iPOND2. Based on the concept of polyribosome fractionation, 
where sucrose density gradients are used to separate mRNA bound to single and 
polyribosomes, we reasoned that the macromolecular structure of the replisome would 
make it denser than post-replicative chromatin, resulting in the subsequent separation of 
these complexes into different gradient fractions (Lou, Baser, Klußmann, & Martin-Villalba, 
2014). Separation in this manner would provide a means to better enrich actively 
replicating forks prior to the biotin-streptavidin affinity step, thereby reducing background 
and increasing both the specificity and sensitivity of the assay. We analyzed iPOND2 
samples using the recently described label-free quantitative MS approach, DRIPPER 
(directed RIPPER) (Thu et al., 2015; Van Riper, Higgins, Carlis, & Griffin, 2016). DRIPPER 
utilizes a directed MS workflow that allows for the identification of proteins that are 
abundant in different amounts at active replication forks (EdU treatment) and post-
replicative chromatin (Thy chase). Our findings demonstrate increased replication factor 
detection limits of identified proteins for all core replisome components as compared to 
previous publications. Furthermore, our analysis provides a centralized compilation of 
proteins that are stably associated with replication forks based on current understanding 
in the field. These improvements to the iPOND protocol increase specificity and dynamic 
range, potentially allowing for improved monitoring of replisome components.  
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Materials and Methods 
Cellular Treatment 
3x106 logarithmically growing, passage-immortalized 4-3 MEFs (ATRflox/-) (Brown 
& Baltimore, 2003; Ruzankina et al., 2007) were labeled with 20 μM EdU for 10 min. For 
the baseline sample cells were treated with 20 μM EdU for 10 min, followed by washout 
and addition of 100 μM of Thy for 30 min prior to harvest.  
 
Southern Detection of EdU 
DNA in a 1% agarose gel was transferred onto a Hybond-N+ membrane 
(Amersham Biosciences) via the standard Southern transfer protocol. Streptavidin 
(Invitrogen) and biotinylated-alkaline phosphatase (Thermo Fisher) were bound to the 
biotin-conjugated EdU. CDP-Star (Sigma-Aldrich) cleavage of the biotinylated-alkaline 
phosphatase resulted in detectable fluorescence. 
Western blots 
For western blot analysis, bromphenol blue and 5% (vol/vol) BME were added to 
each sample. Samples were then separated by 4-20% SDS-PAGE gel (BioRad), 
transferred onto 0.45μM polyvinylidene fluoride (PVDF) membranes, and detected with 
the indicated antibodies (Supplemental Table 2.1). 
iPOND2  
Treated samples were fixed with 1% formaldehyde for 20 minutes at room 
temperature (RT), and quenched in 0.125 M glycine for 10 minutes. Fixed cells were 
scraped into 50 mL conical tubes and centrifuged at 1,500 RFC for 5 minutes at 4°C. 
Pellets were washed with 30 mL of PBS, spun down, and pellets were frozen at -80°C. 
Cell pellets were permeabilized in 10 mL of 0.25% Triton/PBS for 30 minutes at RT and 
then centrifuged at 4°C and 1,500 RFC for 5 minutes. The resulting pellets were washed 
in 10 mL of 0.5% BSA/PBS and biotin (PEG4-Fisher-Scientific) was conjugated to EdU 
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using a 1 hour click chemistry reaction at RT (Sirbu et al., 2011). Samples were then 
washed with 0.5% BSA/PBS, re-suspended in 1.3 mL of RIPA buffer (1% NP-40, 0.1% 
SDS, 50 mM Tris, pH6.8, 150 mM NaCl, 0.5% Na deoxycholate, 1 mM EDTA, 100 μM 
Na3VO4, 10 μM NaFl, 20 mM Na pyrophosphate, 7 mM β-glycerophosphate, 1 mM DTT, 
Protease inhibitor tablet (Roche)) per harvested plate, and sonicated to a DNA fragment 
size of between 50 nt and 12 Kb using a Biorupter Plus Sonication Device (Diagenode) 
(30 cycles on medium, 30 seconds on and 30 seconds off). The sonicated material was 
centrifuged at 16,000 rpm for 10 minutes and the supernatant was collected and added to 
a 16 mL 5-40% sucrose gradient with a 2 mL 60% sucrose cushion. The gradient was 
centrifuged at 30,000 RFC for 16 hours at 4°C (Fig. 2.1A).  
Samples were divided into 14 fractions using a BR-188 Density Gradient 
Fractionation System (Brandel). The percentage of sucrose in each fraction was 
measured (HI 96801 Refractormeter for Sucrose Measurements, Hanna Instruments) and 
equalized, urea was added to a final concentration of 1 M and fractions were frozen at -
80°C for up to a year. Next, fractions were thawed and incubated with magnetic 
streptavidin-bound beads (Dynabeads® MyOne™ Streptavidin T1, 65602, Invitrogen) 
overnight at 4°C. Beads were washed in RIPA (5 minutes), 500 mM NaCl (5 minutes), and 
1 M urea (1 hour), followed by 2 additional 5-minute RIPA washes, and incubated 
overnight at 55°C in a 1:1 ratio of RIPA to Laemmli sample buffer in order to elute and 
uncrosslink proteins. Finally, samples were removed from beads and boiled for 5 minutes. 
At this point samples were either processed for MS or run on a western. 
Label-free quantification of peptides by Mass Spectrometry  
Fractions 6-14 of 2-5 sucrose gradients were combined, precipitated with acetone, 
and fractionated on a 7.5% Criterion polyacrylamide gel (Thu et al., 2015). After in-gel 
trypsin digestion, peptide mixtures were analyzed by capillary liquid chromatography-MS 
(LC-MC) on an Eksigent 1D plus LC with a MicroAS autosampler (Dublin) online with an 
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Orbitrap Velos MS system (Thermo Fischer Scientific, Inc.). Each sample was analyzed 
in triplicate by 1D LC-MS for each quantification measurement consecutively on the same 
analytical column. We used University of Minnesota based software named RIPPER to 
preprocess the MS1 data, extract peptide signals, and calculate each peptide signal’s 
intensity.  
RIPPER parameters for peptide signal extraction were: S/N ratio 2; minimum 
number XIC peaks 8; maximum analyte grouping retention time tolerance 120 sec; 
maximum analyte grouping m/z tolerance 0.005 units (0.007 units for experiment 2); 
charge states 2 – 4; minimum m/z 100. From RIPPER output, we constructed an inclusion 
list for directed MS. We compared MS1 profiles from EdU and Thy samples, and 
performed a Student’s t-test for each analyte. We chose a p-value of 0.005 (experiments 
1 and 3) and 0.01 (experiment 2) for the inclusion list member threshold, yielding lists 
containing in the range of 2,000 – 5,000 analytes.  Finally, we allowed a ± 2-min retention 
time window for each analyte on the inclusion list. Analytes with inconsistent MS1 profiles 
were eliminated.  
Samples were also analyzed on a Thermo Fusion Mass Spectrometer using a 
combination of MaxQuant and iBAQ to quantify peptides present in Thy chase compared 
to EdU-treated samples. 3 injections of 2.5 µl of each sample were used. A 1% FDR, 2 
standard deviation cut off was used for this analysis.  
Data Analysis 
The fold enrichment of each protein group was determined in the EdU vs. Thy-
sample based on the median fold change of all corresponding peptides in the EdU sample 
compared to the Thy chase. When a peptide was only detected in the EdU sample, the 
Thy value for that peptide was set at the half of the lowest value detected (limit of detection: 
LOD) by the instrument during each technical replicate. Proteins that showed non-uniform 
enrichment were eliminated, such as when a subset of peptides was enriched and another 
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set was depleted. Pre-defined contaminates such as human keratin, BSA, and streptavidin 
were removed from analysis. We used all proteins that were 2.9-fold enriched in the EdU-
treated samples with more than 1 peptide across all replicates. Manual protein-function-
based binning was performed on proteins observed in 2 or 3 of the replicates using a 
combination of GO terms, Uniprot, GeneCards, and PubMed.  
Results  
Sucrose fractionation yields increased specificity of known replication-associated proteins 
from nascent strand capture 
Initial attempts to use iPOND were plagued by the variability of western blot results, 
high levels of background contamination, and the high cost of SILAC-based analysis. 
Thus, we altered the iPOND protocol based on a series of empirical tests that used a 
variety of pulse times, nucleotide analog concentrations, fixatives, bead types, sonication 
conditions, and uncrosslinking conditions. These changes allowed us to perform iPOND 
for analysis by western blot with fewer cells; however, the variability and background 
remained a problem. We hypothesized that active forks were large, dense complexes and 
that early post-replicative complexes were smaller and less dense. Thus, adding a sucrose 
gradient fractionation step to iPOND would separate non-replisome-associated EdU-
containing background fragments from active replication forks (Fig. 2.1A).   
As expected, after fractionation of an iPOND sample with a sucrose gradient 
(iPOND2), we observed a density-based separation of DNA, with smaller fragments 
congregating in the lighter fractions and the larger fragments appearing in the more dense 
fractions (Fig. 2.1B). The distribution of EdU in the sucrose gradient mirrored the pattern 
of the DNA. The average size of EdU-labeled DNA fragments, however, was smaller than 
that of the unlabeled DNA fragments (Fig. 2.1B). This pattern is consistent with our 
hypothesis that DNA containing EdU would be associated with larger macromolecular 
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complexes, such as the replisome, which would result in co-localization with the larger 
DNA fragments.  
To ensure that EdU-containing fragments were fractionating on a basis of 
associated complexes rather than heterochromatin, we examined the distribution of known 
replication- and chromatin-associated proteins in input gradient fractions. Histones 
followed a normal distribution, with the middle fractions having the highest histone density. 
Conversely, the replisome components examined prior to EdU pull-down exhibited a 
bimodal distribution (Fig. 2.1C). To determine the fractions that were associated with 
active replication forks we performed a biotin-streptavidin pull-down on each fraction. 
Known replisome proteins including PCNA and components of the MCM helicase were 
associated with EdU-labeled DNA in the denser fractions. We observed phosphorylation 
of serine 108 on MCM2 (pS108-MCM2), a mark of replication fork activation, in the denser 
fractions of the gradient following pull-down, showing that the dense gradient fractions 
contain the majority of actively replicating forks (Fig. 2.1C) (Montagnoli et al., 2006). High 
levels of replication proteins in the dense fractions correspond to relatively low levels of 
EdU in these fractions, suggesting that comparatively little EdU is bound to known 
replisome components following sample processing, consistent with the majority of 
labeled material being post-replicative (Fig. 2.1B,C).  
Using Coomassie and silver-stain visualization, a large band was visible in the less 
dense fractions that was consistent in size with BSA, which has historically been a 
contaminant (Fig. 2.2). The preferential selection of the denser iPOND2 fractions (fractions 
6-14) for analysis allowed the exclusion of the light fractions containing low levels of EdU-
associated replisome components and high background proteins. Furthermore, iPOND2 
showed a decreased representation of H3.1, a histone isoform loaded on chromatin 
following replication, emphasizing the removal of post-replicative material by iPOND2 (Fig. 
2.3A) (Tagami, Ray-Gallet, Almouzni, & Nakatani, 2004). iPOND2 has greatly increased 
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the resolution of replisome components by western blot (Fig. 2.3A). We hypothesized that 
the increased yield displayed by iPOND2 would translate into improved MS-based 
quantification.  
Use of label-free quantification to assess replisome content.   
Comparison of heavy and light fractions 
To confirm that the enrichment observed by western blot was repeatable by MS, 
we first analyzed heavy (6-14) and light (1-5) fractions from EdU and Thy-treated samples 
by MaxQuant (Fig. 2.3B, Fig. 2.4A-C). Consistent with the western blot data, the EdU-
treated heavy fractions showed enrichment of known replisome components and the light 
fractions contained many histones (Fig. 2.3A, B). Furthermore, the heavy fractions of Thy-
treated samples did not show replisome enrichment (Fig. 2.4A). Following this qualitative 
confirmation of the usefulness of iPOND2 in conjunction with MS, we sought to obtain a 
more quantitative measure of replication fork proteins.   
 
 
DRIPPER: peak selection based on differential abundance  
Most of the laboratories using biotin capture techniques to examine replisome 
components use SILAC-MS. Recently the Griffin Laboratory published a MS analysis 
technique known as DRIPPER (Van Riper et al., 2016). DRIPPER is a label-free 
quantification method that allows the direct comparison of multiple samples with high 
confidence (Thu et al., 2015). When used to direct MS2 runs, DRIPPER avoids problems 
raised by SILAC; e.g., in DRIPPER, each of the samples is fractionated separately by the 
MS, preventing one sample from creating background or peak masking for another sample 
as can occur when samples are run together as in SILAC (Van Riper et al., 2016).   
In order for DRIPPER to be consistent across data sets a baseline reference needs 
to be included. A 30 minute Thy pulse was used as the baseline, allowing the removal of 
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proteins that were unchanged or enriched on post-replicative chromatin so that analysis 
could be focused on replication-associated proteins. Fractions 6-14 of Thy-chased and 
EdU-pulsed iPOND2 samples were analyzed using DRIPPER (iPOND2-DRIPPER) (Fig. 
2.1C). The establishment of an inclusion list, of the peptides that significantly changed 
compared to the baseline, focused our analysis more precisely on changing peptides, 
such as replisome proteins (Fig. 2.5, Fig. 2.6).  
Alternative LC-MS analysis 
One criticism of the DRIPPER protocol is that peptides may be over represented 
in the treatment sample compared to the baseline due to differential total protein 
abundance. To confirm that the enrichments reported were not technical artifacts we 
quantified protiens by a combination of MaxQuant and iBAQ from the same sample set 
that was used for the third iPOND2 replicate of DRIPPER. Of 577 proteins identified, 307 
were significantly different between the EdU and Thy samples, including MCM3-6, PCNA, 
and RFC1-5. 491 of the proteins identified by MaxQuant were also identified in the 
DRIPPER analysis of the same sample. MCM2 and MCM7 were identified by MaxQuant 
but did not pass the significance filters (Fig. 2.4B, C, and Supplemental Table 2.2). 
Although many replication proteins were detected by this method, there were 578 proteins 
detected by DRIPPER that were not detected by MaxQuant, many that have known 
replication and repair functions, such as the GINS complex and XRCC1. Additionally, the 
MaxQuant analysis was non-quantitative, emphasizing the importance of DRIPPER 
analysis for identification of subtle changes in replication fork dynamics. 
Analysis of iPOND2-DRIPPER reproducibility  
Three iPOND2 biological replicates were independently analyzed using DRIPPER. 
Proteins enriched in EdU-treated samples and meeting significance filters in each replicate 
(see Materials and Methods), were compared to one another (Fig. 2.5A). A total of 751 
proteins were upregulated in EdU-treated samples across replicates. 57% of these 
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proteins were only observed in one replicate, 30% were in 2 of 3 replicates, and 13% were 
present in all 3 replicates. In order to develop a consensus replication protein list we 
manually classified proteins identified in 2 or 3 replicates into functional bins 
(Supplemental Table 2.3). There was an increased representation of known replication 
and repair proteins and a decrease in the percent of proteins associated with RNA 
metabolism in 3 out of 3 replicates compared to 2 out of 3 replicates (Fig. 2.5B, C). We 
observed similar patterns using the Kyoto Encyclopedia of Genes and Genomes (KEGG) 
to classify each group of proteins (Fig. 2.6). Based on these trends we determined that 
proteins observed in all 3 replicates were most likely to be associated with active 
replication forks. Many of the proteins enriched in all 3 replicates were consistently 
observed at high levels of enrichment and have been independently validated as 
replication components, such as PCNA, the MCM complex, the RFC complex, and 
replicative polymerases (Supplemental Table 2.3). Furthermore, enrichment of these 
proteins was consistently higher with iPOND2-DRIPPER than other methods for MS 
analysis of replisome enrichment (Fig.  2.8).  
Biotin retrieval-based consensus of replication-associated proteins 
Many proteomic analyses have been performed in recent years and the amount of 
data available is growing quickly. Distilling the important information from these massive 
data sets can be a daunting task. Here we perform a comparative bioinformatic analysis 
using three published data sets in addition to our own, to help define a centralized 
consensus replisome (Fig. 2.7A and Supplemental Table 2.5) (Alabert, Lee, et al., 2014; 
Dungrawala et al., 2015; Lecona et al., 2016). We referred to these data sets as NCC-
SILAC (Alabert, Lee, et al., 2014), iPOND-SILAC (Dungrawala et al., 2015), iPOND-
iTRAQ (Lecona et al., 2016), and iPOND2-DRIPPER (this work). We matched proteins 
from all 4 data sets to one another using gene names and UniProt accession numbers. 
Human gene names were reported here, as all three other data sets were generated using 
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human cell lines. Every data set was analyzed differently and we used each laboratory’s 
own significance criteria so that we did not exclude important data (Supplemental Table 
2.4). It is also important to note that while each group was attempting to identify the 
replisome, every lab used district cell types and methods of control for removal of 
background proteins (Supplemental Table 2.4). For iPOND2-DRIPPER we included the 
proteins common in 2 or more biological replicates that met our significance threshold (see 
Materials and Methods). We classified proteins into Tiers based on the number of data 
sets that they were observed in. Tier 1 proteins were identified by all 4 data sets, Tier 2 
by 3 data sets, etc.. 
Tier 1 and 2: Replication Associated Proteins  
84% of the 42 Tier 1 proteins have been extensively shown to be associated with 
DNA replication and/or repair (Fig. 2.7B and Supplemental Table 2.5). These proteins 
included helicases, polymerases, ligases, primases, initiation factors, stability factors, 
PCNA associated factors, nucleosome remodeling factors, and repair factors. The 
proteins assigned to different functional groups in Tier 1 have also been shown to have 
additional functions related to replication and repair. Even though the four data sets used 
different methods of treatment, isolation, and analysis, they all identified these proteins, 
providing a high level of confidence that these proteins are consistently associated with 
actively-replicating forks. Not only does this help to confirm the validity of iPOND2 (in that 
it shows similar results to related protocols), but it also establishes a highly validated core 
replisome.  
Tier 2 is composed of 45 proteins that were found in 3 of the 4 data sets. Known 
replication- and repair-associated proteins represent 35% and 21% of the proteins in Tier 
2, respectively (Supplemental Table 2.5). The only Tier 2 protein that was not significant 
in the iPOND2-DRIPPER data set was CDC45 (Fig. 2.9). CDC45 only passed significance 
filters in one biological replicate of iPOND2, however, in that replicate it was still enriched 
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more than it was in other data sets. 47% of combined Tier 1 and 2 proteins have replication 
as their primary function and 21% have repair as their primary function. The next most 
abundant functional group was chromatin maintenance (9%), which included many 
proteins involved in nucleosome remodeling that must occur ahead of and directly behind 
the replication fork (Fig. 2.7B-D). The proteins in Tier 2 are likely to be consistently 
associated with actively-replicating forks, possibly indirectly, and merit follow-up 
investigations. The vast majority of Tier 1 and 2 proteins have previously been shown to 
be associated with actively replicating forks. In addition to being identified by our analysis, 
all proteins in Tier 1 and 2 were highly enriched in multiple data sets (Fig. 2.7B-D, Fig. 
2.8A-D, and Fig. 2.9). Thus, Tier 1 and 2 represent a stringent consensus replisome.  
Tiers 3 and 4: Variability between data sets 
Tier 4 and 3 proteins were observed in only one or two data sets, respectively, and 
thereby represented hits that were less likely to be stably associated with the replisome 
or more variable between cell lines. We would caution anyone using this list to perform 
extensive experiments before concluding that these proteins were associated with normal 
actively replicating forks. These proteins were likely to be transiently- or cell type 
specifically-associated with the replisome. This does not mean, however, that they should 
be disregarded as potential replication protein interacting factors. Tier 3 and 4 proteins 
may provide potentially interesting targets following the addition of replication stress to the 
system. One way to increase confidence in Tier 3 and 4 proteins is to look for other 
members of a complex known to associate with that protein. If one is able to identify other 
complex members, especially if they appear in higher Tiers, this may lend credence to the 
association of a Tier 3 or 4 proteins with the replication fork. Examination of the decreasing 
number of replication-associated components moving outward from Tier 1 to Tier 4 further 
supports the transient role of Tier 3 and 4 proteins in replication (Fig. 2.7B-D).  Replication-
associated proteins represented 60% of Tier 1, 35% of Tier 2, 3% of Tier 3, and 1% of Tier 
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4 in the iPOND2-DRIPPER data set (Fig. 2.7B). Repair-associated proteins were more 
consistently spread throughout the Tiers with 24% in 1, 21% in 2, 17% in 3, and 2% in 4. 
Repair proteins were more likely to be transiently associated with replication forks, 
supporting the validity of this analysis for determining consistent and transient replisome 
components. Finally, “Other” proteins (unable to fit into one of the defined bins) increased 
as the Tier number increased (1: 0%, 2: 2%, 3: 5%, 4: 13%); these proteins may have 
important functions at the fork but have not been analyzed thoroughly enough to determine 
their true role at the fork and may represent interesting targets for follow-up analysis.   
Discussion  
Scientific understanding of DNA replication and replication stress has expanded 
greatly within the last century. Recently, however, current methods for replication factor 
analysis are limited. Protocols that identify and quantify proteins associated with nascent 
DNA have become important for the study of replication fork dynamics despite their 
isolation of post-replicative material. Here we discuss the addition of a sucrose gradient 
(iPOND2) and DRIPPER analysis to the iPOND protocol developed by the Cortez 
laboratory (Dungrawala et al., 2015; Sirbu et al., 2013, 2012, 2011). iPOND2 has 
increased specificity is due to optimization of many factors including bead type, sample 
volume, sonication conditions, click chemistry, bead binding time, and uncrosslinking 
conditions. iPOND2 has increased the yield of known replisome components as measured 
by western blot and MS (Fig. 2.3A and Fig. 2.8). iPOND2 also decreased background 
peptides, allowing more accurate identification of peptides of interest and less signal 
masking despite the use of fewer cells. iPOND2 also allows the separation of proteins 
associated with actively replicating forks from post-replicative proteins and non-EdU-
associated replisome components, vastly increasing the replisome specificity of the pull-
down.  
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All of the existing nascent DNA pull-down data sets provide important clues about 
replisome dynamics and we have refined this information into a localized and manageable 
list. This compilation will help to inform the replication community as to the conservation 
of the interaction of a given protein with active replication forks across species. We used 
data sets from the Cortez (iPOND-SILAC), Groth (NCC-SILAC), and Fernandez-Capetillo 
(iPOND-iTRAQ) laboratories for our comparison (Alabert, Lee, et al., 2014; Dungrawala 
et al., 2015; Lecona et al., 2016). This comparison was intended to provide a centralized 
and easy-to-navigate assessment of the possibility that certain proteins appear at a 
normally progressing replication forks. There are 42 proteins that were found in all 4 data 
sets (Tier 1) and 45 proteins reported by 3 groups (Tier 2), these proteins represent the 
high confidence consensus replisome. Of the 45 proteins reported in Tier 2, iPOND2-
DRIPPER identified 44. The only protein that was not included by iPOND2-DRIPPER, 
CDC45, passed significance filters in only 1 of 3 replicates and therefore was not included 
in the final analysis (Fig. 2.9). All of the proteins reported in Tier 1 have been previously 
established to be associated with the replisome and/ or repair functions. Thus, iPOND2-
DRIPPER has allowed us to establish a clearly-defined replisome and excludes fewer 
known replisome components than other published data sets.   
Despite Tier 4 only representing proteins that were reported by one data set, it is 
important to note that the cells contributing to these data sets were all treated differently, 
and variability in identification may be a function of this difference (Supplemental Table 
2.4). For example, proteins that were identified in iPOND2-DRIPPER only could represent 
a difference between the association pattern in mice and humans. Similarly, the proteins 
that appeared only in the NCC-SILAC, may be slightly more distant from the replication 
fork, as a 20 minute rather than ten minute EdU pulse was used for this data set.   
In conclusion, iPOND2 provides an improved way of examining the replication 
forks by increasing the specificity and yield of iPOND. We created a consensus replisome 
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composed of proteins that remain stably associated with active replication forks across 
multiple cell types and isolation methods. This analysis acts as a resource for the 
replication and repair community. There are many opportunities to utilize iPOND2 that 
have not yet been explored. We have developed a method for enriching the replication 
proteins identified by iPOND and established a highly validated list of proteins associated 
with actively replicating forks.  
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Figure legends 
Figure 2.1.  Sucrose gradient fractionation of iPOND samples (iPOND2) successfully 
seperates EdU-associated active replication forks from the majority of post-replicative 
EdU. (A) Schematic of iPOND2. Samples were prepared using iPOND techniques prior to 
sucrose fractionation (see Materials and Methods). Sonication of EdU-containing DNA 
creates fragments of varying size which may or may not contain active replication forks 
(represented by the blue circle). Applying the sonicated sample to a sucrose gradient 
separates fragments based on size and density of associated complexes. Fractions were 
pulled-down and analyzed by western blot and MS. (B) 1% agarose gel showing 
distribution of fragmented DNA across sucrose gradient fractions. DNA extraction from 
sucrose gradient fractions shows a decrease in total DNA and an increase in fragment 
size corresponding to increasing fraction density. An EdU Southern showing fewer EdU-
containing fragments are retained in higher density fractions. (C) Representative western 
blot depicting iPOND2 input and pull-down fractions with indicated antibodies. This figure 
was made by combining 5 separate replicates of input or iPOND2 pulled-down samples 
prior to being run. This figure is consistent across separate runs.  
Figure 2.2. Protein accumulation in the less dense fractions of the iPOND2 sucrose 
gradient input fractions following input treatment, as measured by Coomassie- and silver-
stain.    
Figure 2.3. Specific enrichment of replication-associated proteins by iPOND2 heavy 
fractions (6-14). (A) The iPOND2 protocol pulls down more replisome specific proteins 
relative to the standard iPOND protocol when the same inputs are used for both. Western 
blot showing direct comparison of iPOND and iPOND2 fractions 6-14. 0.1% of input was 
loaded and 7.8% of the iPOND and iPOND2 samples were loaded. (B) MaxQuant analysis 
of EdU treated heavy fractions (6-14) compared to light fractions (1-5) using 1% FDR and 
SO=2, normalized by protein abundance. Peach points are non-significant and lavender 
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points represent significantly enriched proteins. A selection of relevant proteins are further 
marked and labeled. 
Figure 2.4. Replisome-associated proteins are enriched in EdU treatment compared to 
Thy chase in the dense (6-14) and less dense (1-5) fractions. Volcano plot showing the 
Log base 2 means of the proteins identified in the EdU and Thy heavy fractions (6-14) and 
light fractions (1-5) versus the negative Log p-values. Peach points represent proteins 
which were not significantly different in representation between the samples with an FDR 
of 1% and 2 standard deviations, normalized to protein abundance. Lavender points 
represent significantly enriched proteins. (A) Thy chase heavy compared to light fractions. 
(B) EdU compared to Thy light fractions. (C) EdU compared to Thy heavy fractions. 
Figure 2.5. iPOND2-DRIPPER reproducibly enriches of replisome- and repair-associated 
proteins. (A) Significant proteins enriched more then 2.9-fold in EdU treated samples 
compared to the Thy chase in each of three iPOND2-DRIPPER replicates. Replicates 1, 
2, and 3 were run using 5, 2, and 2 iPOND2 samples, respectively. The full list of proteins 
can be found in Supplemental Table 2.3. (B) Pie chart representation of the manually 
binned functional distribution of proteins observed in all 3 replicates shows enrichment of 
proteins with replication- and repair-related functions (inner circle).  Pie chart 
representation of the manually binned functional distribution of proteins observed in only 
2 of 3 replicates (24, 34, and 167) (outer circle). Manual binning was performed as follows: 
each protein was assigned to a functional group based on GO term analysis, GeneCards, 
Uniprot, and PubMed based analysis of the protein. Next, bins were condensed into more 
generic bins for ease of representation in pie chart form. (C) Log2  ratio of the percent of 
proteins in each functional group in all 3 replicates to the number of proteins in that group 
observed in 2 of 3 replicates.  
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Figure 2.6. DNA replication and repair proteins are enriched across three replicates as 
determined by Kyoto Encyclopedia of Genes and Genomics (KEGG). The FDR used for 
all KEGG analyses was <0.05. Pathways are organized from smallest to largest FDR. 
Figure 2.7. Development of a consensus replisome based on current high-throughput 
data sets. (A) Comparison of significantly enriched replisome proteins from NCC-SILAC, 
iPOND-SILAC, iPOND-iTRAQ, and iPOND2-DRIPPER. Significance calculations were 
made by each group, subsequently, differing slightly from one another (Supplemental 
Table 2.4). (B) Pie chart representation of the manually binned functional distribution of 
proteins observed in Tier 1 (inner circle), 2, 3, and 4 (outermost circle) for iPOND2-
DRIPPER. (C) Graphical representation of data displayed in B, showing the Tier 1 
enriched functional groups compared to the Tier 4 enriched groups. Tier 1: blue, Tier 2: 
red, Tier 3: green, Tier 4: purple. (D) Log2 ratio of the percent of proteins from Tier 1 and 
2 in each functional group to the percent of proteins from Tier 3 and 4 in each functional 
group shows enrichment of replication- and repair- related proteins in the lower Tiers.  
Figure 2.8. iPOND2 allows a high detection level of replication proteins in Tier 1 and 2 
compared to enrichment by other data sets. iPOND2-DRIPPER: Blue, iPOND-SILAC: 
Red, iPONd-iTRAQ: Yellow, NCC-SILAC: Green. (A) Log2 enrichment of Tier 1 proteins 
in iPOND2-DRIPPER (replicate 1), NCC-SILAC, iPOND-SILAC, and iPOND-iTRAQ. 
KIAA0101 is PAF15. (B) Log2 enrichment of Tier 2 proteins in iPOND2-DRIPPER, iPOND-
SILAC, and NCC-SILAC. (C) Log2 enrichment of Tier 2 proteins in iPOND2-DRIPPER, 
iPOND-SILAC, and iPOND-iTRAQ. (D) Log2 enrichment of Tier 2 proteins in iPOND2-
DRIPPER, iPOND-SILAC, and NCC-SILAC. 
Figure 2.9. iPOND2 represents the highest enrichment of CDC45 across data sets. 
CDC45 (the sole tier 2 protein not passing iPOND2-DRIPPER significance filters) 
enrichment in all data sets. CDC45 was significant only in replicate 1 for iPOND2-
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DRIPPER.  iPOND2-DRIPPER: Blue, iPOND-SILAC: Red, iPONd-iTRAQ: Yellow, NCC-
SILAC: Green. 
Supplemental Tables 
Supplemental Table 2.1. Information for antibodies used for western blot analysis. 
Supplemental Table 2.2. Proteins identified by MaxQuant analysis of EdU v. Thy chase 
samples from experimental replicate number 3.     
Supplemental Table 2.3.  Comprehensive list of proteins identified in all replicates of EdU 
v Thy chase by iPOND2-DRIPPER. Only significant proteins observed in 2 or more 
replicates were manually binned. 
Supplemental Table 2.4. Experimental differences between data sets used for 
bioinformatics establishment of the consensus replisome. 
Supplemental Table 2.5. The complete list of all proteins identified across all Tiers. 
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Summary 
iPOND2-DRIPPER represents a substantial improvement in isolation of replisome 
components from whole cell lysate compared to previous methods of isolation. In Chapter 
2 we detailed the improvements made to iPOND in order to generate iPOND2. In this 
chapter we used iPOND2 to monitor changes in replication fork dynamics following a 
variety of replicative stress treatments. These treatments included APH, p97 inhibition, 
and ATR inhibition and ATR knockout. We discussed the recruitment of repair proteins 
following replication stress that can be used to further validate iPOND2’s successful 
isolation of replication forks under a variety of conditions. Changes in the consensus 
replisome following replication stress were also assessed, and possible targets of p97 
segregase regulation were noted for further investigation. We explored the overall trends 
in protein regulation in response to ATR depletion with or without stress as well as changes 
in specific replication proteins. Finally, we confirmed some of our ATRKO data using an 
ATR inhibitor run through a different Mass Spec protocol to limit trends due to analytical 
technique. Overall, this chapter presents a wealth of data that will act as a resource to 
guide further exploration.  
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Introduction  
Components of the replication fork have a wide array of responses to different 
types of stress at various points during the cell cycle. In many cases the cell has redundant 
mechanisms for resolving replication stress due to the importance of faithful replication, 
however, loss of key repair factors can lead to cell death and embryonic lethality (Cubillos-
rojas et al., 2016; Vazquez et al., 2016). Defects in replication repair pathways often result 
in severe phenotypes, increased disease susceptibility, and death. One example is 
Fanconi Anemia (FA), a degenerative bone marrow disease that stems from the inability 
of cells to repair interstrand crosslinks (ICLs) (Tan & Deans, 2017). There are currently 
over 20 known FA complex members, with new regulators being discovered each year, 
many that cause ICL sensitivity if lost (Renaudin, Koch Lerner, Menck, & Rosselli, 2016). 
Understanding the regulation of proteins in essential repair pathways and how the 
consensus replisome is regulated in response to stressors provides an important 
expansion in our ability to assess and treat the causes of diseases rather than the 
symptoms alone.  
Furthermore, understanding replication stress response to excessive DNA 
damage has contributed to development of many anti-cancer drugs. For example, the 
Ataxia-telangiectasia mutated and Read3-related (ATR) cell cycle checkpoint is an 
important regulator of cell stress and repair, and inhibitors of ATR and CHK1, a down-
stream regulator of the ATR checkpoint, are in phase 1 trials for treatment of cancer (Hong 
et al., 2016). These drugs rely on prevention of cell cycle stalling in conjunction with 
increased levels of damaging agents in cancer cells so that damage accumulates and is 
not repaired prior to division, leading to cell death. Despite the success of these drugs in 
clinical trials, recent studies have exposed alterative pathways for DNA damage repair 
and cell cycle progression that bypass the ATR checkpoint. For example, inhibition of 
PLK1 and RNF4 in conjunction with ATRKO allows replication to continue following fork 
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stalling, preventing fork collapse and DSB formation (Ragland et al., 2013). This ATR 
checkpoint bypass can result in treatment resistance in cancers treated with ATR and 
CHK1 inhibitors, making it an important avenue of investigation (Min et al., 2017; Viziteu 
et al., 2017).  
Despite its importance in regulation of healthy replication, there are still many 
questions regarding the direct role of ATR at the replication fork following stress. To date 
there are three main models addressing the checkpoint-independent role of ATR in 
preventing fork collapse following prolonged replication stress. First, ATR and its binding 
partner, ATRIP, act directly at the fork to stabilize the replisome until the damage can be 
repaired so that the fork can proceed normally following damage resolution (Carr et al., 
2011; Ragland et al., 2013). Second, some types of replication stress, such as APH 
treatment, result in uncoupling of the helicase and the polymerase, creating tracks of 
ssDNA that are bound by replication associated protein A (RPA) to prevent digestion. 
Toledo et al. argue that in the absence of ATR origin firing is increased, resulting in a 
process known as RPA exhaustion, leading to accumulation of DSBs (Toledo et al., 2013). 
Finally, the third model holds that ATR directly regulates fork repair proteins, such as the 
DNA translocase SMARCAL1, to limit fork remodeling activity that can form cleavage 
structures and lead to DSB formation (Couch et al., 2013). The data has been unclear 
regarding which of these models is most likely to be the dominant mechanism of action in 
ATR’s prevention of DSB formation. Furthermore, it remains possible that ATR’s role in 
DSB prevention is an indirect product of its regulation of the cell cycle. The system is very 
complex, for example, the ability of CDK1 to activate WRN-dependent DSB formation 
(Palermo et al., 2016). It is vital to more fully understand the dynamics of the replication 
fork following replication stress to identify additional drugable targets that can be used to 
prevent ATR checkpoint bypass. Clarifying ATR’s role in fork protection would represent 
an important advancement for basic biology in addition to disease treatment.  
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Finally, many studies have emphasized the importance of ubiquitylation in 
regulation of DNA replication and repair (Branzei, Seki, & Enomoto, 2004; Ragland et al., 
2013; Shi et al., 2008). Subsequently, a thorough assessment of replisome response to 
stress would include an investigation of changing proteins regulated by ubiquitin 
modification and levels of ubiquitylation (see Chapter 5). p97/VCP/Cdc48/Ter94 is a 
ubiquitin segregase that, in conjunction with a series of adaptor proteins, is responsible 
for removal of ubiquitylated proteins from chromatin for recycling or degradation 
(Buchberger, Schindelin, & Hänzelmann, 2015).  Understanding the role of p97 segregase 
in regulation of replisome response to stress would help clarify the complex mechanisms 
of regulation of these proteins. 
The improvements made to iPOND detailed in Chapter 2 provided the tools 
necessary to enhance our understanding of replication fork dynamics following replication 
stress. In this chapter we monitor changes in replisome components identified by iPOND2-
DRIPPER following replication stress with or without ATR knockout and/or p97 inhibition. 
We were able to identify multiple expected, interesting, and surprising trends of replisome 
proteins under various treatment conditions that merit further investigation. Here we 
discuss the wide scope of the impact of iPOND2-DRIPPER in expansion of the DNA 
replication field.  
Materials and Methods 
Cellular Treatment 
The control cells were treated with 20 µM EdU for 10 min. Experimental samples 
were treated as follows; APH: EdU for 5 min followed by the addition of APH for specified 
time, p97 inhibition/ CB5083: 10 µM CB5083 was added to cells for indicated time followed 
by addition of 20 µM EdU without washout of CB5083, APH + CB5083: cells were pre-
treated with CB5083 for 20 min, 20 µM EdU was added for 5 min and APH was added for 
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the indicated time with no washout (Fig. 3.1). Knockout of ATR was achieved through 
tamoxifen treatment 48 hours prior to the indicated treatment and harvested. 1 µM 
ATRN119 was used for indicated time periods to inhibit ATR (Atrin Pharmaceutical Inc., 
unpublished data).   
Western blot analysis 
See Chapter 2. 
EdU Southern 
See Chapter 2.  
DNA combing 
Samples were treated with 5 µM BrdU for 20 min prior to EdU treatment. Cells 
were treated as detailed in “Cellular Treatment”, harvested following APH treatment, and 
analyzed by DNA fiber labeling and combing (Ragland et. al, 2015). 
iPOND2-DRIPPER 
See Chapter 2.  
Data Analysis: Coefficient of Variance (Cv) 
The simultaneous DRIPPER analysis of multiple samples establishes a data set 
composed of all peptides observed in all of the samples, whether or not they were 
significantly different from the Thy baseline by Student’s t-test. In this chapter we used all 
peptides that passed the significance filters detailed below for quantification of proteins in 
each condition. For analysis of changing proteins with replication stress we applied a 
coefficient of variance (Cv) test. We calculated the mean of the technical replicates of 
each peptide with a Cv <1 in both treatments to calculate fold change following imputation 
using half the limit of detection (LOD). The median fold change of all peptides identified 
for each protein was used to represent protein fold change and a 2-tailed Student’s t-test 
was used to determine if the two samples had significantly different quantities of each 
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protein based on peptide fold change variation. Proteins identified by single peptides were 
not considered significant by t-test. 
Column cleaning of the second replicate 
Replicate 2 samples were cleaned up following initial precipitation and in-gel 
digestion using both C18 STAGE tips and MCX STAGE tips prior to DRIPPER analysis in 
order to remove plastic residue of unknown source (Rappsilber, Ishihama, & Mann, 2003).  
 
 
MaxQuant analysis of ATRN119 treated samples  
The protein eluate was concentrated by precipitation using chloroform (CHCl3)-
methanol (MeOH) precipitation (Wessel & Flügge, 1984). The protein pellet from CHCl3-
MeOH precipitation was resuspended in SDS sample buffer. For protein separation by 
SDS–PAGE the NuPAGE 1DE System was used (NuPAGE Novex 4–12% bis–tris 1.5 
mm x 10 well gels, Invitrogen, USA). Visualization of separated proteins was performed 
by overnight staining with Coomassie blue G-250 solution. The in-gel tryptic digestion 
followed by peptide extraction from the gel bands was performed (Shevchenko, Wilm, 
Vorm, & Mann, 1996). The extracted peptides were desalted using Poros Oligo R3 RP 
micro-columns prior to nLC–MS/MS analysis. 
Dried samples were resuspended in buffer-A (0.1% formic acid) and loaded onto 
an Easy-nLC system (Thermo Fisher Scientific, San Jose, CA, USA), coupled online with 
an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific). Peptides were loaded 
into a picofrit 18 cm long fused silica capillary column (75 µm inner diameter) packed in-
house with reversed-phase Repro-Sil Pur C18-AQ 3 µm resin. The gradient length was 
90 min from 4-28% buffer-B (100% ACN/0.1% formic acid), at a flow rate of 300 nl/min. 
The MS method was set up in a data-dependent acquisition (DDA) mode. For full MS 
scan, the mass range of 350-1200 m/z was analyzed in the Orbitrap at 120,000 resolution 
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(FWHM at 200 m/z) and 5x10e5 AGC target value. For MS/MS, HCD collision energy was 
set to 27, AGC target to 10e4 and maximum injection time to 200 msec. Detection of 
MS/MS fragment ions was performed in the ion trap in the rapid mode using the TopSpeed 
mode (3 sec).  
Raw MS files were processed using MaxQuant, version 1.5.5.1 (Cox & Mann, 
2008). The peptide MS/MS spectra were searched by the Andromeda search engine (Cox 
et al., 2011) against the UniProtKB/Swiss-Prot Reviewed Mouse Reference Proteome 
database [10090] (retrieved on November 2015), containing 16,727 entries excluding 
isoforms. Additionally, the database included 247 common contaminants, discarded 
during data analysis. The search of the unmodified fraction included variable modifications 
of methionine oxidation and N-terminal acetylation, and fixed modification of 
carbamidomethyl cysteine. Analysis of ubiquitinated peptides included additionally diglycyl 
of lysine residues. Fragment ion tolerance was set to 0.5 Da. Trypsin was specified as the 
digestive enzyme. Minimal peptide length was set to seven amino acids and a maximum 
of two missed cleavages was allowed. The false discovery rate (FDR) was set to 0.01 for 
peptide-spectrum matches (PSMs) and protein identifications. Protein grouping was 
enabled. Peptide identification was performed with an allowed precursor mass deviation 
up to 4.5 ppm after time-dependent mass calibration and an allowed fragment mass 
deviation of 20 ppm. Protein identification required at least one unique or razor peptide 
per protein group. Label-free quantification in MaxQuant was performed using the 
intensity-based absolute quantification (iBAQ) algorithm (Schwanhausser et al., 2011). 
For matching between runs, the retention time alignment window was set to 20 min and 
the match time window was 1 min. Protein tables were filtered to eliminate the 
identifications from the reverse database, only identified by site and common 
contaminants. 
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Results  
Analysis of EdU incorporation  
Many recent studies have investigated what happens to the replisome following 
replication stress, however, the results of these studies have been inconsistent 
(Dungrawala et al., 2015; Ragland et al., 2013). We hypothesize that this inconsistency is 
due to variability and low resolution in assays used to monitor replisome retention. We first 
wanted to make sure that variations observed were not due to differential EdU 
incorporation, as occurs with some treatments including the doses of HU required for fork 
stalling (Fig. 3.2). In order to ensure that changes in replication protein retention at the 
fork were not dependent on altered EdU incorporation, we performed a series of DNA 
combing experiments to determine the amount of EdU incorporated following each 
treatment examined in this chapter (Fig. 3.3). Treatment with APH, CB5083 (a p97 
inhibitor), and ATRKO combined with APH treatment had similar track lengths to EdU 
treatment alone, indicating that overall, EdU incorporation was similar. Combined 
inhibition of p97 and APH treatment resulted in a slightly decreased track length with and 
without ATR (Fig. 3.3). Despite this insignificant decrease, the sonication and gradient 
fractionation employed by iPOND2 likely mitigated any changes that would have resulted 
from differential EdU incorporation. Thus, we could examine changes in replisome 
retention at the forks without worrying about biased results due to altered EdU 
incorporation. 
Comparison between replicates 
Having limited labeling as a source of technical variation, we sought to characterize 
replisome component changes following short-term fork stalling using iPOND2-DRIPPER. 
We performed 2 biological replicates of our first set of experimental conditions, in which 
we tested the response of the replisome to stress by APH and p97 inhibition. We used 
APH treatment for replication stress as it causes the accumulation of ssDNA through the 
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uncoupling of the DNA helicase and polymerase via polymerase inhibition, resulting in 
ATR activation without limiting nucleotide incorporation. Each of the following conditions 
were run together in two biological replicates; Thy, EdU, 2 and 4 hr APH, 2 and 4 hr 
CB5083, 2 and 4 hr CB5083 + APH. The second replicate had a contaminant and had to 
be further cleaned resulting in identification of fewer peptides (see Materials and 
Methods). While there are likely differentially regulated targets that are important for 
further investigation, we included only co-regulated proteins between both replicates in 
our analysis here (Fig. 3.4, Fig. 3.5, and Supplemental Table 3.1). Overall, more proteins 
were significantly decreased than increased in both replicates (Fig. 3.5 A and E). The 4 hr 
CB5083 treatment was unique, as there were more significantly increased than decreased 
proteins, consistent with p97 contributing to the removal and degradation of proteins (Fig. 
3.5D and Table 3.1).  
Recruitment of repair machinery to the replisome in response to stress 
Proteins associated with ATR activation, including RPA1-3, HUS1, RAD9a, ATRIP 
and ATR, increased approximately 8-150-fold upon fork stalling at both 2 and 4 hrs (Fig. 
3.6A and D). As expected, no ATR or ATRIP was observed at the replication fork in any 
ATRKO conditions, however, HUS1 and TOPBP1 were significantly enriched following 
APH treatment in cells lacking ATR, consistent with their roles binding DSBs (Fig. 3.6A, 
D, and Supplemental Table 3.2). Although we did not have a replicate of the ATRKO data 
set, we conducted an analysis using quantitative MaxQuant of iPOND2 samples treated 
with ATRN119, a potent and specific ATR inhibitor, for 2 hrs with or without APH treatment 
(Supplemental Table 3.3). While RAD9a was not present in any of the iPOND2-DRIPPER 
samples with ATRKO, it was increased following ATRN119 treatment (Supplemental 
Table 3.3). In addition, many well-characterized repair factors were recruited to forks upon 
stalling, such as ATM, MDC1, 53BP1, FANC complex members, SMARCAL1, and BLM, 
suggesting a substantial recombinogeneic response to fork stalling, consistent with 
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previous observations (Fig. 3.6B and E) (Cahill, Connor, & Carney, 2006; Dungrawala et 
al., 2015; Ragland et al., 2013).  
Similarly, the core BRCA1-A complex (BRCA1, BARD1, ABRAXAS, MERIT40, 
BRCC36 and RAP80), RAD18, and USP37 were upregulated in response to replication 
stress, consistent with K63 upregulation (Fig. 3.6C, F, and Table 5.2). Other notable 
recruited factors included RAD51, not previously observed in iPOND retrievals upon APH 
stalling, the RTEL1 helicase, and the DNA endonuclease CTIP (RBBP8) that are both 
important for repair of replication forks. SMARCAL1, a Tier 2 member of the consensus 
replisome, was upregulated following APH treatment, consistent with prior reports (Couch 
et al., 2013). Furthermore, while the levels of SMARCAL1 were never increased above 
those exhibited by 2 hr APH treatment, ATRKO and ATRN119 treatment alone were both 
sufficient to significantly increase levels of SMARCAL1 (Fig. 3.6B, E, and Supplemental 
Table 3.3). This pattern was repeated with ATRKO when protein levels were normalized 
to ATRKO rather than EdU (Fig. 3.7B). These results support the model of ATR fork 
protection in a manner associated with SMARCAL1 regulation. 
 
 
Detection of nuclear pore-associated proteins following replication stress 
Recent data suggests that damaged DNA localizes to the nuclear pore in yeast and 
drosophila, thus we wanted to examine the association of these protiens with the 
replication fork following stress in mammalian systems. We observed a significant 
increase in LINC complex member, SUN2, at the replication fork following fork stalling with 
2 hr APH compared to EdU treatment (Fig 3.8A). While SUN2 was not observed at 4 hr 
APH, it was significantly increased with 4 hrs of APH and p97 inhibition (Fig. 3.8B). Other 
LINC associated cytoskeletal structures, LMNA-B2 and FLNA-C, and many nuclear pore 
components were upregulated following 2 hr of replication stress, however, were largely 
65 
 
downregulated with 4 hrs of APH treatment (Fig. 3.8). While 2 hr dual treatment did not 
record lamins or filamins, 4 hr dual treatment significantly increased lamin association with 
the replication fork (Fig. 3.8B). ATRKO or ATRN119 treatment alone significantly 
decreased the representation of the SUN1, LMN, and FLN complexes at all time points 
examined (Fig. 3.8 and Supplemental Table 3.3). For all of the nuclear pore and 
cytoskeletal proteins examined p97 inhibition rescued replication fork association 
following APH treatment after 4 but not 2 hrs of treatment, and loss of ATR prevented this 
rescue (Fig. 3.8 and 3.9B). These data suggest roles for both ATR and p97 in the 
localization of damaged forks to the nuclear pore, a hypothesis largely unexplored in 
mammalian systems. 
Consensus replisome response to replication stress 
iPOND2-DRIPPER allowed us to track changes in the consensus replisome 
following different stress conditions. We observed significant upregulation of only a few 
core replisome components following APH stress, including POLD and RPA (Fig. 3.10). 
While there were more upregulated Tier 2 replisome components than were observed in 
Tier 1, the majority of consensus replisome components were downregulated (Fig. 3.11). 
All of the upregulated proteins in the 2 hr APH treatment were significantly increased but 
were inconsistent, not observed, or insignificant after 4 hrs of APH treatment. Among 
these proteins only RAD18 and MMS22L were observed with combined APH treatment 
and p97 inhibition, however, the enrichment’s observed were not significantly different 
from those observed with APH treatment alone (Table 3.4).  
The most enriched Tier 1 protein rescued by p97 inhibition was DTL, suggesting 
that p97 segregase may be responsible for the removal of DTL from replication forks (Fig. 
3.10). DTL was one of the few proteins that were significantly increased with 4 hr p97 
inhibition alone compared to EdU. While ATRKO increased DTL levels moderately 
compared to EdU, combination with p97 inhibition further increased DTL levels, both with 
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and without APH treatment, further supporting a role for p97 in regulation of DTL (Fig. 
3.10). When compared to EdU treatment, dual treatment did not have a significant effect 
on the MCM helicase in cells lacking ATR, however, when normalized to ATRKO alone 
the MCM helicase showed significant decrease following this treatment (Fig. 3.12). Both 
DTL and the MCM helicase were significantly enriched with dual treatment compared to 
APH treatment (Fig. 3.9C). Following 2 hr ATRN119 treatment the MCM helicase 
representation at the fork decreased. This decrease continued with ATR inhibition + APH 
for 2 hrs (Supplemental Table 3.3). This suggests a potential role for p97 in the regulation 
of consensus replisome components, DTL and the MCM helicase, in response to stress.  
Global changes in replication proteins in response to ATRKO 
To assess global changes in protein patterns following replication stress we used 
a Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis to identify significantly 
enriched or decreased functional protein groups in each ATRKO treatment described 
above. ATRKO alone resulted in significant upregulation of multiple pathways associated 
with DNA replication and repair (Fig. 3.13, 3.14). All of the ATRKO treatment conditions 
other than those treated with CB5083 for 4 hrs demonstrated an enrichment of the DNA 
replication protein group by KEGG compared to EdU treatment alone; however, many of 
these treatments also show a decreased DNA replication protein group by KEGG (Fig. 
3.13). These patterns support the conclusion that replication-associated proteins are 
highly dynamic following replication stress. Unsurprisingly, all of the ATRKO treatment 
conditions resulted in enrichment of DNA repair related protein groups by KEGG (Fig. 
3.14). Multiple protein groups including, spliceosome and RNA transport were significantly 
decreased compared to EdU (Fig. 3.14). These enrichment groups can be used to help 
guide hypothesizes and future experiments and help determine which identified proteins 
might be most important for further investigation.  
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Discussion  
We originally developed the iPOND2-DRIPPER protocol to assess replisome 
dynamics under a variety of replication stress conditions. This chapter explores some of 
our most interesting preliminary findings and the potential implications of these findings. 
After ensuring that our results would not be skewed due to changing treatment conditions 
we were able to examine a series of conditions designed to address replisome response 
to APH stress with or without ATR and/or p97 segregase. We preformed 2 replicates of 
our first set of experimental samples. Although the second replicate had a contaminant 
and necessary cleaning reduced the peptide numbers recorded, we were still able to 
identify over 2000 proteins that were co-regulated relative to EdU treatment (Supplemental 
Table 3.1). We decided that these co-regulated proteins would provide the clearest picture 
of changing replisome components and help to eliminate any technical variation, so in this 
report these were the proteins we focused on, however, all of the identified proteins can 
be found in Supplemental Table 3.1, 3.2, and 3.3. Some of these proteins may be exciting 
targets for further investigation, particularly those identified in replicate 1 but not replicate 
2, as they may simply have been lost during the cleaning of replicate 2.  
Having identified the co-regulated proteins, we were able to query the data set for 
changes in known DNA repair and replisome-associated proteins following different 
treatments. ATR, ATRIP, HUS1, RAD9a, RPA, and TOPBP1 were recruited to the fork 
following replication stress by APH, supporting previous reports of recruitment of ATR and 
related proteins to stalled replication forks and validating iPOND2-DRIPPER as a useful 
analytical tool (Fig. 3.6A and D) (Cimprich & Cortez, 2008). Unsurprisingly, ATR and 
ATRIP were not observed at the fork in cells lacking ATR, however, HUS1 and TOPBP1 
remained upregulated in these samples. The maintenance of HUS1 and TOPBP1 at the 
fork in cells lacking ATR but having undergone replication stress was consistent with the 
role of these proteins in upstream activation of the ATR checkpoint (Navadgi-Patil & 
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Burgers, 2009). RAD9a, part of the 9-1-1 complex with HUS1 was also upregulated 
following inhibition of ATR when measured using the Fusion MS (Supplemental Table 3.3). 
It is likely that RAD9a was not identified by iPOND2-DRIPPER because it was not one of 
the most drastically changing proteins, suggesting the utility of analysis of iPOND2 by 
multiple MS methods.  
Many other well-established repair factors were also recruited by APH treatment, 
including ATM, BLM, FANC, MDC1, SMARCAL1, p53, and the BRCA1-A complex, as 
expected (Cahill et al., 2006; Dungrawala et al., 2015; Y. Kim et al., 2013; Ragland et al., 
2013). Of note, the increase in the BRCA1-A complex coincided with an increase in K63 
ubiquitin known to regulate this complex, presenting the possibility that we may be able to 
match ubiquitylation patterns to complex patterns across multiple treatment conditions to 
identify ubiquitin substrates (Ng, Wei, Lan, & Huen, 2016). Additionally, iPOND2 was able 
to identify increases in some repair proteins not previously identified by iPOND-MS, 
including RAD51, RTEL helicase, and DNA endonuclease CTIP (RBBP8), under 
conditions of replication stress, emphasizing the improvement in monitoring replisome 
dynamics by iPOND2 (Dungrawala et al., 2015). While many of the changes observed 
were not surprising, they pave the way for further exploratory treatments using iPOND2 
isolation techniques.    
Additionally, we observed increased filamins, lamins, SUN complex members, and 
multiple nuclear pore proteins following APH treatment (Fig. 3.8). A previous iPOND–MS 
study also observed a small increase in FLNA-B, LMNB, and a variety of nuclear pore 
components following 2 hrs APH treatment (Dungrawala et al., 2015). Taken together 
these data suggest that stalled replication forks may be transported to the nuclear pore 
for repair in response to acute stress and removed at longer time points (Dungrawala et 
al., 2015). With the growing appreciation for the importance of localization within the 
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nucleus of certain functions (such as transcription and replication factories), more scrutiny 
must be applied to nuclear proteins previously considered to be background.  
Data directly linking nuclear pore and cytoskeletal proteins to DNA replication and 
repair is still limited. A functional genomics analysis of a new class of eukaryotic Y-NUPs 
(NUP84/ NUP107-160) suggested the association between NUPs and multiple nuclear 
processes, including DNA repair and chromatin maintenance (Katsani et al., 2014). The 
authors specifically note the association of RAD51 with Nup160, Nup107, Nup133, and 
Nup43, all of which were identified by iPOND2-DRIPPER, across species. Additionally, 
recent evidence showed that accumulation of prelamin A (LMNA) in U2OS cells resulted 
in increased levels of DNA damage that, the authors hypothesized, was due to LMNA’s 
ability to out-compete mature lamin A for replication fork binding necessary to stabilize 
replication forks (A. M. Cobb et al., 2016). In our analysis we observed a significant 
increase in LMNA levels following replication stress, confirming the recruitment of LMNA 
to replication forks following stress, although whether it is a help or hindrance remains 
unclear (Fig. 3.8).  
Some reports have shown an effect of lamin-associated SUN1 and SUN2 deletion 
on the DNA damage response (Lei et al., 2012; Lottersberger et al., 2015). The results of 
short APH treatment, as characterized by iPOND2-DRIPPER, were consistent with these 
findings and emphasized the importance of investigating the nuclear localization of 
damaged replication forks. The increases we observed in filamins, lamins, and NUPs after 
2 hrs of stress were often not maintained after 4 hrs of stress unless p97 was inhibited 
(Fig. 3.8). Thus, it is possible that recruitment of stalled forks to nuclear pores by 
cytoskeletal factors is time dependent and regulated by p97-dependent removal of 
ubiquitylated proteins following extended fork stalling. Finally, both ATRKO and ATRN119 
treatment alone resulted in the significant downregulation of multiple filamins, lamins, and 
NUPs compared to EdU treatment, suggesting that ATR may function in recruitment of 
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lamins to sites of replication fork stalling (Fig. 3.8 and Supplemental Table 3.3). This 
hypothesis is consistent with data found in yeast suggesting a partial role for ATR (Mec1) 
in localization of damage to the nuclear pore (Nagai et al., 2008). We also observed that 
the accumulation of nuclear pore related proteins at the fork with p97 inhibition was 
mitigated when ATR was absent (Fig. 3.7D). ATR has been reported to have a pivotal role 
association of APAF-1 with the nuclear pore and subsequent nuclear import, however, 
ATR driven recruitment of replication forks to the nuclear pore has not been previously 
reported in mammals (Jagot-Lacoussiere et al., 2015). We hypothesize that stalled 
replication forks are localized to nuclear pores by cytoskeletal factors, such as lamins, for 
repair in an ATR and p97-dependent manner.  
We examined the regulation of the consensus replisome, as established in Chapter 
2, following replication stress in an attempt to help clarify the role of ATR in DSB 
prevention. When we examined the APH-driven changes of the consensus replisome we 
only observed a few significantly increased proteins, including RPA, MMS22L, and POLD, 
with the majority of the replisome being down-regulated in response to stress (Fig. 3.10). 
The observed recruitment of the repair factors such as RPA and MMS22L within the 
consensus replisome to the forks following stalling was consistent with previous reports 
(Dungrawala et al., 2015). Increased POLD at the replication fork following stress, 
however, has not been widely documented. POLD has been suggested to be involved in 
an alternative break excision repair (BER) pathway following replication stress, potentially 
accounting for its increased representation at the fork following APH treatment (Fortini et 
al., 2003). Further investigation into the role of POLD at stalled replication forks will need 
to be conducted to further examine its potential function in repair of stalled replication 
forks. 
Following 4 hrs of CB5083 and APH treatment, MCM helicase levels were 
significantly increased compared to APH treatment alone, despite no observable increase 
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compared to EdU (Fig. 3.9C and D). It appears that p97 segregase contributes to the 
removal of the MCM helicase following prolonged replication stress, a previously 
unexplored hypothesis, despite the known role for p97 in MCM helicase removal following 
fork termination (Maric et al., 2014; Moreno et al., 2014). Despite the fact that the MCM 
helicase representation at the fork did not change substantially following APH treatment 
alone, the MCM helicase decreased with both ATRKO and ATR inhibition following 
replication stress and p97 inhibition. This decrease is consistent with the trends shown by 
the MCM helicase following dual treatment in the presence of ATR at all time points (Fig. 
3.10 and 3.12). This data seems to contradict the model of ATR as a direct contributor to 
replisome retention following replication stress, consistent with previous data from high-
throughput analysis of iPOND-SILAC data (Dungrawala et al., 2015). Furthermore, the 
insignificantly increased RPA following replication stress when compared to ATRKO 
contradicts the RPA exhaustion hypothesis (Fig. 3.10). RPA in ATRKO cell compared to 
EdU was significantly increased, however, APH treatment alone increased RPA more than 
any ATRKO treatment, calling this hypothesis into question (Fig. 3.10 and 3.14). Finally, 
the significant increase in SMARCAL1 at replication forks following ATRKO or ATRN119 
treatment was consistent with a role in ATR limiting SMARCAL1’s accumulation at the 
replication fork and the third model of DSB prevention detailed above (Fig. 3.6) (Couch et 
al., 2013; Dungrawala et al., 2015). KEGG analysis of the data gathered herein illustrates 
the immense complexity of replisome variation that takes place, and the large number of 
inter-related pathways involved in these changes. High-throughput analysis of replication 
stress is the most efficient way to investigate large scale changes in protein groups and 
complexes following different stressors. 
Additionally, it is important to note that p97 appears to play an important role in 
regulation of some core replisome components following replication stress. For example, 
DTL (CDT2) was significantly upregulated with p97 inhibition alone and rescued by p97 
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inhibition at both 2 and 4 hours following replication stress both with and without ATR (Fig. 
3.9C and 3.10). DTL in complex with E3 ubiquitin ligase CRL4 regulates replication 
licensing factor CDT1 under normal conditions and in response to DNA damage (Arias, 
Arias, Walter, & Walter, 2007; Arias & Walter, 2006; Kirchmaier, 2011). CDT1 binds to 
PCNA under conditions of replication stress and DTL has been shown to contribute to 
PCNA monoubiquitylation  at lysine K164 to promote TLS (Terai, Abbas, Jazaeri, & Dutta, 
2010). p97 and its adaptor, UFD1, have been linked to the regulation of DTL-ubiquitylated 
substrates, however, p97 has never been implicated in the direct regulation of DTL 
(Raman, Havens, Walter, & Harper, 2011). The data presented here suggest two potential 
models of DTL regulation by p97. Firstly, it is possible that p97 is responsible for the 
removal of DTL through an unreported ubiquitylation event. Secondly, it is possible that 
DTL remains present at its site of ubiquitylation until p97 is recruited and that inhibition of 
p97 subsequently prevents DTL loss from the replication fork. Regardless of the model 
that holds true, further investigation of the regulation of DTL by p97 will help expand our 
understanding of both normal replication and replisome response to replication stress.  
Overall, these preliminary analyses using iPOND2 have generated many intriguing 
hypothesis for further investigation and presented data contradicting one of three models 
of ATR DSB prevention. Our analysis here provides insight into regulation of the 
consensus replisome and repair proteins by replication checkpoint protein ATR and 
ubiquitin segregase p97. There is still are large amount of validation and exploration of 
the data sets that remains to be done, however, this data represents a high potential for 
advancement of our understanding of replisome dynamics following replication stress and 
an important resource for the replication community.  
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Figure Legends  
Figure 3.1. Illustration of treatment protocols used for cell treatment with EdU and drugs.  
(A) Control 20 µM EdU (green) treatment. (B) 10 µM APH treatment (purple) for specified 
time with EdU. (C) 10 µM CB5083 treatment/ p97 inhibitor (orange) for specified time with 
EdU for 10 min. (D) 10 µM CB5083 treatment/ p97 inhibitor (orange) with EdU for 5 min 
and addition of APH (purple) for specified time. 
Figure 3.2. EdU incorporation can be altered following different drug treatments used. (A) 
Schematic clarifying treatment times prior to harvest. EdU (green) remained in media 
during drug treatment (purple). (B) Western blot analysis of input and iPOND pull-down 
samples following different drug treatments. EdU Southern was also performed on DNA 
digested off iPOND beads. 
Figure 3.3. EdU incorporation of all treatment conditions used in this thesis was similar 
across conditions. Track length v. the frequency of EdU incorporation for the types of 
treatment used in this chapter. These measurements were taken following DNA combing 
and are compiled from 3 biological replicates. n=20.  
Figure 3.4. Log2 comparison of significantly co-regulated replicate 1 and replicate 2 
treatments normalized to EdU following 2 hr treatments. (A) Proteins significantly 
decreased compared to EdU following 2 hr APH treatment. (B) Proteins significantly 
increased compared to EdU following 2 hr APH treatment. (C) Significantly altered co-
regulated proteins following 2 hr p97 inhibition + APH treatment normalized to EdU. 
Replicate 1 is blue and replicate 2 is orange. **, p-value<0.01. *, p-value<0.05. 
Figure 3.5. Log2 comparison of significantly co-regulated replicate 1 and replicate 2 
treatments normalized to EdU following 4 hr treatments. (A) Proteins significantly 
decreased compared to EdU following 4 hr APH treatment. (B) Proteins significantly 
increased compared to EdU following 4 hr APH treatment. (C) Significantly increased co-
regulated proteins following 4 hr p97 inhibition + APH treatment normalized to EdU. (D) 
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Significantly altered co-regulated proteins following 4 hr p97 inhibition normalized to EdU. 
(E) Proteins significantly decreased compared to EdU following 4 hr APH treatment with 
p97 inhibition. Replicate 1 is blue and replicate 2 is orange. **, p-value<0.01. *, p-
value<0.05. 
Figure 3.6. Changes in selected repair-associated proteins following treatment 
normalized to EdU. Only co-regulated proteins from replicate 1 and 2 are included here. 
Log2 values from replicate 1 are represented here. (A) Log2 comparison of proteins 
related to the ATR pathway and checkpoint, normalized to EdU following 2 hr treatments. 
(B) Log2 comparison of proteins related to a variety of repair pathways, normalized to EdU 
following 2 hr treatments. (C) Log2 comparison of proteins related to BRCA, normalized 
to EdU following 2 hr treatments. (D) Log2 comparison of proteins related to the ATR 
pathway and checkpoint, normalized to EdU following 4 hr treatments. (E) Log2 
comparison of proteins related to a variety of repair pathways, normalized to EdU following 
4 hr treatments. (F) Log2 comparison of proteins related to BRCA, normalized to EdU 
following 4 hr treatments. **, p-value<0.01. *, p-value<0.05. ATRKO: light blue, ATRKO+ 
APH+ p97i: green, ATRKO +p97i: blue, ATRKO + APH: yellow, APH + p97i: grey, p97i: 
orange, APH: purple.  
Figure 3.7. Changes in select repair-, nuclear pore-, and cytoskeleton-associated proteins 
following treatment, normalized to ATRKO. (A) Log2 comparison of proteins related to the 
ATR pathway and checkpoint, normalized to ATRKO following treatments. (B) Log2 
comparison of proteins related to a variety of repair pathways, normalized to ATR following 
treatments. (C) Log2 comparison of proteins related to BRCA, normalized to ATRKO 
following treatments. (D) Log2 comparison of proteins related to the nuclear pore and 
LINC complex, normalized to ATRKO following treatments. **, p-value<0.01. *, p-
value<0.05. ATRKO+ APH+ p97i: green, ATRKO +p97i: blue, ATRKO + APH: yellow, APH 
+ p97i: grey, p97i: orange, APH: purple. 
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Figure 3.8. Changes in select nuclear pore and cytoskeleton-associated proteins 
normalized to EdU for all treatments. Only co-regulated proteins from replicate 1 and 2 
are included here. Log2 values from replicate 1 are represented here. (A) Log2 
comparison of proteins related to the nuclear pore and LINC complex, normalized to EdU 
following 2 hr treatments. (B) Log2 comparison of proteins related to the nuclear pore and 
LINC complex, normalized to EdU following 4 hr treatments.**, p-value<0.01. *, p-
value<0.05. ATRKO: light blue, ATRKO+ APH+ p97i: green, ATRKO +p97i: blue, ATRKO 
+ APH: yellow, APH + p97i: grey, p97i: orange, APH: purple. 
Figure 3.9. Changes in select repair-, nuclear pore-, and replisome-associated proteins 
dependent on p97 inhibition following stress. Co-regulated proteins from replicate 1 and 2 
are included here. Log2 values from replicate 1 are represented here. (A) Log2 
comparison of repair proteins in samples treated with APH and CB5083 (p97 inhibitor) 
normalized to APH treatment alone following 2 hr or 4 hr treatments with and without ATR. 
(B) Log2 comparison of proteins related to the nuclear pore and LINC complex in samples 
treated with APH and CB5083 normalized to APH treatment alone following 2 hr or 4 hr 
treatments with and without ATR. (C) Log2 comparison of Tier 1 proteins in samples 
treated with APH and CB5083 normalized to APH treatment alone following 2 hr or 4 hr 
treatments with and without ATR. (D) Log2 comparison of Tier 2 proteins in samples 
treated with APH and CB5083 normalized to APH treatment alone following 2 hr or 4 hr 
treatments with and without ATR.**, p-value<0.01. *, p-value<0.05. 4hr ATRKO: orange, 
4 hr: light blue, 2 hr ATRKO: dark blue, 2 hr: green. 
Figure 3.10. Changes in Tier 1 consensus replisome normalized to EdU. Only co-
regulated proteins from replicate 1 and 2 are included here. Log2 values from replicate 1 
are represented here. (A) Log2 comparison of Tier 1 proteins, normalized to EdU following 
2 hr treatments. (B) Log2 comparison of Tier 1 proteins, normalized to EdU following 4 hr 
treatments. **, p-value<0.01. *, p-value<0.05. ATRKO: light blue, ATRKO+ APH+ p97i: 
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green, ATRKO +p97i: blue, ATRKO + APH: yellow, APH + p97i: grey, p97i: orange, APH: 
purple. 
Figure 3.11. Changes in Tier 2 consensus replisome normalized to EdU. Only co-
regulated proteins from replicate 1 and 2 are included here. Log2 values from replicate 1 
are represented here. (A) Log2 comparison of Tier 2 proteins, normalized to EdU following 
2 hr treatments. (B) Log2 comparison of Tier 2 proteins, normalized to EdU following 4 hr 
treatments. **, p-value<0.01. *, p-value<0.05. ATRKO: light blue, ATRKO+ APH+ p97i: 
green, ATRKO +p97i: blue, ATRKO + APH: yellow, APH + p97i: grey, p97i: orange, APH: 
purple. 
Figure 3.12. Changes in Tier 1 and 2 consensus replisome normalized to ATRKO. Only 
co-regulated proteins from replicate 1 and 2 are included here. Log2 values from replicate 
1 are represented here. (A) Log2 comparison of Tier 1 proteins, normalized to ATRKO. 
(B) Log2 comparison of Tier 2 proteins, normalized to ATRKO. **, p-value<0.01. *, p-
value<0.05. ATRKO: light blue, ATRKO+ APH+ p97i: green, ATRKO +p97i: blue, ATRKO 
+ APH: yellow, APH + p97i: grey, p97i: orange, APH: purple. 
Figure 3.13. KEGG analysis of proteins significantly enriched in treatment samples as 
compared to EdU using a 0.05 FDR. (A) Observed gene count for proteins significantly 
enriched in ATRKO compared to EdU treated samples as measured by iPOND2-
DRIPPER. (B) Observed gene count for proteins significantly enriched in ATRKO 2 hr 
APH compared to EdU treated samples as measured by iPOND2-DRIPPER. (C) 
Observed gene count for proteins significantly enriched in ATRKO 4 hr APH compared to 
EdU treated samples as measured by iPOND2-DRIPPER. (D) Observed gene count for 
proteins significantly enriched in ATRKO 2 hr APH and p97i compared to EdU treated 
samples as measured by iPOND2-DRIPPER. (E) Observed gene count for proteins 
significantly enriched in ATRKO 4 hr APH and p97i compared to EdU treated samples as 
measured by iPOND2-DRIPPER. (F) Observed gene count for proteins significantly 
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enriched in ATRKO 2 hr p97i compared to EdU treated samples as measured by iPOND2-
DRIPPER. (G) Observed gene count for proteins significantly enriched in ATRKO 4 hr 
p97i compared to EdU treated samples as measured by iPOND2-DRIPPER. **, 
FDR<0.01. *, FDR<0.05. 
Figure 3.14. KEGG analysis of proteins significantly decreased in treatment samples as 
compared to EdU using a 0.05 FDR. (A) Observed gene count for proteins significantly 
decreased in ATRKO compared to EdU treated samples as measured by iPOND2-
DRIPPER. (B) Observed gene count for proteins significantly decreased in ATRKO 2 hr 
APH compared to EdU treated samples as measured by iPOND2-DRIPPER. (C) 
Observed gene count for proteins significantly decreased in ATRKO 4 hr APH compared 
to EdU treated samples as measured by iPOND2-DRIPPER. (D) Observed gene count 
for proteins significantly decreased in ATRKO 2 hr APH and p97i compared to EdU treated 
samples as measured by iPOND2-DRIPPER. (E) Observed gene count for proteins 
significantly decreased in ATRKO 4 hr APH and p97i compared to EdU treated samples 
as measured by iPOND2-DRIPPER. (F) Observed gene count for proteins significantly 
decreased in ATRKO 4 hr p97i compared to EdU treated samples as measured by 
iPOND2-DRIPPER. Note that no proteins were significantly decreased compared to EdU 
following ATRKO and 2 hr p97i. **, FDR<0.01. *, FDR<0.05. 
Figure 3.15. Changes in consensus repair- and replication-associated proteins following 
ATRKO normalized to APH at 2 (blue) and 4 (green) hrs. (A) Log2 comparison of Tier 1 
proteins, normalized to APH. (B) Log2 comparison of Tier 2 proteins, normalized to APH. 
(C) Log2 comparison of repair proteins, normalized to APH. (D) Log2 comparison of 
nuclear pore and cytoskeletal proteins, normalized to APH. (E) Log2 comparison of BRCA-
associated proteins, normalized to APH. (F) Log2 comparison of ATR-associated proteins, 
normalized to APH. **, p-value<0.01. *, p-value<0.05. 
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Tables Legends  
Table 3.1. The total number of proteins significantly (p-value < 0.05) changed across two 
experimental replicates. 
Table 3.2. The total number of proteins significantly enriched or decreased in ATRKO 
treatments normalized to EdU treatment (p-value < 0.05). 
Table 3.3. The total number of proteins enriched or decreased in ATRKO treatments 
normalized to ATRKO (p-value < 0.05). 
Table 3.4. The total number of proteins significantly (p-value < 0.05) changed at 2 or 4 hrs 
of APH and p97 inhibitor treatment normalized to APH treatment alone. 
Supplemental Table Legends  
Supplemental Table 3.1. Log2 comparison of replicate 1 and 2 treatments (2 and 4 hr 
APH, p97i, and dual treatment) normalized to EdU treatment using Cv analysis. 
Treatments included in these replicates included Thy, EdU, 2 and 4 hr APH, CB5083, and 
APH + CB5083 treatment. Changes compared to EdU were are presented as Log base 2 
with a 2 tailed Student’s t-test. In “variation between replicate” columns diff was used to 
indicate proteins that were differentially regulated, and decreased and increased are used 
to indicate changes in co-regulated proteins.  
Supplemental Table 3.2. Results of ATRKO treatments normalized to EdU and ATRKO 
alone using Cv analysis. Treatments included here are Thy, EdU, ATRKO, 2 and 4 hr APH 
+ ATRKO, CB5083 + ATRKO, and APH + CB5083 + ATRKO treatment. Changes 
compared to EdU and ATRKO were presented as Log base 2 with a 2 tailed Student’s t-
test. 
Supplemental Table 3.3. EdU normalized ATR-deficient cells with and without 2 hr APH, 
comparing DRIPPER (ATRKO) with MaxQuant (ATRN119) MS analysis. Changes 
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compared to EdU and treatments were presented as Log base 2 with a 2 tailed Student’s 
t-test. 
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Summary 
Input iPOND2 fractions displayed a bimodal distribution of known replisome components, 
however, EdU-associated replisome components were mostly present only in the denser 
fractions. We hypothesized that the non-EdU-associated replisome components in the 
light fractions represented replication-associated complexes not involved in active 
replication such as terminated replication forks, complexes ready for loading, or origins of 
replication. We applied a pS108-MCM2 immuno-precipitation (IP) to iPOND2 supernatant 
and determined that non-EdU-associated pS108-MCM2 was still bound to other 
components of the MCM helicase. Furthermore, when the segregase thought to be 
responsible for removing terminated forks, p97, was inhibited we observed a decrease in 
non-EdU-associated MCM7 in the light fractions relative to the heavy fractions, indicating 
that MCM7 was more efficiently maintained on EdU-labeled DNA following p97 inhibition. 
This data suggests the possibility that iPOND2 in conjunction with a pS108-MCM2 IP 
could be used to study terminated replication forks. Furthermore, this protocol could be 
used with only slight modifications to examine other replication-associated complexes 
such as origins of replication. The utility of this protocol will require further research to 
confirm and optimize but, this work provides an important building block for expansion of 
our understanding of replication fork dynamics and termination.  
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Introduction  
iPOND2-DRIPPER provides an improved method for analysis of changing 
replisome components, as discussed in Chapter 2. Furthermore, the separation of 
complexes by a sucrose gradient may allow further expansion of iPOND2 in order to 
examine other cellular complexes. For example, it might be possible to use the EdU-bound 
material in less dense fractions to examine changes in post-replicative proteins and post-
translational modifications under various treatment conditions. One aspect of iPOND2 that 
caught our attention was the different distributions of replication components in the input 
and pull-down fractions. The EdU-associated replisome components were located in the 
more dense fractions; however, there was a large pool of replisome components, including 
the MCM helicase, in the lighter fractions that was not associated with EdU (Fig. 2.1C). 
The MCM helicase is present at the fork from replication initiation until termination and has 
multiple important roles in all aspects of replication. While many MCM subunits have been 
shown to be subject to phosphorylation, MCM2 phosphorylation most consistently occurs 
during S-phase of the cell cycle (Masai et al., 2000).  
MCM2 can be phosphorylated on multiple residues including on serine (Ser)- 13, 
27, 40, 41, 53, 108, and 139. Phosphorylation at Ser-13, 27, or 41 is consistent with cyclin 
dependent kinase 1 (CDK1) consensus sites and is subsequently involved in cell cycle 
regulation. CK2 was shown to drive phosphorylation of MCM2 on Ser-139, while MCM2 
Ser-40, 53, and 108 were the first reported phosphorylation sites of CDC7 (Montagnoli et 
al., 2006). CDC7 and DBF4 together comprise the DDK complex, whose phosphorylation 
of MCM2-7 is crucial for initiation of replication (Duncker & Duncker, 2016). DBF4 mutation 
suppresses lethality of MCM2 mutation and it is possible that MCM2 phosphorylation 
causes a structural change to increase affinity of CDC45 for the helicase during formation 
of the CMG helicase (Nishitani & Lygerou, 2002). MCM2 can also be phosphorylated on 
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Ser-108 (pS108-MCM2) by ATR in response to replication stress (Charych et al., 2008; 
Cortez, Glick, & Elledge, 2004; Montagnoli et al., 2006).  
The occurrence of non-EdU-associated phosphorylated-MCM2, indicative of 
replication fork activation or stress, in the light non-stressed iPOND2 fractions could be 
for a variety of reasons including modification of soluble components, un-fired origins, 
dissociation due to sonication, or the removal of the helicase from DNA due to replication 
fork termination. Phosphorylation of MCM components must be carefully controlled to 
prevent re-replication. Phosphorylated MCM2 has been previously observed in soluble 
nuclear fractions, however, the broad distribution in the light fractions suggests that the 
non-EdU-associated material might be part of complexes rather than individual proteins 
resulting in variable size fractionation (Montagnoli et al., 2006). Similarly, if these 
replisome components became disassociated from DNA due to high strength sonication 
they would likely be separated from their complexes and fractionate consistently in one of 
two fractions. Furthermore, histone distribution in the input fractions closely mirrors the 
distribution in the pull-down, suggesting that accumulation of non-EdU-associated 
proteins is not likely to be due to sonication driven dissociation (Fig. 2.1C). 
Replication termination is thought to occur mainly due to the collision of two 
replicating forks (Ramadan et al., 2016). Despite extensive investigation of replication 
initiation and elongation, studies of replication termination have been limited. Within the 
last decade the Walter laboratory has presented evidence suggesting that the replicative 
helicases bypass one another following termination (Dewar et al., 2015). Recent studies 
from the Labib and Gambus laboratories, however, have examined the removal of 
replication fork components following termination in yeast and Xenopus (Maric et al., 2014; 
Moreno et al., 2014). In yeast, upon replication fork termination, MCM7 is K48 
ubiquitylated by SCF-Dia2, allowing the recognition and removal of the MCM helicase from 
chromatin by p97 (VCP, Cdc48, Ter94) (Maric et al., 2014). Inhibition of p97 results in 
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inability of the replication machinery to leave the chromatin and accumulation of 
ubiquitylated MCM7 on DNA (Maric et al., 2014). Similar results were observed in 
Xenopus and within the last few months papers from the Labib and Walter laboratories 
have identified LRR1 as the E3 ligase responsible for MCM7 ubiquitylation in eukaryotes 
(Dewar et al., 2017; Moreno et al., 2014; Sonneville et al., 2017). Thus, p97 has been 
shown to have a conserved role in replication termination. 
p97 is a highly versatile, ubiquitin-dependent molecular segregase. p97 is involved 
in a wide variety of cellular processes including chromatin-associated degradation, 
autophagy, and mitochondria-associated degradation. p97 recognizes ubiquitylated 
substrates and promotes substrate recycling or degradation by the proteasome (Meyer, 
2012; Richly et al., 2005). p97’s activity is directed by approximately 30 currently known 
cofactors that confer specificity of interaction similar to an E3 ligase in the ubiquitin 
modification pathway (Buchberger et al., 2015). CB5083, a potent p97 inhibitor that 
prevents ATP binding, is currently in phase 1 clinical trials for treatment of multiple 
myeloma and solid tumors, emphasizing the importance of p97 in a wide range of cellular 
processes (Zhou et al., 2015). 
In this chapter we discuss our initial attempts to characterize the non-EdU-
associated replication components observed in Chapter 2. A pS108-MCM2 IP was applied 
to supernatants from the binding of iPOND2 samples to streptavidin beads, showing that 
the helicase is still in complex with non-EdU associated material, both by western blot and 
MS. We utilized inhibition of p97 to assess the likelihood that these complexes 
represented terminated replication forks. Overall, this chapter presents preliminary 
evidence suggesting the ability of iPOND2 to act as an analytical tool for complexes not 
associated with actively replicating forks, such as terminated replication forks or origins of 
replication. 
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Materials and Methods 
pS108-MCM2 Immunoprecipitation 
iPOND2 was completed as described in Chapter 2 and the supernatant following 
streptavidin bead binding was frozen as -80⁰C for up to 1 year. Following thawing, 
supernatants were pooled (fractions 1-7 and 8-14) and each pooled sample was bound to 
160 µl of Dynabeads® MyOne™ Streptavidin T1 beads overnight at 4⁰C to remove and 
residual EdU. 320 µl of Dynabeads® Proteins A beads (ThermoFischer Scientific) per 
gradient were washed with RIPA three times using standard magnetic bead wash protocol 
(see Materials and Methods Chapter 2). The washed beads were resuspended in 1 mL of 
1% BSA in RIPA and 80 µg of anti-pS108-MCM2 (Bethyl Laboratories; A300-094A) per 
gradient and rotated overnight at 4⁰C. The anti-pS108-MCM2-bound beads were washed 
with 500 µl RIPA for 5 min at RT three times, added to each sample, with heavy and light 
fraction pools kept separate for each gradient, and incubated with beads overnight at 4⁰C 
on a rotator. The next morning the sample bound beads were washed with 1 mL RIPA, 1 
mL 0.5 M NaCl in RIPA, and 1 mL RIPA for 10 min each at 4⁰C on a rotator. A 1:1 ratio of 
RIPA and Lamellae sample buffer was added to the beads for elution. Beads were boiled 
for 5 min and the supernatant was removed for analysis by western blot or MS (Fig. 4.1).  
Treatment of cells for analysis  
See Chapter 3. 
Western Blot 
See Chapter 2.  
Quantification of western blot band density 
Band densities from western blots were determined using the ImageJ® software 
for image processing and analysis in Java. A box was drawn and duplicated so that the 
area from which the band intensity for each band was calculated remained the same. 
Following band intensity measurements ratios were calculated as described in the text.  
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Mass Spectrometry 
A DDA analysis was performed using an Orbitrap Velos MS System (Thermo 
Fischer Scientific, Inc.) with both MaxQuant and iBAQ being utilized to quantify peptides 
present in Thy chase compared to EdU-treated samples. 3 injections of 2.5 µl of each 
sample were used. A 1% FDR, 2 standard deviation cut off was used for this analysis.  
Results  
EdU-associated MCM7 localization in iPOND2 fractions 
In Chapter 2 it was noted that many replisome components, including the MCM 
helicase, exhibited a bimodal distribution in the input fractions of iPOND2, but only the 
replisome factors in the denser fractions were EdU-associated (Fig. 2.1C). We pooled 
fractions 1-5 and 6-14 to determine the relative amount of EdU-associated MCM7 in the 
iPOND2 samples (Fig. 4.2A). There was approximately 4-fold more EdU-associated 
MCM7 in the dense fractions then the light fractions of the EdU treated sample consistent 
with MS analysis (Fig. 2.3B). The baseline, Thy treatment, had undetectable levels of EdU-
associated MCM7 in the light fractions and levels comparable to the EdU light fractions in 
the heavy fractions (Fig. 4.2A and 2.4).  
When cells were treated for 2 hrs with CB5083, a potent p97 ATP competitive 
inhibitor, they displayed a similar pattern to the one observed in the EdU treated sample. 
The ratio of MCM7 in the dense to light fractions in the CB5083 treated sample increased 
to approximately 7 fold likely due to increased retention of terminated replication forks 
following p97 inhibition. In the dense fractions of both EdU and p97 inhibitor treated 
samples there was a larger band detected by the MCM7 antibody. This band was not due 
to non-specific interaction between antibody and substrate, as it did not appear in the Thy 
treated samples, and may represent a post-translational modification of MCM7 (Fig. 4.2A). 
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These results suggest that p97 inhibition leads to MCM7 retention on EdU-labeled 
material, likely due to inability of this complex to be removed. 
Non-EdU-associated pS108-MCM2 remains associated with MCM7 
In order to assess the changes occurring in non-EdU-associated material we ran 
an α-pS108-MCM2 IP. The heavy chain of the pS108-MCM2 antibody was still recognized 
by all secondary antibodies tested (Lane 1 Fig. 4.2B). Unfortunately, when a rabbit 
secondary antibody was used this background band became more prominent and created 
difficulties in visualization other signals. Fractions 1-7 and 8-14 of iPOND2 supernatant 
were combined in order to separate the peaks of the bimodal distribution most effectively 
for analysis by pS108-MCM2 (Fig. 2.1C). In the Thy treated dense sample there was a 
pool of non-EdU associated pS108-MCM2-asscociated MCM7 that was not present in the 
EdU treated sample (Fig. 4.2B). This likely represents active forks that are no longer 
associated with EdU due to the Thy chase, consistent with our expectations. There was 
an accumulation of MCM7 and possibly modified MCM7 in the less dense Thy and EdU 
treated samples. The ratio of pS108-MCM2-associated MCM7 in the light to dense pools 
of the EdU treatment was approximately 22, indicating that MCM7 in the light fractions 
was still largely in complex with activated MCM2 (Fig. 4.2B). 
When cells were treated with CB5083 for 2 hrs there were populations of pS108-
MCM2-asscociated MCM7 and possibly modified MCM7 in both the light and dense 
fractions. The ratio of unmodified MCM7 in the light to the dense fractions was 
approximately 6, nearly ¼ the ratio observed between the light and dense fractions with 
EdU treatment alone (Fig. 4.2B). This decrease was consistent with the hypothesis that 
inhibition of p97 prevents the removal of terminated forks, resulting in decreased levels of 
non-EdU-associated helicase in the light fractions. Furthermore, the observation of non-
EdU/pS108-MCM2-associated MCM7 in the denser fractions of p97 treated samples is 
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consistent with continued helicase progression on replicated DNA following termination if 
p97 is not able to remove this complex (Dewar et al., 2015). 
The MCM helicase is associated with non-EdU bound pS108-MCM2 
Due to the limitations of pS108-MCM2 IP detection by any antibodies using a rabbit 
secondary antibody or proteins near the heavy chain size range (approximately 50 kDa), 
we examined pS108-MCM2 pull-down by MS. Three samples were IPed using α-pS108-
MCM2 and examined by DDA: a RIPA only control, pooled supernatant from iPOND2 
fractions 1-7, and pooled supernatant from iPOND2 fractions 8-14, both from an EdU 
treated sample. The control sample showed only background proteins present such as 
keratin (Table 4.1). The only replication-associated proteins identified were the MCM 
helicase members. MCM 2, 3, 4, 6, and 7 were identified in the dense fractions and MCM2-
7 were identified in the light fractions. There were approximately 5-fold more MCM 
peptides identified in the light fractions compared to the dense fractions, consistent with 
the trends observed by western (Table 4.1).  The low number of proteins identified is likely 
due to the fact that supernatent from only 1 gradient was used and protein A beads were 
saturated. Increased input and antibody bound beads may lend higher resolution results. 
Due to cost, we were unable to repeat this experiment with p97 inhibited samples, 
however, this would be an important experiment in the exploration of pS108-MCM2 IP as 
a method for terminated fork analysis. 
Discussion  
The input iPOND2 samples displayed a bimodal distribution of known replisome 
components (Fig. 2.1C). Despite the lower level of EdU in the more dense gradient 
fractions we observed accumulation of EdU-bound actively replicating forks in these 
fractions. While we have performed extensive analysis of the EdU-bound material in 
iPOND2, the source of the less dense population of non-EdU-associated replisome 
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components was still unclear. One hypothesis regarding the source of the non-EdU 
associated replisome components was that these proteins were dissociated during 
sonication. If this were the case then it is likely that complex association would not be 
maintained between these proteins. Furthermore, other proteins such as histones did not 
follow the same pattern, decreasing the likelihood that it was caused by a technical artifact 
(Fig. 2.1C). It is also a possibility that these replication proteins, if they remain in complex 
form, represent complexes distinct from active replication forks but still meriting further 
investigation such as pre-fired origins or terminated replication forks.  
The non-EdU-bound replisome components identified by western blot included 
multiple members of the MCM helicase. We specifically identified phosphorylated MCM2 
at Ser-41, 108, and 139 (Fig. 2.1C), these sites are phosphorylated by CDK2, DDK, and 
CK2, respectively (Montagnoli et al., 2006). CDK2, DDK, and CK2 are each involved in 
cell cycle regulation, however, DDK phosphorylation of MCM2 is most directly linked to 
replication initiation (Duncker & Duncker, 2016). While pS108-MCM2 can also be driven 
by ATR in response to replication stress, there was no external stress applied to the cells 
analyzed, making this phosphorylation source unlikely (Fig. 2.1C) (Charych et al., 2008; 
Cortez et al., 2004). We developed an α-pS108-MCM2 IP protocol that was applied to the 
supernatant of iPOND2 streptavidin retrievals (Fig. 4.1). We observed increased 
association of MCM helicase components with pS108-MCM2 in the less dense (1-7) 
compared to the denser (8-14) fractions following the IP of EdU treated samples (Fig 4.2B 
and Table 4.1). This result was expected, as analysis of iPOND2 pull-downs showed an 
increased representation of MCM helicase in the heavy fractions, suggesting that in these 
fractions the MCM helicase and other replisome components were being preferentially 
depleted from the supernatant (Fig. 4.2A). Importantly, this assay confirmed that the MCM 
helicase is in complex and not associated with EdU in the light fractions of the input 
iPOND2 samples. Experiments in S. pombe suggest that MCM complexes are actually 
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assembled in the cytoplasm and then transported to the nucleus via nuclear localization 
signals on MCM2 and MCM3 (Pasion & Forsburg, 1999). Although, the location of MCM 
assembly in eukaryotes is still unclear, the helicase is loaded onto origins of replication as 
a hexamer, potentially explaining the presence of partially-formed MCM complexes in the 
nucleus (Evrin et al., 2009; Pasion & Forsburg, 1999). If these complexes were being 
prepared for loading onto origins, however, they should not already display any post-
translational modifications, especially phosphorylation associated with carefully controlled 
initiation of replication. 
Based on preliminary evidence compiled here, we hypothesized that the proteins 
associated with pS108-MCM2 represented terminated replication forks. Recent evidence 
from the Labib and Gambus laboratories showed that in yeast and Xenopus egg extracts 
replication proteins, specifically the MCM2-7 complex, were removed from duplicated DNA 
in an ubiquitin- and p97- dependent manner (Maric et al., 2014; Moreno et al., 2014). With 
its adaptor protein, DVC1, p97 has been shown to remove ubiquitylated MCM7 and 
associated components from DNA following replication (Maric et al., 2014). This is likely 
the same mechanism of terminated fork removal in mammalian systems. Following 2 hr 
p97 inhibition, the ratio of EdU-associated MCM7 in the dense compared to light fractions 
increased relative to EdU treatment alone, consistent with changes observed in the larger 
band, possibly representing ubiquitylated MCM7 (Fig. 4.2A). It is possible that the 
increased representation of MCM7 (whether modified of not) on chromatin following p97 
inhibition is due to the inability to remove these complexes from chromatin following 
termination. Consistent with the hypothesis that p97 inhibition results in terminated fork 
retention on chromatin, there is a decreased representation of non-EdU-associated 
pS108-MCM2-assocaited MCM7 in the light (1-7) compared that the dense (8-14) 
fractions. As was the case with the iPOND2 samples, the patterns observed for total 
MCM7 were mirrored by the potentially modified band (Fig. 4.2B). Of note, as measured 
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by DRIPPER, the MCM helicase decreased at replication forks following p97 inhibition for 
2 hrs (See Chapter 3 for complete analysis); however, in both replicates this treatment 
experienced technical issues, rendering firm conclusions based on this data difficult. The 
data presented in this chapter are difficult to interpret consistent with the widespread 
regulatory role of p97, however, they provide an interesting basis for future investigation. 
Some suggested experiments include isolation of DNA from pS108-MCM2 IP to 
assess if these complexes are associated with non-EdU labeled or are free floating and a 
more in-depth assessment of pS108-MCM2 IP samples with or without p97 inhibition. 
Regardless of the potential to use iPOND2 to examine terminated forks, this secondary IP 
can be employed to analyze proteins and complexes that are removed from the replisome 
under certain conditions. There are also many opportunities for refinement and 
improvement of this protocol, for example, through use of a tagged protein to avoid 
antibody based background. 
In this chapter we have demonstrated that the non-EdU-associated MCM proteins 
observed in the light (1-7) fractions are in a complex with phosphorylated MCM2 Ser-108. 
Furthermore, we showed altered MCM7 association with EdU and pS108-MCM2 in 
response to p97 inhibition. Taken together, this suggests that, with further refinement, 
iPOND2 could be used to examine replication fork termination in mammals, a topic that is 
currently underdeveloped. Understanding replication termination is important for basic 
biology as well as potential avenues of treatment for replication-associated diseases. The 
density based separation of iPOND2 isolated samples in combination with replication 
protein IPs will help shed light on replication associated processes and mechanism of 
replisome recycling or degradation.  
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Figure Legends 
Figure 4.1. Schematic showing the combination of pS108-MCM2 IP with iPOND2 (see 
Materials and Methods for details). iPOND2 supernatent is further depleted of EdU and 
bound to α-pS108-MCM2 beads. 
Figure 4.2. Non-EdU-associated pS108-MCM2 remains associated with the MCM 
helicase complex, specifically MCM7. Western blot showing ratio of MCM7 in heavy and 
light pooled fractions changes with p97 inhibition. (A) Western blot showing MCM7 in 
heavy (6-14) and light (1-5) fractions following treatment and iPOND2 pull-down. (B) 
Western blot showing MCM7 in heavy (8-14) and light (1-7) fractions following treatment 
and pS108-MCM2 IP of iPOND2 supernatant. Lane 1 is antibody bound beads incubated 
with RIPA overnight. Ratios were calculated using ImageJ quantification of band intensity.   
Table Legends 
Table 4.1. DDA measurement of protein abundance in heavy (8-14) and light (1-7) 
fractions following EdU treatment and pS108-MCM2 IP of iPOND2 supernatant. 
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Summary 
Post translational modifications (PTMs), including ubiquitylation, are essential for the 
regulation of cellular growth and development. PTMs play a variety of roles including 
regulation of protein-protein interactions, quality control, and protein degradation. 
Historically it has been difficult to assess PTMs of replication fork components in a high-
throughput way due to the transient nature of these marks and difficulty of isolating only 
active forks. Fortunately, the improvements to iPOND, discussed in Chapter 2, resulted in 
high levels of replisome peptide enrichment, allowing the identification of PTMs, 
specifically ubiquitylation, by iPOND2-DRIPPER. In this chapter we discuss the 
identification of known and novel replisome ubiquitylation sites identified by iPOND2-
DRIPPER. We monitor changes in ubiquitin levels at these sites following replication 
stress. Furthermore, we detail the use of a tandem affinity iPOND2-K-ɛ-GG purification of 
ubiquitylated replisome components to identify more replisome ubiquitin sites. iPOND2-K-
ε-GG identified many known and previously unreported sites of replisome ubiquitylation 
and has vastly improved our ability to monitor changes in ubiquitylation at the replication 
fork under a variety of conditions. Based on the success of this purification protocol, it may 
be possible for iPOND2 to be further expanded to examine other PTMs including, 
SUMOylation, phosphorylation, and acetylation.   
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Introduction  
Faithful replication of DNA during cell division is critical for healthy cellular 
development and avoidance of disease. Understanding the dynamics of replication fork 
components in response to stress may be crucial for effective treatment of many diseases 
(Hira et al., 2015). Replication stress results in a series of post-translational modifications 
(PTMs) that regulate subsequent changes in replisome localization and function (Povlsen 
et al., 2012; Qin, Bai, Sun, Niu, & Xiao, 2016). One PTM known to contribute to regulation 
of cell cycle progression and DNA repair is ubiquitin. Ubiquitylation  is also important for 
proteasome-dependent protein degradation, protein-protein interaction, protein trafficking, 
and more (Chaugule & Walden, 2016; Sidor-Kaczmarek et al., 2017). Ubiquitin is 
conjugated to specific lysines (K) on target proteins through the sequential action of 
activating enzymes (E1s), conjugating enzymes (E2s), and ligases (E3s) (Pickart, 2001). 
The large number of potential E2 (approximately 40 currently known) and E3 
(approximately 600 currently known) enzyme interactions creates a high level of substrate 
specificity (Tsukamoto, 2016). Ubiquitin is able to modify itself on multiple lysine residues 
(K6, K11, K27, K29, K33, K48, and K63), creating ubiquitin chains and branched 
structures. The site and type of ubiquitylation determines how modified proteins are 
regulated. For example, K48 modification often signals protein degradation while K63 
modification more commonly leads to protein recycling (Zhang et al., 2017).  
The Fujimuro laboratory recently showed that many common cellular stresses 
result in highly increased levels of cellular poly-ubiquitylation and that distinct stress 
differentially drives ubiquitylation of K119 on histone H2A, emphasizing the importance of 
cellular ubiquitin regulation in response to stressors (Nakata et al., 2016). Similarly, in 
response to DNA damage and replication fork stalling, the core Fanconi Anemia (FA) 
complex (FANC) acts as both E2 and E3 ligase to drive mono-ubiquitylation  of FANCD2 
and FANCI, required for their interaction with and recruitment of DNA repair proteins 
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(Machida et al., 2006; Renaudin et al., 2016; Rickman et al., 2015). These represent just 
two of many examples of ubiquitin regulation of DNA repair. While the ubiquitin sites 
mentioned above are known, there are still many ubiquitylated replisome and repair 
proteins whose sites of ubiquitylation are unknown. A clear example of our dearth of 
knowledge regarding replisome ubiquitylation was recently illustrated using RPA. 
Although RPA has many important roles in replication and repair and has been 
investigated extensively, it was only recently that 18 previously unknown sites of 
ubiquitylation across RPA were identified in HELA cells that may be responsible for its 
regulation in response to stress (Elia et al., 2015). This advance in our knowledge of RPA 
came from an RPA directed screen and uncerscores the importance of developing a 
screen capable of assessing ubiquitylation of replisome and repair proteins in a high-
throughput manner.  
Due to the importance of ubiquitylation in cellular regulation, there are many 
systems in place within the cell for monitoring and control of ubiquitylation. There are many 
deubiquitinating enzymes (DUBs) that are important for removing ubiquitin from proteins 
after it has fulfilled its role in signaling or degradation. For example, USP1 is a DUB 
responsible for de-ubiquitylation  of FANCD2 and FANCI as well as PCNA, whose 
mutation results in constitutive ubiquitylation  and FA-like disease progression in mice 
(Nijman et al., 2005; Parmar et al., 2010). p97/VCP is an ubiquitin segregase involved in 
the removal of ubiquitin and ubiquitylated proteins from chromatin after they have fulfilled 
their role. p97 helps control a wide variety of ubiquitin-dependent processes and regulates 
many aspects of DNA replication and repair. In order to truly understand replisome 
component regulation under stress conditions it is important to understand the role of 
these modifications in protein function and localization at the replication fork.  
Assessment of PTMs of replisome components can be difficult due to the low level 
of modified compared to unmodified peptides for each protein in a sample, the low level 
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of replisome compared to background proteins, and the large amount of material required 
for analysis. Many of the advancements our understanding of PTMs at the replication fork 
have been made using point mutant studies (Garcia-Higuera et al., 2001). While 
experiments utilizing point mutation can be very informative, they must be based on an 
initial hypothesis. The ability to identify potential sites of PTMs using MS analysis would 
allow expansive hypothesis generation, accelerating the rate of discovery and advancing 
our understanding of replisome dynamics and regulation.  
Recent advances in MS technology and purification protocols have allowed 
laboratories including the Garcia laboratory at the University of Pennsylvania to begin 
identifying PTMs by MS (Cao & Garcia, 2016). The Carr laboratory developed a diGly IP 
that enriches ubiquitylated peptides using an antibody raised against the K-ε-GG motif 
that is exposed following trypsin digestion of a ubiquitin modified protein (Udeshi, Mertins, 
Svinkina, & Carr, 2013). This protocol allows analysis of ubiquitylation sites on a specific 
protein under various treatments. Unfortunately, a large amount of purified material is 
required to detect ubiquitylation sites, rendering this method of minimal use when sample 
is limited, such as patient samples or isolated replication proteins.  
As demonstrated in Chapter 2, iPOND2 enrichment of replisome components 
resulted in increased yield and specificity compared to previous iterations of iPOND. Thus, 
using iPOND2-DRIPPER we were able to identify ubiquitylation sites on replisome 
components across multiple treatment conditions, however, these sites were infrequent 
and variable between samples. Thus, we combined iPOND2 and the K-ε-GG IP developed 
by the Carr laboratory to identify sites of ubiquitylation at the replication fork following 
replication stress. Using our new tandem affinity purification protocol, we were able to 
identify multiple known ubiquitylation sites in addition to novel sites meriting further 
investigation. We have begun generation of many preliminary models regarding p97 
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regulation of ubiquitylation at the replication fork following replication stress, requiring 
further investigation.  
Materials and Methods 
Cell Treatment 
See Chapter 3.  
 
iPOND2-DRIPPER 
See Chapter 2. Peptide and protein quantifications were made using only Cv 
calculation, as described in Chapter 3.  
Analysis of 114 Da shifted peptides detected by iPOND2-DRIPPER 
The fold changes of ubiquitylated peptides compared to EdU were calculated by 
comparing the average abundance between the three technical replicates of each sample. 
Two tailed Student’s t-tests were performed between the three technical replicates of each 
sample.  
iPOND2-K-ε-GG IP Trial 2 
After elution from streptavidin beads, samples were combined and acetone 
precipitated. Samples were then resuspended in 2 mL lysis buffer A (50 mM Tris-HCl pH 
8, 20 mM NaCl, 0.125 mM EDTA, 0.25 µg/mL aprotinin, 1.25 µg/mL leupeptin, 6.25 µM 
PR-619, 0.125 mM chloroacetamide, 0.125 mM PMSF) with 8 M urea, diluted to 4 M using 
50 mM Tris pH 8.2, and digested with 0.24 AU of Lysyl endopeptidase LysC digestive 
enzyme (Wako Chemicals USA, Inc.) for 1.5 hrs. Samples were then diluted to 1 M urea 
and digested using trypsin (PierceTM Trypsin Protease, MS Grade) at a 1:200 enzyme: 
substrate ratio at 37⁰C overnight. The remainder of the protocol was followed as reported 
in the “Final iPOND2-K-ε-GG IP” section. 
Final iPOND2-K-ε-GG IP 
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iPOND2 as described in Chapter 2 was completed using double the normal beads 
to bind each fraction. 10 gradients of fractions 6-14 from the same treatment were 
combined and precipitated (Wessel & Flügge, 1984). Precipitation and subsequent 
digestions were performed in 600 µl aliquots of each sample in low bind tubes (Protein 
LoBind Tube, 1.5 mL, Sigma). Following precipitation, each pellet was resuspended via 
vortexing in 20 µl of 8 M urea buffer (6 M urea, 2 M thiourea, and 50 mM ammonium 
bicarbonate pH 8.2). 0.03 AU of Lysyl endopeptidase LysC digestive enzyme was added 
to each aliquot and incubated at room temperature for 3-4 hours. Each aliquot was diluted 
to a final concentration of 1 M urea using lysis buffer A, and trypsin was added at a ratio 
of 1:80 enzyme to substrate. The trypsin digestion proceeded overnight at RT and then all 
aliquots for each sample were combined and acidified with 0.4% (vol/vol) TFA. Samples 
were centrifuged at 2,500 RFC for 10 min at RT and supernatant was collected in a fresh 
low bind tube. Peptide desalting was performed using a reverse phase tC18 sep-PAK 
solid-phase cartridge (sep-PAK® Vac 6cc (500mg) tC18 Cartridges, Waters). The 
cartridge was prepared for samples with the following washes: 1) 9 mL ACN, 2) 3 mL 50% 
ACN, 3) 0.5% HAcO and, 4) 9 mL of 0.1% TFA. Then the sample was run through the 
cartridge. Next the cartridge was washed with 9 mL of 0.1% TFA followed by 1.5 mL 0.5% 
HAcO. The cartridge was moved to a 50 mL collection tube and eluted with 4 mL 50% 
ACN 0.5% HAcO and 4 mL 80% ACN 0.5% HAcO. The eluant was incubated on dry ice 
for 45 minutes and then lyophilized (VirTis DBT 3.5 Freeze Dryer) for approximately 24 
hours or until all liquid was gone.  
During lyophilization, antibody was cross-linked to beads (PTMScan® Ubiquitin 
Remnant Motif [K-epsilon-GG] Kit, Cell Signaling Technology) (Udeshi et al., 2013). 
Lyophilized sample was resuspended in 1.3 mL of 1X IAP (50 mM MOPS-NaOH pH 7.5, 
10 mM Na2HPO4, 50 mM NaCl) and bound to 5 µl of K-ɛ-GG specific antibody bound 
beads for 2 hrs at 4⁰C while rotating. Samples were centrifuged at 2000 RFC for 30 sec 
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at RT and supernatent was transferred to the next set of pre-prepared beads. Peptide 
bound beads were washed with 1 mL 1X IAP 3 times and 1 mL PBS before elution with 
55 µl followed by 45 µl of 5% formic acid for 10 min each at RT. Each sample was bound 
to 5 µl of beads 4 consecutive times. The first and second elutions were combined and 
the third and fourth elutions were combined to maximize MS hits and ensure that sites 
were not missed due to bead saturation. The flow-through was collected to use for peptide 
normalization. 
nLC-MS/MS analysis 
All chemicals used for preparation of nLC-MS/MS samples were of at least 
sequencing grade and purchased from Sigma-Aldrich, unless otherwise stated. The 
lyophilized unmodified and ubiquitylated peptide samples were reconstituted in 0.1% 
trifluoroacetic acid (TFA) and desalted using Poros Oligo R3 RP (PerSeptive Biosystems) 
P200 columns. The peptide samples were subsequently lyophilized and stored at −80°C 
for further analysis. 
Tryptic digests of the ubiquitylated fraction were analyzed by nLC-MS/MS on an 
Orbitrap Fusion mass spectrometer (Thermo) with a spray voltage of 2.3 kV and a capillary 
temperature of 275°C. The mass spectrometer was coupled online with a nanoLC Ultra 
2D+ (Eksigent, Sciex).  Peptides were separated by a two column system consisting of a 
trap column (100 μm id x 2 cm) and analytical column (75 μm id x 25 cm) both packed in-
house using reversed phase C18 Reprosil-pur 3μm, 120A (Dr. Maisch). Mobile phase A 
consisted of water + 0.1% formic acid and mobile phase B of 100 acetonitrile + 0.1% formic 
acid. Peptides were eluted using a flowrate of 300 nL/min with each run comprising a 75 
min gradient from 1 to 28% B, followed by 5 min from 28 to 80% B, and 5 min isocratic at 
80% B. The mass spectrometer was set to perform a full MS scan with an m/z from 300 
to 1200 in the Orbitrap (R = 120,000) followed by data-dependent MS/MS scans in the 
Orbitrap (R = 15,000) using HCD fragmentation (for charge states 2-3+, NCE = 27) and, 
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in parallel, ETD fragmentation (for charge states 3-7+, reaction time = charge dependent 
calibrated). The MS/MS duty cycle was set to 3 sec. The threshold for MS/MS selection 
was set to 20,000 counts. Dynamic exclusion was enabled with a repeat count of 1, repeat 
duration of 30s, exclusion size of 500 and duration of 40s. MS/MS isolation width was set 
to 2.0.Data type was centroid. Maximum injection time for MS/MS was set to 150 msec 
for HCD and 200 msec for ETD. MS/MS AGC target was set to 50,000 for HCD and 
100,000 for ETD. Inject ions for all available parallelizable time was set to true. 
Tryptic digests of the unmodified fraction were separated using an EasyLC 1000 
(Thermo) equipped with a one column system (75 μm id x 25 cm, reversed phase C18 
Reprosil-pur 3μm, 120A (Dr. Maisch)). The gradient was 120 min from 1% to 28% B, 5 
min from 28% to 80% and 10 min isocratic at 80% B. The HPLC was coupled online with 
the same Orbitrap Fusion (Thermo). The MS acquisition method was performed with the 
same settings as for the ubiquitylated fraction samples, except for the following: MS/MS 
was performed only using HCD fragmentation (charge states 2-5+, NCE = 32). Detection 
was performed in the ion trap, using an AGC target of 10,000 counts, a maximum injection 
time of 120 msec, a scan type Normal. Dynamic exclusion was set to 60 sec. The threshold 
for triggering MS/MS fragmentation was set to 50,000 counts. 
MS data processing and database searching 
Raw MS files were processed using MaxQuant, version 1.5.5.1 (Cox & Mann, 
2008). The peptide MS/MS spectra were searched by the Andromeda search engine (Cox 
et al., 2011) against the UniProtKB/Swiss-Prot Reviewed Mouse Reference Proteome 
database [10090] (retrieved on November 2015), containing 16,727 entries excluding 
isoforms. Additionally, the database included 247 common contaminants, discarded 
during data analysis. The search of the unmodified fraction included variable modifications 
of methionine oxidation and N-terminal acetylation, and fixed modification of 
carbamidomethyl cysteine. Analysis of ubiquitylated fraction included additionally diGly of 
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lysine residues. Fragment ion tolerance was set to 0.5 Da for the unmodified fraction and 
0.05 Da for the ubiquitylated fraction. Trypsin was specified as the digestive enzyme. 
Minimal peptide length was set to seven amino acids and a maximum of two missed 
cleavages was allowed. The false discovery rate (FDR) was set to 0.01 for peptide-
spectrum matches (PSMs) and protein identifications. Protein grouping was enabled. 
Peptide identification was performed with an allowed precursor mass deviation up to 4.5 
ppm after time-dependent mass calibration and an allowed fragment mass deviation of 20 
ppm. Protein identification required at least one unique or razor peptide per protein group. 
Label-free quantification in MaxQuant was performed using the intensity-based absolute 
quantification (iBAQ) algorithm (Schwanhausser et al., 2011). For matching between runs, 
the retention time alignment window was set to 20 min and the match time window was 1 
min. Protein tables were filtered to eliminate the identifications from the reverse database, 
only identified by site and common contaminants. The MaxQuant output files were viewed 
and analyzed with the Perseus  software package (Tyanova et al., 2016). 
For comparison, the raw data were also processed using Proteome Discoverer 
version 1.4 (Thermo Scientific) and searched against the UniProtKB/Swiss-Prot Reviewed 
Mouse Reference Proteome database [10090] (retrieved on November 2015), containing 
16,727 entries excluding isoforms, using an in-house MASCOT server (version 2.5, Matrix 
Science Ltd, London, UK). Database searches were performed with the following 
parameters: precursor mass tolerance of 10 ppm, product ion mass tolerance of 0.5 Da 
for the unmodified fraction and 0.05 Da for the ubiquitylated fraction, 
carbamidomethylation of cysteine as fixed modification, and two missed cleavages for 
trypsin. Searches were also conducted with the following variable modifications: oxidation 
of methionine and acetylation of protein N-terminal. Analysis of ubiquitylated fraction 
included additionally diGly of lysine. Minimal peptide length was set to six amino acids. 
Only peptides with high confidence (FDR 0.01), Mascot rank 1, search engine rank 1, and 
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a cut-off value of Mascot score ≥ 20 were considered for further analysis (Engholm-Keller, 
Hansen, Palmisano, & Larsen, 2011). All accession codes with peptide sequences 
containing 100% sequence identity against an individual peptide characterized by MS/MS 
in the database search were grouped together as a single protein description to remove 
protein name redundancy. 
Data Normalization and Significance Analysis 
The quantitative analysis was carried out on the log2-values of the measured 
peptide intensities or protein iBAQ intensities, and the data were normalized based on the 
average. The ubiquitylated peptide intensities were divided by the respective protein 
abundance to obtain true changes in the modification abundance. When no protein was 
identified in the unmodified fraction, the abundance of the peptide was not normalized. 
Results  
iPOND2-DRIPPER identification of ubiquitylated peptides 
Residual glycine-glycine (gly-gly) isopeptide linkage of ubiquitin to a substrate 
following trypsin digestion results in a 114 Da shift in peptide mass, allowing identification 
of ubiquitylated peptides by MS (Bauden, Kristl, Andersson, Marko-Varga, & Ansari, 
2017). Previous iPOND-MS studies did not report any ubiquitylation sites on replication 
proteins (Dungrawala et al., 2015; Lecona et al., 2016). Due to the increased protein yield 
and specificity from iPOND2 and sensitivity afforded by label-free quantitative MS, 
ubiquitin modifications were observed. Furthermore, approximately 70% of ubiquitylated 
peptides were significantly increased in the EdU-pulse retrievals compared to Thy-chased 
controls. We detected poly-ubiquitin modifications (K48, K63), H2A/X ubiquitylation 
(K119/120), and replication-associated ubiquitylation of PAF15 (K24) (Table 5.1). Some 
of these served as validation of the utility of iPOND2-DRIPPER in identification of 
ubiquitylation sites on the replisome, such as the replisome-specific ubiquitylation  of 
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PAF15 (K24) (Povlsen et al., 2012). Other nascent strand-associated ubiquitylation events 
identified using iPOND2-DRIPPER, however, had not been previously reported. These 
sites included histone-lysine N-methyltransferase EHMT1 (K999), activity-dependent 
neuroprotector homeobox protein (K198), and histone H2B.1 (K117), each of which were 
significantly enriched over 10-fold in EdU retrievals compared to Thy controls (Table 5.1).  
Thus, iPOND2-DRIPPER can provide potential avenues of investigation for expanding our 
understanding of ubiquitin regulation of the replisome. 
iPOND2-DRIPPER identified changes in ubiquitylation following replication stress 
Next we wanted to examine changes in replisome ubiquitylation following 
replication stress. K63 ubiquitin peptides increased nearly 9-fold upon replication fork 
stalling for 2 hrs with APH treatment. This pattern mirrors that of the BRCA1-A complex 
(see Chapter 3) upregulation at the fork. The BRCA1-A complex is recruited to sites of 
damage through the K63-linked poly-ubiquitin binding protein RAP80 (Table 5.2) (Hu, 
Paul, & Wang, 2012; H. Kim, Chen, & Yu, 2007). In addition, other previously reported 
stress-regulated ubiquitylation events were observed in our iPOND2-DRIPPER analysis, 
such as decreased abundance of K24-ub of PAF15 and an increase in H2A/X 
ubiquitylation (K119/120) with 2 hr APH treatment (Povlsen et al., 2012). When APH 
treatment was increased to 4 hrs, K24-ub of PAF15 decreased further and significantly (p-
value 0.019), however, none of the other changes noted with 2 hr APH treatment showed 
significant persistence after 4 hrs (Table 5.3).  
We hypothesized that treatment of samples with CB5083, a potent p97 inhibitor, 
would increase the likelihood of ubiquitin site identification. Subsequently, we treated 
samples with CB5083 alone or with APH for 2 or 4 hrs. Following dual treatment we 
observed an increased number of significantly changing peptides at both time points 
relative to either single treatment (Table 5.2 and 5.3). When CB5083 was added to APH 
treatment for 2 hrs and normalized to 2 hr APH we observed a 2.74-fold (p-value 0.007) 
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increase in K164-ub of PCNA. This increase was amplified to approximately 50-fold after 
4 hrs of treatment, but was no longer significant (p-value 0.079) (Table 5.4). When dual 
treatment in ATR deficient cells was compared to 2 hr APH treatment in cells lacking ATR 
there was a significant increase in K164-ub of PCNA (p-value 0.036) (Table 5.9). 
Surprisingly, levels of K48 and K63 were not significantly altered with additional CB5083 
treatment compared to APH alone at either time point (respective p-values at 2 hrs and 4 
hrs: K48 0.222, 0.358, K63 0.108, 0.058). K11 ubiquitylation, however, increased 
approximately 5-fold (p-value 0.001) in dual treatment compared to 2 hr APH treatment 
and nearly 8-fold (p-value 0.006) compared to 4 hrs APH treatment (Table 5.4). 
Furthermore, iPOND2-DRIPPER identified a novel ubiquitylation site for histone H2B at 
K117. K117-ub of histone H2B was increased in EdU treatment compared to Thy and 2 
hr APH compared to EdU, but significantly decreased in all treatment conditions other than 
2 hr APH compared to ATRKO alone (Table 5.7 and 5.8). 
ATR regulates cell cycle and DNA damage response, so we examined replisome 
ubiquitylation in cells lacking ATR following replication stress. ATR-deficient cells showed 
no significant alterations in ubiquitylation compared to EdU, but when normalized to 
ATRKO alone, CB5083 treatment with or without APH for 2 hrs caused significantly 
decreased K164-ub of PCNA (Table 5.5-5.8). K164-ub on PCNA decreased with 2 hrs of 
APH treatment compared to ATRKO and with dual treatment normalized to 2 hrs APH with 
ATRKO. When 4 hr dual treated samples were compared to 2 hr APH, however, there 
was a significantly increased level of PCNA ubiquitylation with or without ATR present, 
consistent with the reported role of p97 in regulation of PCNA-ub (Table 5.4) (Davis et al., 
2012). Despite the advancement in our capacity to identify and monitor of replisome 
ubiquitylation sites by iPOND2-DRIPPER compared to other iPOND-MS data sets, only 1 
of 11 peptides were observed in multiple replicates, very few novel sites were identified, 
and the number of ubiquitylated peptides identified varied greatly between experiments, 
125 
 
leaving much to be desired with regards to consistent identification (Dungrawala et al., 
2015; Lecona et al., 2016).   
Initial attempts at tandem affinity purification of replisome-associated sites of ubiquitylation   
In order to expand our ability to identify and monitor ubiquitylation at the replication 
fork, we sought to create a tandem affinity enrichment protocol through combination of 
iPOND2 with the K-ɛ-GG developed by the Carr laboratory. We began by establishing a 
baseline functionality of the K-ɛ-GG IP by treating 6x107 NIH 3T3 mouse embryonic 
fibroblasts with 10 mM CB5083 for 6 hrs before harvest and then preforming a K-ɛ-GG IP 
on whole cell lysate (Udeshi et al., 2013). MS (Q exactive HF, Thermo) analysis was 
performed on 1/10 of the eluted sample and the ratio of 114 Da shifted peptide spectral 
counts to total protein was calculated. A pool of ubiquitylated replisome components was 
identified including PCNA, MCM7, MCM4, and RPA70, but the majority of ubiquitin sites 
identified were not replisome-associated and many known sites of replisome ubiquitylation 
were not identified (data not shown). Next we used 4 EdU treated iPOND2 gradients 
(fractions 1-14) that had undergone standard elution procedures in an attempt to purify 
ubiquitylated replisome components. All steps of the K-ɛ-GG IP remained the same as in 
the initial attempt, however, no peptides were observed in the tandem affinity pull-down.  
Subsequently, we increased our input material to 10 gradients treated with CB5083 
and APH for 6 hrs to maximize the retention of ubiquitylation on proteins and increase our 
chances of detection. Ubiquitylation sites were observed by MS analysis, however, no 
ubiquitin chains were detected (Table 5.10). Based on previous experiments and iPOND2-
DRIPPER results, there should have been ubiquitin chains present, suggesting that a 
large amount of material was being lost. We decreased the CB5083 and APH treatment 
time to 2 and 4 hrs in order to prevent off target effects and ran the protocol again. The 
results were comparable to the 6 hr treatment. In all of these trials we observed 
ubiquitylated peptides that had been only partially digested. We hypothesized that the 
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amount of SDS remaining in the samples following iPOND2 elution and precipitation was 
diminishing the ability of the enzymes to effectively digest the proteins.   
We switched from an acetone to chloroform based precipitation, increased the 
input material by increasing the number of beads used in the iPOND2 pull-down, altered 
the digestion conditions (see Materials and Methods), and switched to analysis using an 
Orbitrap Fusion Tribrid Mass Spectrometer following consultation with Dr. Katarzyna Kulej 
in the laboratory of Dr. Benjamin Garcia. We tested 10 iPOND2 gradients (fractions 1-5) 
treated for 2 hrs with APH or 2 hrs APH and CB5083 (Fig. 5.1). The updated protocol 
resulted in the identification of K11, 63, and 48 ubiquitylation marks, among others. 
Furthermore, some unique histone ubiquitylation sites were identified, but due to the 
combined samples; we can only note the identification of these sites and not draw 
conclusions regarding their functions (Table 5.11).  
Detection of replisome ubiquitylation in response to stress by iPOND2-K-ε-GG enrichment 
Having established a protocol for the enrichment and identification of ubiquitylation 
sites on replication-associated proteins, we sought to determine the changes in replisome 
ubiquitylation that occurred with APH treatment. We compared untreated samples to those 
treated with APH for 2 hrs with or without p97 inhibition using iPOND2 fractions 6-14. To 
ensure that resin saturation did not prevent the identification of important sites we 
performed a secondary K-ɛ-GG IP on the flow-through from the first set of bindings. In 
most cases peptides identified by this secondary binding followed the same patterns as 
seen in the original binding but at a lower level, indicating that the beads were not 
saturated (Supplemental Table 5.1 and 5.2). There were no sites that were only identified 
in the second binding, suggesting that in the future only the first set of bindings need to be 
analyzed.  
In order to narrow the focus of analysis we only discuss the sites identified by both 
Proteome Discoverer and MaxQuant, however, each method has strengths and 
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weaknesses and sites identified by one method alone still merit further investigation. 26 
proteins were identified to have one of more di-Gly shifted peptide by both MaxQuant and 
Proteome Discoverer analyses including some that have been identified in pervious 
iterations of iPOND2-K-ɛ-GG such as FANCD2, FANCI, FAM111A, PAF15, PCNA, and 
RAD18 (Table 5.12). Sites identified only by the most updated iteration of iPOND2-K-ɛ-
GG include ASXL1 (K351; a transcriptional regulator), BCOR (K1464, K1491; a 
transcriptional corepressor), CUL5 (K724; a ubiquitin ligase), DNMT1 (K985; a 
methyltransferase), EHMT1 (K966, K968; a methyltransferase), HNRNPK (K405; a pre-
mRNA binding protein), RFC1 (K22; a replisome protein), SPRTN (K432; a p97 adaptor 
protein), SUMO2 (K11, K32/33), and SUPT16H (K228; a part of FACT complex). Of the 
sites identified by both analyses, 35 have been reported on Proteome Scout 
(https://proteomescout.wustl.edu/) and 29 sites have not been reported (Table 5.12).   
Using iPOND2-K-ε-GG we were able to identify all of the known ubiquitylation sites 
on ubiquitin, which was one of our metrics for successful pull-down (Table 5.12). 
Consistent with the prolific nature of K48 chains, K48 ubiquitin showed the highest 
increase relative to protein abundance in the EdU treated sample alone. Of note, while 
K48 ubiquitylation was high in all three samples, APH treatment and p97 inhibition resulted 
in slightly decreased K48 ubiquitylation relative to EdU treatment alone. K11-Ub followed 
a similar pattern to that observed for K48 (Table 5.12). Interestingly, K6 showed the largest 
decrease of all of the ubiquitin modifications following treatment with p97 inhibitor and 
APH compared to APH alone. Alternatively, K63 and K27 both increased following 
treatment with p97 inhibitor and APH compared to APH alone (Table 5.12). These patterns 
can be used to determine potential protein targets of these PTMs through identification of 
similarly regulated proteins.  
iPOND2-K-ɛ-GG was able to identify three previously unreported ubiquitylation 
sites on FAM111a, a replication associated protein. K39 and K169-ub FAM111a were both 
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observed in all three samples. Both of these sites show decreased representation when 
p97 inhibition was combined with APH treatment (Table 5.12). Similarly, a novel 
ubiquitylation site of RFC1 (K22) was reported to increase in response to DNA damage 
by iPOND2-K-ɛ-GG. Both FAM111a and RFC1 are known to regulate PCNA loading at 
the replication fork, suggesting that their ubiquitylation may be related to regulation of this 
crucial replication protein (Alabert, Bukowski-Wills, et al., 2014; Shiomi & Nishitani, 2017). 
Additionally, K559-ub of FANCD2 increased with APH treatment consistent with previous 
reports but decreased with dual treatment, potentially  indicating a role for p97 in 
maintenance of FANCD2-ub (Yeran Yang et al., 2015). FANCI ubiquitylation on K714, a 
previously unreported site, followed the same pattern as K559-ub of FANCD2, however, 
was not detected in the EdU treated sample, so fold changes could not be calculated 
(Table 5.12). Ubiquitylation of RAD18 at K127 and K197 sites was increased with APH 
treatment; however, neither of these sites had been previously reported to be modified in 
response to replication stress (Table 5.12). Finally, multiple, previously unreported 
ubiquitylation sites of replication protein RPA1 (K262, K276, K344, K419, K467, and K562) 
were reported by iPOND2-K-ɛ-GG. Many of these sites were identified in the dual 
treatment and increased relative to EdU, suggesting potential p97 regulation of 
ubiquitylation on RPA. Thus, it is evident that iPOND2-K-ɛ-GG can help us identify multiple 
ubiquitination of replication and repair associated proteins.  
When we sorted identified peptides based on their enrichment in 2 hr APH + 
CB5083 treatment relative to 2 hr APH treatment alone, multiple histone ubiquitylation 
sites were enriched, many of which have been previously reported (Table 5.12). One of 
these sites is K120-ub of histone H2AX, which has previously been reported to be involved 
in DNA damage signaling. Overall, many potentially important sites of replisome 
ubiquitylation were identified by iPOND2-K-ε-GG, supporting further use and refinement 
of this protocol. Furthermore, validation and more in depth investigation of the sites 
129 
 
identified here will likely help expand our knowledge of replisome ubiquitylation in 
response to stress.  
Discussion  
iPOND2-DRIPPER has the capacity to identify and monitor changes in 
ubiquitylated peptides between treatment conditions. Even without treatment to enhance 
levels of ubiquitylation we were able to observe ubiquitylation of multiple peptides using 
iPOND2-DRIPPER alone (Table 5.1). Approximately 70% of the identified peptides 
increased significantly in EdU compared to Thy treated samples, indicating that these 
proteins were ubiquitylated under conditions of normal replication. iPOND2-DRIPPER was 
able to identify previously established ubiquitylation sites, validating this method for 
identification of ubiquitylation sites. One of these sites was K24-ub of PAF15 that, in 
conjunction with PAF15 (K15-ub), is important for regulating the TLS polymerase access 
to PCNA during DNA replication (Povlsen et al., 2012).  
Furthermore, iPOND2-DRIPPER identified multiple novel replisome ubiquitylation 
sites. For example, while K123-ub of histone H2B is known to be required for TLS, K117-
ub of H2B, which was identified by iPOND2-DRIPPER, has not been previously reported 
(Hung et al., 2017). We observed significant enrichment of K117-ub of H2B compared to 
the Thy chase and compared to the total protein enrichment, suggesting that this 
ubiquitylation occurs during normal replication and may have a role related to TLS or other 
replication associated processes. Histone H2B ubiquitylation at K117 did not show any 
significant changes with treatment, suggesting that its role in DNA replication is not 
regulated by stress (Table 5.2 and 5.3). When normalized to ATRKO, however, most 
treatments resulted in decreased levels of ubiquitin at this site (Table 5.7 and 5.8). K117-
ub increased in ATR-deficient cells compared to EdU treatment alone, suggesting the 
possibility that ATR minimizes changes in ubiquitylation in response to stress, so that 
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when ATR is missing, stress is more likely to cause loss of ubiquitylation, potentially to 
promote ATR-independent damage repair. Other novel sites detected, such as K999 on 
EHMT1, showed significant enrichment in the EdU treatment compared to the Thy chase, 
however did not show a high ratio of peptide ubiquitylation to total protein enrichment, 
indicating that the ubiquitylation itself may not be as important as the presence or absence 
of the protein for regulation of replication (Table 5.1). Thus, understanding the replisome 
ubiquitylation can help inform further investigation of the mechanism driving replisome 
component change following stress. 
Furthermore, iPOND2-DRIPPER can be used to discover new patterns of 
regulation for previously identified ubiquitylation sites. For example, while the 
ubiquitylation  of PAF15 (K24) has been shown to decrease significantly with ultra violet 
(UV) or hydroxyurea (HU) induced replication stress, it has never been examined with 
APH treatment (Povlsen et al., 2012). iPOND2-DRIPPER showed a significant decrease 
in K24-ub of PAF15 following APH treatment at multiple time points (Table 5.2). APH 
treatment can now be counted among the replication stressors that promote the loss of 
K24-ub of PAF15, an important advancement for treating diseases associated with failures 
in TLS processing such as xeroderma pigmentosum (Beagan & McVey, 2016).  
We were also able to monitor K164-ub of PCNA using iPOND2-DRIPPER. This 
site is important because its monoubiquitylation is used to signal the need for TLS, but it 
can be further modified to signal the need for additional repair pathways in response to 
other stressors (Table 5.2) (Qin et al., 2016). In response to replication stress PCNA is 
further ubiquitylated at K164, consistent with the significant increase in K164-ub of PCNA 
observed following 2 hr APH treatment, helping to activate the ATR checkpoint (Qin et al., 
2016). The significant increase in K164-ub following the addition of CB5083 to APH 
treatment suggests that p97 helps regulate the removal of K164 ubiquitylated PCNA from 
the replication fork (Table 5.2-5.4). This is consistent with SPRTN/DVC1 recruitment of 
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p97 to sites of replication fork stalling (Davis et al., 2012). Compared to ATRKO alone, 
p97 inhibition with or without APH for 2 hrs resulted in a significant decrease in K164-ub 
of PCNA (Table 5.6 and 5.7). When dual treatment with ATRKO was compared to ATRKO 
+ APH treatment there was significant enrichment with the dual treatment, as observed in 
the absence of ATRKO (Table 5.9). This suggests that PCNA ubiquitylation is decreased 
in the presence of ATRKO; however, ATRKO compared to EdU shows a large increase in 
K164-ub of PCNA (p-value 0.281) (Table 5.5). One explanation for these interesting 
patterns is that total levels of PCNA are decreasing with ATRKO, resulting in decreased 
observation of ubiquitylation, although, total PCNA levels with ATRKO treatments do not 
decrease much more than treatments without ATRKO (Fig. 3.10). An alternative 
hypothesis is that p97 removal of K164-ub may be negatively regulated by ATR, or ATR 
and p97 may co-regulate K164-ub. Further investigation clarifying these interactions 
through increased replicates, time points, and directed experimentation will likely provide 
important advancements in understanding the regulation of replication repair proteins.  
In addition to understanding changes in patterns of protein ubiquitylation, it is 
important to be able to monitor changes in ubiquitylation levels of ubiquitin itself. As 
expected, K11 and K48 levels were increased following p97 inhibition, consistent with 
many previous reports that suggest a role for p97 in regulation of K48 and K11 
ubiquitylation but not K63 (Dantuma & Hoppe, 2012; Meerang et al., 2011). K63 ubiquitin 
levels were significantly increased with dual treatment compared to EdU. K63 levels did 
not significantly increase compared to APH treatment alone, however, suggesting that 
while K63 may not be p97-dependent it still likely plays a role in stress response (Table 
5.2-5.4). We are currently working with the Mailand laboratory to create an iPOND2-K63-
Super-UIM-specific IP hybrid protocol. This protocol will allow us to detect K63 specific 
ubiquitylation of replication proteins under a variety of conditions, helping to determine 
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which of the PTMs observed are K63 modifications, providing more insight into the roles 
of these ubiquitylation events.  
Despite our intriguing observations and the extensive interest expressed in 
iPOND2-DRIPPER by other laboratories, iPOND2-DRIPPER only provided a few 
ubiquitylation sites from each sample set and was inconsistent in its ability to identify the 
same peptides across replicates. To establish a more expansive list of ubiquitylated 
peptides we combined iPOND2 with a K-ɛ-GG IP. During the development of this protocol 
we identified new ubiquitylation sites on multiple histones that appeared in cells treated 
with APH and p97 inhibitor in the less dense gradient fractions associated with EdU (Table 
5.11). While we were unable to draw definitive conclusions regarding these sites due to 
the combination of multiple samples, the identification of novel sites in these samples 
emphasizes the importance of further application of the iPOND2-K-ɛ-GG protocol to 
different gradient fractions to identify important targets for further investigation.   
We preformed iPOND2-K-ε-GG on EdU, 2 hr APH, and 2 hr APH + p97 inhibited 
samples using the replisome containing fractions (6-14). Among the ubiquitylation sites 
identified by iPOND2-K-ε-GG were some sites identified by iPOND2-DRIPPER including 
K24-ub of PAF15 and K119/120-ub of histone H2AX (Table 5.1,5.2, 5.5,5.6, and 5.12). 
Many additional sites were identified, some that were previously unreported by 
ProteomeScout including K22-ub of RFC1 and K714-ub of FANCI (Table 5.12). iPOND2-
K-ɛ-GG identified over 6 times more ubiquitylation sites than iPOND2-DRIPPER alone, 
many of which were identified across multiple samples (Fig. 5.1 and Table 5.12). iPOND2-
K-ε-GG represents an improvement in our ability to monitor and understand changes in 
ubiquitylation at the replisome. Furthermore, the conditions used for iPOND2-K-ɛ-GG can 
be used to explore other PTMs and help inform other tandem affinity purification protocols 
such as the iPOND2-K63-SUPER-UIM IP, or purification of acetylation or phosphorylation 
modifications.  
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FANCD2 and FANCI have previously been shown to be monoubiquitylated at K559 
and K522, respectively, in response to ICLs (Bick, Zhang, Meetei, & Andreassen, 2016; 
Renaudin et al., 2016). Our observation of increased ubiquitylation at these sites following 
replication stress is expected, but it is notable that additional p97 inhibition decreased 
K559-ub of FANCD2 compared to APH treatment alone (Table 5.12). It is possible that 
p97 regulates a protein, such as USP1, that limits FANCI and FANCD2 ubiquitylation, 
resulting in upregulation and increased loss of ubiquitin marks following prolonged p97 
inhibition (Nijman et al., 2005). A recent study reported a role for p97 in the removal of 
FANCD2 and FANCI from replication forks following stress by MMC or HU (Gibbs-
Seymour et al., 2015). iPOND2-DRIPPER showed an increased level of FANCI and 
FANCD2 after 4 hrs with dual treatment compared to APH alone, suggesting that APH 
may result in stress response similar to those triggered by MMS and HU (Fig. 3.9). More 
replicates of this analysis will need to be run in order to calculate significance of these 
changes and assesses their importance for DNA damage response.  
iPOND2-K-ε-GG also reported two known RAD18 ubiquitylation sites (K127 and 
K197) (Table 5.12). RAD18 is an important component in the ubiquitylation of PCNA in 
response to replication stress in order to activate DNA damage tolerance pathways 
(Davies, Huttner, Daigaku, Chen, & Ulrich, 2008). While both of the identified sites have 
been reported by proteome wide screens and recorded in ProteomeScout, neither has 
been examined in any detail in conjunction with replication fork stress. Both of these 
ubiquitylation sites were upregulated following replication stress, making them interesting 
targets for further investigation with regards to regulation of DNA damage response (Table 
5.12).  
iPOND2-K-ɛ-GG also reported increased ubiquitylation on multiple histones 
following the addition of p97 inhibition to APH treatment including K120-ub of histone 
H2AX (Table 5.12). While no direct evidence has linked histone H2AX ubiquitylation 
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(K119/120) to p97 regulation, a recent study indicated that SPRTN/DVC1, a p97 adaptor 
protein, is important for repair of ICLs in a p97-dependent manner (Cheng et al., 2016; 
Davis et al., 2012). It is possible that upregulation of histone H2AX ubiquitylation in 
stressed cells lacking functional p97 is due to increased persistence of damage, rather 
than a direct interaction of p97 with H2AX. These H2AX patterns were not repeated in the 
iPOND2-DRIPPER analysis, however, indicating that further replicates and validation are 
required (Table 5.4). The discovery that p97 was involved in regulation of H2AX-ub would 
be important for the study of DNA damage signaling treatment of DNA damage related 
diseases.  
In addition to monitoring changes in ubiquitylation of known replisome sites, 
iPOND2-K-ɛ-GG can help guide investigation into new sites. For example, FAM111a was 
recently identified to be a replication associated protein involved in PCNA loading, 
however, no ubiquitin sites have been identified on FAM111a (Alabert, Bukowski-Wills, et 
al., 2014). We identified three novel FAM111a ubiquitylation sites (K7, K39, and K165) 
using iPOND2-K-ɛ-GG (Table 5.12). Both K39- and K165-ub of FAM111a were increased 
with 2 hr APH treatment compared to EdU, indicating that these marks occur in response 
to replication stress and may contribute to recruitment of DNA repair proteins (Table 5.12). 
These ubiquitylation sites appear to be independent of p97 regulation. Directed validation 
is required to determine the function and importance of FAM111a ubiquitylation at the 
replication fork following replication fork stalling, however, this site identification represents 
an expansion of our understanding of one of the core replication proteins that was made 
possible by iPOND2-K-ɛ-GG.  
Similarly, six previously unreported ubiquitylation sites of RPA1 (K262, K276, 
K344, K419, K467, and K562) were identified by iPOND2-K-ε-GG (Table 5.12). RPA1 is 
recruited to single stranded DNA and is important for both normal replication of the lagging 
strand, and recruitment and activation of ATR following replication stress (Acevedo, Yan, 
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& Michae, 2016). For the most part these sites do not appear to be upregulated in 
response to stress with APH and it is unclear what roles these ubiquitylation sites may 
play in DNA replication or regulation. Ubiquitylation at one of the identified sites (K276) 
increased nearly 4 fold on a log base 2 scale in response to replication stress, indicating 
a likely role for this site in regulation of RPA or recruitment of DNA repair proteins in 
response to replication fork stalling (Table 5.12). It would be particularly interesting to 
determine if these sites were mono-ubiquitylated or poly-ubiquitylated and what type of 
ubiquitylation may be occurring at these sites. This is a question that can be at least 
partially addressed through the development of the iPOND2-K63-SUPER-UIM IP analysis 
of K63 ubiquitination sites of the replisome. All of these ubiquitylation sites warrant further 
investigation due to the essential nature of RPA1 in regulation of DNA damage response.  
Overall, iPOND2-K-ɛ-GG represents a notable advancement in our ability to 
assess replisome ubiquitylation in a high-throughput, hypothesis generating manner; 
however, additional refinement of this protocol would expand its utility. In its current state 
iPOND2-K-ɛ-GG requires 10 iPOND2 gradients of material per sample, which can be time 
and cost prohibitive. Additionally, there are some known sites of replisome ubiquitylation 
that were not identified by the screen, indicating further room for improvement of the 
protocol. We hypothesize that the reason for missed sites is due to the use of 
choloracetamide in the peptide digestion buffer to prevent formation of di-sulfide bonds. 
Choloracetamide can alkylate cysteine, resulting in a 59 Da shift in peptide size, limiting 
our ability to detect and identified these peptides. One example of a case for which we 
believe this occurred is the identification of the K164-ub site on PCNA. We were able to 
identify this site in iPOND2-DRIPPER samples, but not in the full iPOND2-K-ɛ-GG run, 
likely due to the presence of a cysteine in the peptide only two bases before the modified 
lysine (Table 5.1-5.9, and 5.12).  
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Despite the room for improvement, our initial examination of changes in replisome 
components following stress and p97 inhibition has generated multiple potential targets 
for follow-up investigation. The development of iPOND2-K-ɛ-GG represents an important 
advancement in our ability to assess changes in ubiquitylation at the replication fork and 
provides a useful tool for further investigation. The use of iPOND2 in conjunction with other 
protocols has already begun to generate interest in the field, and we are currently working 
with the Mailand laboratory to create an iPOND2-K63-Super-UIM-specific ubiquitin IP 
hybrid protocol. This protocol could be compared to iPOND2-K-ε-GG to determine which 
identified sites were K63 modified compared to other site modifications. Furthermore, this 
emphasizes the potential for iPOND2 to be combined with multiple protocols to advance 
the replication field in a variety of directions such as investigation of other PTMs on the 
replisome in a high-throughput manner.  
In conclusion, we have developed an improved iPOND protocol allowing the 
identification of multiple novel ubiquitylation sites at the replication fork, and the ability to 
monitor changes in known ubiquitylation sites following replication stress. We were able 
to use iPOND2-DRIPPER to expand our understanding of the regulation of PAF15 
ubiquitylation on K24 following replication stress by APH. The results presented in this 
chapter suggest multiple unique ways that known ubiquitylation sites are regulated by p97 
in response to replication stress. We have identified multiple novel ubiquitylation sites for 
further investigation including K117 on histone H2B, FAM111a (K7, K39, and K165), and 
RPA1 (K262, K276, K344, K419, K467, and K562). The development of iPOND2-K-ε-GG 
will expand the field’s ability to identify and monitor changes in ubiquitylation of replisome 
components in response to a wide variety of conditions.  
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Figure Legends 
Figure 5.1. Schematic showing the combination of K-ɛ-GG IP with iPOND2. Following 
elution of iPOND2 samples, material is precipitated and digested using LysC and trypsin. 
Peptides are desalted using a C18 Waters SepPak filter, lyophilized, and bound to α-K-ε-
GG beads (see Materials and Methods). 
Table Legends 
Table 5.1. The fold change of ubiquitylated peptides observed across 3 replicates 
between EdU and Thy treatments. A two tailed Student’s t-test between each condition 
using the technical replicates was performed to determine the significance of the fold 
change. The ratio of the EdU/Thy fold change for each ubiquitylated peptide over the 
EdU/Thy fold change for the source protein was calculated. 
Table 5.2. The fold change of ubiquitylated peptides observed with 2hr APH treatment, 
p97 inhibition (p97i), and dual treatment (APH +p97i) compared to EdU. A two tailed 
Student’s t-test between each condition using the technical replicates was performed to 
determine the significance of the fold change.  The ratio of the treatment/EdU fold change 
for each ubiquitylated peptide over the treatment/EdU fold change for the source protein 
was calculated. 
Table 5.3. The fold change of ubiquitylated peptides observed with 4hr APH treatment, 
p97 inhibition (p97i), and dual treatment (APH +p97i) compared to EdU. A two tailed 
Student’s t-test between each condition using the technical replicates was performed to 
determine the significance of the fold change.  The ratio of the treatment/EdU fold change 
for each ubiquitylated peptide over the treatment/EdU fold change for the source protein 
was calculated. 
Table 5.4. The fold change of ubiquitylated peptides observed with 2 and 4 hr APH 
treatment compared to dual treatment (p97i +APH). A two tailed Student’s t-test between 
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each condition using the technical replicates was performed to determine the significance 
of the fold change. 
Table 5.5. The fold change of ubiquitylated peptides following ATRKO, ATRKO + 2 hr 
APH treatment, ATRKO + 2 hr p97 inhibition (p97i), and ATRKO + 2 hr dual treatment 
(p97i +APH) with calculated fold change over EdU. A two tailed Student’s t-test between 
each condition using the technical replicates was performed to determine the significance 
of the fold change.  The ratio of the treatment/EdU fold change for each ubiquitylated 
peptide over the treatment/EdU fold change for the source protein was calculated. 
Table 5.6. The fold change of ubiquitylated peptides following ATRKO + APH treatment, 
ATRKO + p97 inhibition (p97i), and ATRKO + dual treatment (p97i +APH) normalized to 
EdU after 4hrs. A two tailed Student’s t-test between each condition using the technical 
replicates was performed to determine the significance of the fold change.  The ratio of 
the treatment/EdU fold change for each ubiquitylated peptide over the treatment/EdU fold 
change for the source protein was calculated. 
Table 5.7. The fold change of ubiquitylated peptides observed with ATRKO + APH 
treatment, ATRKO + p97 inhibition (p97i), and ATRKO + dual treatment (p97i + APH) 
normalized ATRKO after 2 hrs. A two tailed Student’s t-test between each condition using 
the technical replicates was performed to determine the significance of the fold change.  
The ratio of the treatment/EdU fold change for each ubiquitylated peptide over the 
treatment/EdU fold change for the source protein was calculated. 
Table 5.8. The fold change of ubiquitylated peptides observed with ATRKO + APH 
treatment, ATRKO + p97 inhibition (p97i), and ATRKO + dual treatment (p97i +APH) 
normalized to ATRKO after 4 hrs. A two tailed Student’s t-test between each condition 
using the technical replicates was performed to determine the significance of the fold 
change.  The ratio of the treatment/EdU fold change for each ubiquitylated peptide over 
the treatment/EdU fold change for the source protein was calculated. 
139 
 
Table 5.9. The fold change of ubiquitylated peptides following 2 and 4 hr APH treatment 
calculated fold change normalized to dual treatment (p97i +APH) with in cells lacking ATR. 
A two tailed Student’s t-test between each condition using the technical replicates was 
performed to determine the significance of the fold change. 
Table 5.10. The fold change of ubiquitylated sites identified by three initial iPOND2-K-ɛ-
GG tandem affinity purification attempts. 
Table 5.11. The fold change of ubiquitylated sites identified by final iPOND2-K-ɛ-GG 
tandem affinity purification using iPOND2 fractions 1-5 from combined 2 hr APH and 2 hr 
APH + p97 inhibited (p97i) samples. Ubiquitylation sites were identified using both 
Proteome Discover erand MaxQuant analysis. Sites were reported as identified in both or 
MaxQuant, as there were no unique sites to Proteome Discoverer. ProteomeScout was 
used to determine the novel sites identified. 
Table 5.12. The fold change of ubiquitylated sites identified by iPOND2-K-ɛ-GG tandem 
affinity purification using iPOND2 fractions 6-14 from EdU treatment, 2 hr APH, and 2 hr 
APH + p97 inhibited (p97i +APH) samples identified by both Proteome Discoverer and 
MaxQuant. The following proteins and sites were not included in the Table because they 
were not able to be normalized by protein abundance but were observed (see 
Supplemental Tables 5.1 and 5.2 for values); ASXL1 (K351), BCOR (K1464; K1491), 
Histone H2A (K120, K126), Histone H2B (K121), PAF15 (K15, K24), SPRTN/DVC1 
(K432), SUPT16H (K228). The quantification presented in this table is from MaxQuant 
only; please refer to Supplemental Table 5.1 for the values obtained by Proteome 
Discoverer. 
Supplemental Table Legends 
Supplemental Table 5.1. Ubiquitylated peptides identified by iPOND2-K-ε-GG MS by 
Proteome Discoverer analysis. 
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Supplemental Table 5.2. Ubiquitylated peptides identified by iPOND2-K-ε-GG MS by 
MaxQuant analysis. 
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Table 5.11  
Names GlyGly (K) site positions Novel sites Analysis 
FAM65A 949 949 MaxQuant 
FANCD2 559 Both
FANCI 522 MaxQuant 
Histone H2AFY 123 MaxQuant 
Histone H2AFZ 126 126 MaxQuant 
Histone H2AX 120;134;135 134,135 Both
Histone H2B 6;109;121 Both
Histone H3.1 19;24;28 Both
Histone H4A 21 21 MaxQuant 
PCNA 168 MaxQuant 
PDE4DIP 502;504 502;504 MaxQuant 
Poly-Ubiquitin B 11;27;29;48;63;113 Both 
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Discussion of the development and potential impact of iPOND2. 
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Development of an improved method for assessment of replisome dynamics and 
ubiquitylation of replication-associated proteins. 
Altered regulation of DNA replication and repair proteins has a widespread impact 
on cellular health; but assessment of the subtle changes in replisome components in 
response to stress has been difficult. In order to address this deficiency multiple similar 
protocols have recently been developed that isolate replication-associated proteins based 
on their presence on newly replicated DNA. These protocols include isolation of protein 
on nascent DNA (iPOND), nascent chromatin capture (NCC), and DNA mediated 
chromatin pull-down (Dm-Chp) (Alabert, Bukowski-Wills, et al., 2014; Kliszczak et al., 
2011; Sirbu et al., 2013, 2012). These protocols represent a notable improvement in our 
ability to assess the association of previously difficult to detect proteins, such as 
polymerases, with actively replicating forks without isolation of other insoluble material. 
Despite the many improvements in replisome analysis attributed to these protocols, they 
also isolate a large amount of post-replicative material (Sirbu et al., 2011). A 10 minute 
pulse of EdU, the minimum time required for effective labeling, results in a labeling of at 
least 10 Kb of DNA in normally replicating mammalian cells. Actively replicating forks 
occupy at most 100-200 base pairs of DNA, meaning that the EdU pulses used by the 
protocols mentioned above are associated with significantly more post-replicative material 
than active replication forks.  
Here we describe the addition of a sucrose gradient fractionation to the iPOND 
protocol developed by the Cortez laboratory in an attempt to minimize the isolation of post-
replicative chromatin-associated proteins and to subsequently enrich actively replicating 
forks. Density based fractionation of iPOND samples resulted in the separation of large, 
dense replisomes from non-replisome-associated EdU, allowing the physical removal of 
much of the post-replicative material prior to bead binding (Fig. 2.3B and C). Our improved 
iPOND protocol (iPOND2) reduced the isolation of post-replicative proteins and increased 
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the specificity for active replication forks as measured by western blot and MS (Fig. 2.3 
and 2.4). We confirmed the ability of iPOND2 to specifically isolate replisome components 
using the DRIPPER method of MS analysis on three biological replicates. DRIPPER 
allowed us to analyze proteins that were enriched on EdU compared to a 30 minute post-
replicative control, further removing highly post-replicative proteins from our analysis (Fig. 
2.5). When we compared the iPOND2 data to replisome data sets collected by other 
laboratories, iPOND2 more consistently identified proteins observed by other protocols 
than the other data sets did (Fig. 2.7). For example, only 1 Tier 2 protein was not included 
in the iPOND2 data set while each of the other data sets lacked at least 9 proteins 
observed by the other groups (Fig. 2.7). Furthermore, compared to data sets from other 
protocols, iPOND2 resulted in higher log base 2 fold changes over baseline, emphasizing 
the improvement in our ability to monitor changes in replisome components represented 
by iPOND2 (Fig. 2.8 and 2.9).  
Having clearly established iPOND2 as a method providing increased sensitivity 
and specificity for the detection of proteins at actively replicating forks, we sought to further 
expand iPOND2 for use in identification of PTMs at the replication fork. Due to the 
importance of ubiquitylation in regulation of DNA replication and repair we began our 
exploration of replisome PTM enrichment with an attempt to isolate ubiquitylated 
replisome components (Lecona et al., 2016; Qin et al., 2016; Ragland et al., 2013; 
Rickman et al., 2015; Wei, Zhai, Xu, & Wang, 2006). As described in Chapter 5, we 
successfully combined iPOND2 with the K-ε-GG IP developed by the Carr laboratory 
(Udeshi et al., 2013). This tandem affinity purification of ubiquitylated replisome 
components has already yielded a wealth of data for further exploration, including p97-
regulated sites and many novel ubiquitylation sites. The iPOND2-K-ε-GG protocol 
represents a novel capacity to analyze replisome ubiquitylation in a high-throughput 
manner that will improve the field of ubiquitin-dependent replisome regulation; however, 
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this protocol requires a large amount of substrate and still suffers from an inability to detect 
ubiquitylated peptides that contain the amino acid cysteine. It is likely that the amount of 
substrate needed can be decreased by refinement of peptide digestion buffers to ensure 
detection of ubiquitylated peptides including cysteine. We hypothesize that the reason for 
our inability to detect cysteine-containing peptides may be due to a 59 Da shift caused by 
cysteine alkylation by the choloracetamide contained in the digestion buffer and we are 
exploring this hypothesis bioinformatically. Although this protocol could benefit from further 
refinement it has already provided an interesting list of known and novel ubiquitylation 
sites at the replisome in response to replication stress (Table 5.12). Thus, the improved 
replisome enrichment by iPOND2 allows identification of ubiquitylation sites and the 
possibility for enrichment and identification of other PTMs. While this protocol has not been 
published yet, it is already generating significant interest in the field, underscoring its ability 
to assess replisome regulation with never before achieved clarity.  
Furthermore, the observation of non-EdU-associated activated replisome 
components in iPOND2 input fractions suggested that enrichment of replication features 
other than nascent DNA synthesis might allow high-throughput investigation important 
replication-related processes. For example, isolation of replication-associated complexes 
at terminated replication forks or at origins prior to firing would allow in depth investigation 
of these processes under a variety of conditions. Subsequently, we utilized a pS108-
MCM2 IP of EdU-depleted fractions to assess the proteins associated with this active 
replisome component. Our results provide very preliminary indications that we might be 
able to analyze terminated replication forks using combined iPOND2-protein IP protocols. 
Terminated replication forks have historically been very difficult to assess in mammalian 
systems, meaning that further development of iPOND2 in this direction would represent a 
notable advancement in techniques associated with terminated fork analysis. 
Furthermore, we demonstrated how IPs can be used to isolate complexes from iPOND2 
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supernatant, a protocol that can be developed to answer many questions. Overall, 
iPOND2 represents a notable improvement in our ability to assess replisome dynamics, 
and we have demonstrated the wide utility of iPOND2 for multiple different types of 
analysis including replication associated processes and regulation of components by 
ubiquitylation.   
The establishment of a consensus replisome 
There are a large number of papers discussing the roles of a huge variety of 
proteins in DNA replication, damage resistance, and repair at replication forks. All of this 
information is important for understanding the complexity of these processes, but it can 
be overwhelming, especially for someone new to the field. Previously there has been no 
centralized/ consistent list of proteins that are present at active DNA replication forks. Our 
bioinformatic compilation of multiple replisome data sets, including our own, provides the 
first high-throughput consensus replisome (Fig. 2.7 and Supplemental Table 2.5). 
Previous attempts to define the replisome have been based only on one data set, many 
that did not include substantiation by replicates; however, the analysis presented here 
exemplifies combined data from four laboratories, each utilizing unique significance 
thresholds. Furthermore, the data set that we contributed to this analysis was highly 
validated across 3 replicates, using only proteins that displayed a 2.9-fold or higher 
enrichment on nascent DNA and that were identified by more than one peptide. The 
consensus replisome presented was consistent between mice and humans, as well as 
across multiple human cell lines. We also provided a list of proteins that were not 
consistently regulated across data sets, representing targets that are more likely to be 
transiently or differentially regulated across cell lines. While our analysis is subject to the 
technical limitations of current MS protein identification, this consensus replisome list will 
provide an important reference tool for researchers examining replication fork association 
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of given proteins. We have distilled and presented a large amount of data in an attempt to 
help the field paint a clear picture of replisome regulation.  
The role of ATR in DSB prevention at stalled replication forks 
The role of the ATR cell cycle checkpoint in regulation of cell cycle progression 
and to avoid the accumulation of DNA damage has long been established, however, the 
mechanism of ATR’s direct role at the replication fork in preventing DSB formation is less 
clear. It is known that following recruitment of ATR to stalled replication forks, ATR is 
responsible for the phosphorylation of multiple replisome substrates, including the MCM 
(2-7) helicase, MCM10, RPA, and several DNA polymerases. The function of many of 
these phosphorylations are largely unknown, although they are believed to contribute to 
replication fork stability (Cimprich & Cortez, 2008). There are three main models for the 
mechanism of DSB prevention by ATR at the replication fork: ATR stabilizes replication 
fork components, ATR prevents RPA exhaustion, and ATR regulates remolding, such as 
replication fork reversal, and endonuclease complexes preventing them from forming 
DSBs (Couch et al., 2013; Dungrawala et al., 2015; Ragland et al., 2013; Toledo et al., 
2013).  
Due to the wide ranging coverage by iPOND2, we were able to provide some clarity 
for understanding ATR’s role in DSB prevention. The data presented herein support the 
model of ATR’s regulation of replication fork remodeling proteins such as SMARCAL1, 
which was present at an elevated level following ATR loss (Fig. 3.6). Data regarding ATR’s 
stabilization of replisome components was less clear, requiring further exploration. MCM 
helicase levels were significantly increased with ATRKO alone compared to EdU treated 
forks, however, this increase could be due to increased origin firing with ATR loss (Toledo 
et al., 2013). If more origins were firing than more forks were being EdU labeled, leading 
to a perceived increase in MCM levels. In order to negate this effect, we normalized 
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ATRKO treatments to ATRKO alone rather than EdU, removing any variation caused by 
increased origin firing. When normalized to ATRKO, APH treatment decreased MCM 
helicase retention at 2 hrs and increased retention at 4 hrs (Fig. 3.12A). Thus, our data 
suggests that if ATR stabilizes replisome components at the fork it is likely a transient 
function occurring only at short time points that can be bypassed following prolonged 
exposure to stress. Upon direct comparison by iPOND-SILAC of replisome components 
in HU + ATR inhibition compared to HU, there was no significant change in replisome 
components up to 8 hrs following treatment, although there was a slight accumulation of 
replisome components observed and maintained over time due to increased origin firing 
(Dungrawala et al., 2015). The apparent differences in replisome response observed at 
longer time points may be due to altered responses to HU or APH treatment. Both of these 
analyses should be repeated with additional controls in order to confirm these patterns. 
Dungrawala et al. did observe increases in DNA remodeling and repair enzymes including 
RPA, SMARCAL1, ATM, and the MRN complex when they compared HU with ATR 
inhibition to HU treatment alone, similar to what we observed (Fig. 3.15).  
Finally, our data seem to contradict the RPA-exhaustion model of ATR’s DSB 
prevention, as APH treatment alone was able to increase RPA levels above those 
observed with ATRKO (Fig. 3.10). We suggest that ATR stabilizes replisome components 
only acutely in response to APH stress and that lack of ATR regulation of fork remolding 
contributes to DSB formation in a more lasting manner. While the results here do not 
completely clarify the role of ATR in DSB formation at stalled replication forks, they do 
help to disprove one of the three mechanistic hypothesizes. Further exploration and 
replicated analysis are required, for clarification of these results and some seemingly 
contradictory evidence previously published. Previously published data sets provide no 
replication of these results (Dungrawala et al., 2015). While we did preform a replicate, it 
was using an ATR inhibitor (ATRN119) rather than ATRKO, so in order to verify these 
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patterns direct biological replication is necessary. Additionally, some of the inconsistencies 
observed may be due to differences in ATRKO and different ATR inhibitors, subsequently, 
a direct and well controlled comparison of ATRKO, ATRN119, and VE821 should be made 
in an attempt to clarify these differences. Preliminary analysis in our laboratory suggests 
that VE821, the ATR inhibitor used by the Cortez laboratory, inhibits other repair pathways 
such as ATM and DNA-PK mediated pathways, potentially leading to confusion in 
interpretation of their results (data not shown). Overall, our iPOND2 data provides the 
most thorough high-throughput analysis of ATR regulation of the replication fork following 
fork stalling. However, additional validation steps are required to support these findings. 
The data presented here helps to clarify the function of ATR in DSB formation. 
Evidence supporting recruitment of stalled replication forks to the nuclear pore 
for repair 
While cytoskeletal proteins such as lamins and filamins or nuclear pore proteins 
(NUPs) are often detected by MS, they are generally considered to be background 
contamination (Supplemental Table 2.5) (Alabert, Bukowski-Wills, et al., 2014; 
Dungrawala et al., 2015). iPOND2 detection of these components was originally 
considered to be background as well; however, we measured significant increases in 
many of these proteins following replication stress (Fig. 3.8). We also observed a 
significant increase in SUN2 levels at the replication fork following 2 hrs of APH treatment 
(Fig. 3.8A). SUN1 and SUN2 are nuclear envelope proteins that have recently been shown 
to be associated with DNA damage response in mammalian cells (Lei et al., 2012).  While 
studies in yeast suggesting the association of DSB repair proteins with the nuclear 
envelope have been around since the early 2000’s, it has only been within the last few 
years that two studies have emerged suggesting possible links between  NUPs, lamins, 
and DNA repair proteins in higher eukaryotes (A. M. Cobb et al., 2016; Katsani et al., 
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2014; Nagai et al., 2008). All of this taken together supports the hypothesis that lamins 
and filamins help to localize stalled forks to the nuclear envelope for repair following 
replication stress. Furthermore, mutations in lamin A have been shown to result in 
increased DNA damage and Hutchinson-Gilford progeria syndrome (HGPS) (Baohua Liu 
et al., 2005). The data gathered by iPOND2 supports a role for lamin based nuclear pore 
association of DNA damage.  
We observed a significantly increased level of NUP and lamin association with the 
replication fork under conditions of replication stress following p97 inhibition (Fig. 3.9B). 
While there is some prior evidence suggesting an association between lamins and DNA 
damage, to our knowledge, this is the first time that a role for p97 regulation of this 
interaction has been suggested. Further investigation will be required to determine the 
mechanism of this p97 regulation, although, an analysis of proteins changing by iPOND2 
may provide some initial insight. Additionally, we observed a significant down regulation 
of lamins and NUPs following loss of ATR, suggesting that the association of these 
proteins with actively replicating forks may be ATR-dependent (Fig. 3.8). This hypothesis 
is further supported by the failed rescue of many NUPs, lamins, and filamins following the 
addition of CB5083, a potent p97 inhibitor, to APH treatment in cells lacking ATR, 
suggesting that ATR may be required for recruitment of stalled replication forks to the 
nuclear pore following loss of p97 (Fig. 3.9B). While ATM and DNAPK activation have 
been monitored following lamin mutation in Xenopus extract, no direct connections has 
been established between ATR and damaged replication fork association with the nuclear 
pore in higher eukaryotes (A. M. Cobb et al., 2016). Notably, studies in yeast have 
demonstrated a role for Mec1/Tel1 (ATR/ATM) in relocation of DSBs to the nuclear pore 
2 hrs after DSB induction, however, it is unclear which of these proteins would be required 
for recruitment in higher eukaryotes (Nagai et al., 2008). Furthermore, this study showed 
that Slx5/Slx8, a SUMO targeted ubiquitin ligase (STUbL), was involved in the interaction 
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of the replisome and the nuclear pore following replication stress. Currently, it is still 
unclear which potential replisome targets are ubiquitylated and removed at the nuclear 
pore, although Pol32, Rad27, and Srs2 are some of the suspected targets (Nagai et al., 
2008). This role of Slx5 in resolution of damaged and resected forks is consistent with the 
role of RNF4 that was suggested in a recent paper published by our lab (Ragland et al., 
2013).  
These results represent one of the first times these trends have been reported in 
mammalian systems and should be further explored. For example, iPOND2 analysis of 
RNF4 knockdown would help to determine if the nuclear pore-association of stressed forks 
in yeast is mirrored in mammalian cells, consistent with observed correlations (Nagai et 
al., 2008; Ragland et al., 2013). The strong evidence supporting replication fork 
localization to the nuclear pore for repair would alter many scientists views of nuclear 
envelop proteins and change the way many approach the examination of DNA damage 
repair. Not only does our data provide strong evidence supporting this hypothesis, but it 
also suggests two potential mechanisms of regulation, one of which is completely novel. 
The localization of replication forks to the nuclear pore, especially following 
replication stress, could have multiple functions. Current data suggests that DSBs are 
localized to the nuclear envelope in order to avoid accidental HR with homologous regions 
in heterochromatin (Nagai et al., 2008). With growing evidence supporting the idea of 
transcription factories, it is not outside the realm of possibility that there are nuclear pore 
adjacent repair factories that cater to replication defects more broadly then simply DSBs. 
This broad functionality may account of the high levels of nuclear pore- and lamin-
associated proteins that are observed on unperturbed replication forks. The idea of p97 
and ATR regulated replication factories is fairly new and previous microscopy data 
showing replication protein foci not at the pore would seem to contradict this model. 
Directed examination of replication fork association with the nuclear pore under a variety 
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of conditions through a method such as FRET would help to clarify the potential for 
replisome localization following fork stalling.   
Future Directions 
In the future we hope for iPOND2 to be used extensively for analysis of replisome 
components under a wide variety of conditions by western and MS. iPOND2 has 
generated a lot of interest in the field following presentation at conferences and we hope 
to collaborate with many labs to get them started using iPOND2, following publication. 
Herein iPOND2 has been combined with multiple purification protocols in order to improve 
enrichment of specific aspects of replication associated proteins including ubiquitylation. 
Despite the impressive level of success displayed by these tandem affinity purification 
techniques, they need to be further optimized before they can be widely used. For 
example, there are multiple replisome ubiquitylation sites that were not detected by 
iPOND2-K-ε-GG despite the long list of identified ubiquitylation sites. iPOND2-K-ε-GG 
should be repeated to verify reproducibility and the pull-down affinity should be further 
improved. It may be possible to further improve iPOND2-K-ε-GG pull-down through 
modification of trypsin lysis buffer to increase our ability to resolve cysteine containing 
peptides more effectively through removal or decreased concentration of 
chloroacetamide. Optimizing pull-down affinity will decrease the amount of input material 
necessary and increase the number of targets identified. The utility of iPOND2 should be 
further explored as a means for enrichment of further PTMs including phosphorylation and 
acetylation.  
Furthermore, a more thorough assessment of the ability of the iPOND2 protocol to 
isolate terminated replication forks should be pursued. A protocol capable of consistently 
isolating terminated forks in mammalian cells would improve the field and our 
understanding of how replication termination occurs in mammalian cells.  
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Additionally, while the pS108-MCM2 IP of the iPOND2 supernatant was 
moderately successful, western analysis of the purified material was difficult due to the 
high level of background antibody interacting with secondary antibodies. The ability to 
perform an IP of iPOND2 supernatants with clearly interpretable results would help to 
monitor what happens to replication fork components after leaving the replication fork in 
addition to potentially providing an assay for monitoring terminated replication forks. 
Finally, in regards to protocol development, we believe that development of an IP of EdU-
bound replisome components following iPOND2 would provide an important tool for more 
in-depth investigation of replisome component dynamics and associations with one 
another at and behind the fork. While this is difficult due to the denaturing conditions 
necessary for elution from streptavidin beads, some potential avenues for exploration 
include use of a cleavable biotin tag or IP prior to streptavidin bead binding. The success 
of an IP of fractionated material from iPOND2 suggests that the latter protocol may be 
more achievable than previously expected.  
Additional future directions based on this work include validation and following up 
upon many of the targets that were identified here. Above we have discussed multiple 
interesting and unique trends in proteins and ubiquitylation following a variety of replication 
stressors. Due to the immense size of the data sets gathered here we were unable to 
discuss most of the trends observed. These data sets should be extensively mined and 
explored as they likely contain important information about the patterns of replication fork 
regulation. Here we highlight a few of the most interesting patterns that were observed in 
our data sets that should be further validated.  
There has been a longstanding debate regarding the mechanism by which ATR prevents 
DSB formation at stalled replication forks. Here we present data contradicting the RPA 
exhaustion model and supporting the model that argues that ATR is responsible for 
regulation of remolding complexes. Our data remains unclear regarding ATR’s ability to 
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stabilize the fork, however, suggesting that it may be time dependent. In order to further 
validate these findings it is important that the iPOND2-ATRKO and ATRN119 data sets 
be repeated and analyzed by MS and western. Furthermore, a more in-depth analysis of 
how SLX4, the endonuclease scaffold thought to be directly responsible for DSB cleavage 
following remodeling, results in DSB formation in the absence of ATR should be assessed 
using iPOND2 (Dungrawala et al., 2015; Ragland et al., 2013). Additionally, we believe 
that the field or DNA replication and repair would greatly benefit from a target investigation 
of the interactions between replication and repair components, cytoskeletal proteins, 
and/or nuclear pore components discussed above. How ATR and p97 contribute to this 
regulation should also be analyzed at length. Similarly, analysis of changing replication 
proteins in response to RNF4 loss in stressed cells with or without ATR may help elucidate 
the roles of ubiquitin and SUMO modification in the recruitment of damaged forks to the 
nuclear pores.  
Herein we have presented the development and validation of multiple interrelated 
protocols that will enable an expansion in our understanding of replisome regulation. 
iPOND2 represents a notable improvement over previous protocols as demonstrated by 
the multiple successful refinements and additions that have been successfully applied to 
it. It is likely that iPOND2 will continue to be expanded upon to help advance our 
understanding of DNA replication, repair, and associated processes. This thesis is 
intended to provide a broad overview of the progress made so far to aid others in 
expansion of this highly versatile protocol as well as a resource for the investigation into 
patterns of replisome regulation. 
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